[
  {
    "miRNA_name": "Family (miR-200a,200b,200c,miR-141)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "Barrett,gastric,duodenal epithlia &EAC",
    "expression": "Downregulated",
    "expression_details": "Downregulated (all miR-200 in EAC compared with BE,miR-141 & miR-200c in BE compared with GC & duodenal epithlium,miR-200a & 200b in BE compared with gastric epithelium)",
    "significance": "p=0.0008(miR-141:duodenal vs BE),p<0.0001(miR-200c: duodenal vs BE),p=0.0004(miR-141:gastric vs BE),miR-200a,200b,200c:p=0.0078,0.0001&<0.0001 respectively in gastric vs BE",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21448356"
  },
  {
    "miRNA_name": "Family (miR-200a,200b,200c,miR-141,miR-429)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: predictor of aggressiveness of GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low expression of all 5 family members associated with histological grade & presence of intravascualr embolus(both p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26137064"
  },
  {
    "miRNA_name": "Family (miR-200b,miR-200a,miR-429)",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(miR-200b),p=0.001(miR-200a),p=0.037(miR-429)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with lymph node metastasis(p=0.002),advanced clinical stage(p=0.020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "Family (miR-34a,miR-34b,miR-34c)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-34a and miR-34c)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24970812"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "172 patients were treated with cetuximab plus irinotecan as salvage therapy for metastatic colorectal cancer. 59 patients harboring KRAS mutations, FFPE Samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Let-7a levels were significantly associated with better survival outcomes",
    "therapy": "Chemotherapy",
    "therapy_details": "May rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22584434"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0120, 73.61% sensitivity and 66.38% specificity",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer: upregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "let-7a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 pairs of GC & adjacent normal gastric tissues,SGC7901,BGC823,AGS,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression in tissues with poorly and moderately differentiated type, lymph node metastasis N1-N3 and stage III-IV.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26745603"
  },
  {
    "miRNA_name": "let-7a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Serum Tissue",
    "sample": "192 CRC patients,  serum and tumour tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.024",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predict prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Negatively correlated with the tumour size, stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27262492"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Candidate molecular markers of cetuximab resistance",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "let-7c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "115 FFPE biopsy samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori related GC)",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26701848"
  },
  {
    "miRNA_name": "let-7c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "let-7d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "let-7d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (postoperative serum)",
    "significance": "p<0.01(55 paired pre-postoperative),p<0.05(in 15 paired pre-postoperative serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "let-7d*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.46, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Candidate molecular markers of cetuximab resistance",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "let-7e",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "let-7f",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (postoperative serum)",
    "significance": "p<0.01(in 55 paired pre-postoperative),p<0.05( in 15 paired pre-postoperative serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "let-7g",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "128 pretherapeutic biopsies of rectal cancer patients treated with 5FU",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of let-7g was associated with better DFS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932154"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "31 samples of tumor and paired normal mucosa obtained from 31 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change >15 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, Fifty-six tissue specimens, including 28 tumor tissues and 28 paired adjacent normal mucosal tissues, were selected from 28 cases of CRC. There were 15 cases of stage II disease and 13 cases of stage III disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Stage II: Fold Change=-17544, p<0.001; Stage III Fold Change =-15.152, p<0.001; AUC 0.806, sensitivity 78.57%, specificity 78.57%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045793"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "64 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with tumor  invasion(p=0.22) & advanced clinical stage(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25672418"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression correlated with lymph node(p=0.002),histological classification(p=0.000),vessel invasion(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26414725"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "34 pairs of ESCC & adjacent non tumor tissues,Het-1A,Kyse150,QBC939,AGS,HepG2",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues and KYSE-150 vs Het-1A)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247259"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "AGS,SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25874496"
  },
  {
    "miRNA_name": "miR-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "90 paired tissues,GES1,MKN28,SGC7901,NCI-N87,BGC-823,AGS,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-worse OS for low expression(p=0.0027)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression associated with higher potential to develop vascular invasion(p=0.033),lymph node involvement(p=0.040),distant metastasis(p==0.020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28493075"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 CRC specimens, CRC and normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "MiRNA sequencing followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Upregulated-regulation sensitized CCL-244 cells to X-ray irradiation",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973296"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "6 patients with submucosal invasive CRC with lymph node metastasis and 10 patients with submucosal invasive CRC without lymph node metastasis, CRC tissues with lymph node metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis in submucosal CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28032929"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "101 surgical tissues,3ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "34 pairs tiisues,ECa109,KYSE150,TE1,HEPG2,HT-29,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25109390"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "120 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic  for LPFs,DPFS &OS(multivariate analysis)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression correlated with great depth of invasion(p=0.02),advanced clinical stage & distant metastasis( both p=0.008)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25218280"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Human epithelium derived GC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Silencing of miR-100 expression sensitizes gc cells to chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25703026"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC samples and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated (C/EBPα  could induce the expression of miR-100 by binding to the putative promoter region of miR-100)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26404754"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 GC & 18 non tumor tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues), p=0.0077(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23611267"
  },
  {
    "miRNA_name": "miR-100",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 pairs of human CRC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Correlated with larger tumor size, higher incidence of lymph node metastasis, and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25216869"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-100-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.0",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "316 patients, 193 prospectively recruited patients with colorectal cancer,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Tissue microarrays containing 56 specimens of normal mucosa, 51 adenoma and 735 colorectal cancer and  5 specimens of normal mucosa, 5 adenoma and 47 colorectal cancer for Real time PCR), CRC cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated in stage I and Downregulated from stage II to stage III",
    "significance": "Increased gradually from normal mucosa, adenoma to stage I  (p<0.01), and decreased gradually from stage II to stage IIII (p<0.01)",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic factor of overall survival (HR=0.550, 95% CI: 0.351-0.863) and disease free survival(HR=0.562, 95% CI: 0.397-0.794)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Overexpression of miR-101 corelated with lower incidence of lymph node metastasis, lower metastasis rate, higher differentiation and lower recurrence rate (all P<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940181"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression  significantly correlated with tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 pairs of tissues,Het-1A,KYSE30,KYSE70,KYSE150,KYSE450,KYSE410,KYSE510,TE1,TE9,TE11,EC9706,EC109",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.05(EC cell lines compared to Het-1A)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26556718"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs of H.Pylori positive & -ve tissues,7901,GES-1,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in tumor compared to normal & down in H.pylori positive compared to -ve  tumor & normal tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561270"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Portugal",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to deletions and/or microdeletions at miR-101 genomic loci)",
    "significance": "p<0.0089",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450781"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 patients tumor & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lower miR-101 was associated with increased tumor invasion and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013439"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 paired GC & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23644120"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.029",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Cell lines- GES1,SNU5,HGC27,BGC823,SGC7901,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26573417"
  },
  {
    "miRNA_name": "miR-101",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues and drug resistance cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28609840"
  },
  {
    "miRNA_name": "miR-101-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue Cell-line",
    "sample": "25 paired tissues,AGS,MKN-28,MKN-45,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "70 patients and CRC cell lines: Caco-2, SW480, HT-29, HCT-116, LOVO and HCEpic cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24393525"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Decreased after surgery. p=0.0004, and p=0.0274, respectively",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-103 was significantly associated with histological differentiation, lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 CRC tissues and the paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "For survival p=0.007",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Significantly associated with a more aggressive phenotype of CRC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27602163"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-103/107 sensitized SGC7901/ADR cells to dexorubicin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "expression": "No Significant Difference",
    "expression_details": "No alteration",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.548,plasma miR-103 level is not a biomarker for DGC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "92 primary Gc,20 adjacent non tumorous tissues,SGc7901,MKN45,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic-high expression had poor OS & DFS for Gc patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Expression correlated with tumor size,Lauren's classification,lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28445396"
  },
  {
    "miRNA_name": "miR-103",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR, TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-103a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line Tissue",
    "sample": "Cell lines,clinical specimen",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25530421"
  },
  {
    "miRNA_name": "miR-103a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in high risk group",
    "significance": "p=0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-105",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-105",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "36 paired surgically resected GC tissues & matched adjacent normal",
    "expression": "Downregulated",
    "expression_details": "Hypermethylation of promoter region,DNMT3A mediate downregulation)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829505"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "22 normal epithelia,24BE,22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,MKN45,MKN28,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(MKN45),p=0.003(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803041"
  },
  {
    "miRNA_name": "miR-106",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Colombia",
    "sample_type": "N/A",
    "sample": "N/A",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28489839"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "N/A",
    "sample": "110 colon cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Downregulation of miR-106a predicted shortened DFS (P = 0.03) and OS (P = 0.04)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18521848"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "Blood samples from 100 CRC patients and 79 cancer-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261602"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples from 8 healthy volunteers and 29 samples collected via fecal occult blood testing from subjects with normal colonoscopies, colon adenomas, and CRCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20551304"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in non-responders",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 50 colorectal cancer patients and 47 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012, sensitivity of 62.3%, and a specificity of 68.2%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Significantly decreased after the operation",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670448"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 sporadic early-onset Turkish CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.031",
    "detection_method": "miRNA PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24746948"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "81 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis,nerve invasio & pathological stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314216"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "28 pairs of GC  and adjacent tissues, 48 pairs of plasma samples before and after operation from GC patients, and 22 plasma samples from healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues & plasma,Upregulated due to promoter hypomethylation)&Downregulated (in plasma after gastrectomy)",
    "significance": "p<0.05(tissue and plasma)",
    "detection_method": "qRT-PCR,MSP",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic and Prognostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High miR-106a expression was closely related to the degree of lymphatic metastasis and TNM staging of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26179261"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "55 GC & 17 non-tumor FFPE tissues,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissues(p=0.026),SGC7901(p<0.01),MGC-803(p<0.05)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "miR-106a level  associated with tumor stage,size(p<0.001),differentiation(p<0.001),lymphatic and distal metastasis(p<0.001)invasion(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18996365"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22431000"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/ADR,SGC7901/VCR",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/ADR/VCR",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-106a suppressed sensitivity of Gc cells to anticancer drug(ADR,CDDP,5-FU)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23932924"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-106a in SGC7901 confers resistance to DDP",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24108762"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES1, SGC7901,BGC823,MKN28",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.000(tissues,SGC7901,BGC823)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-106a positively correlates with metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24440352"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 GC & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-flourescent PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC curve was 0.895 (95% CI: 0.846~0.943), specificity-93.8% and sensitivity-77.5%",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Level was also correlated with cancer differentiation stage, lymph node metastasis, TNM stage and tumor size (P<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722506"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.8, p<0.0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-106a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Stool",
    "sample": "Fecal samples from 117 colorectal cancer patients and 107 healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive marker to identify colorectal cancer patients from among those with negative iFOBT results",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23950216"
  },
  {
    "miRNA_name": "miR-106a*",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26314198"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=21.1",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180 colonic cancer cases",
    "expression": "Downregulated",
    "expression_details": "Upregulated in paracancerous tissues compared to colonic cancer tissues",
    "significance": "p<0.001",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755775"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Cell line HT29, SW480, SW620 and LOVO",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Induced resistance to IR in vitro and in vivo in SW620 cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238857"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical specimens of cancer tissue and adjacent normal mucosa from 95 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall and disease free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26223867"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 kazakh's ESCC & paired adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulation of miR-106b was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619676"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.Pylori positive & negative GC tissues,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (LPS from H.Pylori 26695 downregulates miR-106b expression)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25307786"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "Downregulated (order of decreasing level of miR-106b in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.856 with 75.0% sensitivity and 92.5% specificity for discriminating GC patients from controls, AUC of 0.700 with 87.2% sensitivity and 45.0% specificity for discriminating GC from BGD patients and  AUC of 0.739 with 75.0% sensitivity and 68.7% specificity for discriminating BGD patients from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression of miR-106b  was associated with patients age(p<0.05)  but  not  with tumor differentiation ,TNM stage or lymph node metastasis(p>0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-106b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC fibroblasts,normal fibroblasts",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc fibroblast compared to norma fibroblast)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-106b stromal expression in in GC is associated with decreased overall survival(p=0.03)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24842611"
  },
  {
    "miRNA_name": "miR-106b*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-106b-25 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues from 13 cases of colorectal cancer and 4 normal colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-25 expression group had more advanced venous invasion compared with the low expression group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22452939"
  },
  {
    "miRNA_name": "miR-106b-25 cluster",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue",
    "sample": "40 operative & 20 preoperative plasma,40 GC & adjecent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Tumor-size",
    "tumor_size_details": "Expression of miR-106b-25 cluster in GC tissues  & plasma  correlated with tumor size,borrmann type,TNM stage(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25218271"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Predicts chemotherapy response",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "Tissue Serum",
    "sample": "Tissues, serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.004( tissues),p=0.007(serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23627613"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901/ADR,SGC7901 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-103/107 sensitized SGC7901/ADR cells to dexorubicin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25407491"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "GAC & healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25824045"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "36 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.04 in both plasma and tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406411"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "65 paired GC & adjacent normal non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "miR-107 expressionwas associated significantly with tumor size (p=0.0032) and differentiation (p=0.028))",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24374340"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 paired tissues,TCGA data",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.001(TCGA)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Associated with tumor sizes(p=0.015)and depth of invasion(p=0.010).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27827403"
  },
  {
    "miRNA_name": "miR-107",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "expression": "No Significant Difference",
    "expression_details": "No alteration",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.563, plasma miR-107 level is not a biomarker for DGC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "26 pairs of FFPE specimens (primary CRC tissues and lymph node metastasis tissues) and cell line (SW480)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Inversely correlated with distant metastasis and invasion depth",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28383561"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "33 patients for GC & correspondinf normal gastric gastric mucosa tissues,GES1,MKN28,SGC7901,AGS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues),15 fold in MKN28,11.7 fold in SGC7901,10.1 fold AGS",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-10a expression was associated with lymph node metastasis(p=0.047)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969895"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "100 pateints GC  &  adjacent non neoplastic tisssues,HGC27,MGC803,SGC7901,MKN45,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to hypermethylation of CpG island Upregulatedstream of miR-10a",
    "significance": "N/A",
    "detection_method": "qRT-PCR,qMSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24498243"
  },
  {
    "miRNA_name": "miR-10a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-10a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with mucinous tumors and progressively increased from stage I to IV disease",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "78 samples (23 normal colon mucosa, N; 31 primary colon carcinoma, T; and 24 liver metastases, M), obtained from 46 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.00052",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with high levels of miR-10b expression in their metastatic disease have a shorter time to event",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "246 pairs of samples, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "rea time PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival (P < 0.0001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with advanced stage (P < 0.0001), lymph node metastasis (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27592860"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer samples and non-tumorous adjacent mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0025",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Associated with tumor size, distant metastasis, non-differentiated tumors and vascular invasion.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28345456"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20075075"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC= 0.72(95% CI:0.62-0.83,sensitivity=70%,specificity=84%",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "15 GC patients ,GES-1,AGS,N87,SGC7901,BGC-823,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in metastasis positive gc)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22293682"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 gastric tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "reverse transcriptase-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : in stage I,II,III 5 year survival rate with high miR-10b exp. Was significantly lower than with low miR-10b exp.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-10b high expression correlates with size of tumor,Lauren clasiification,depth of invasion,lymph node and distant metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23351547"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "100 pairs of GC & matched adjacent normal tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to methylation of miR-10b Upregulatedstream)",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR,MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481854"
  },
  {
    "miRNA_name": "miR-10b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "88 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-10b associated with poor prognosis",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-10b confers chemoresistance in colorectal cancer cells to 5-FU",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression of miR-10b associated with high incidence of lymphatic invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322955"
  },
  {
    "miRNA_name": "miR-10b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "196 samples in TNM stage I-III, 88 selected for deep sequencing",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Localization",
    "tumor_size_details": "Associated with tumors located in the right colon relative to the left colon and rectum",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-1-133a cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "64 paired tissue samples (CRC tumor and adjacent normal mucosa)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22766685"
  },
  {
    "miRNA_name": "miR-1179",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-1179",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25755718"
  },
  {
    "miRNA_name": "miR-1184",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.46, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1201",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "49 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with lymph node metastasis and poor tumor differentiation(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25695396"
  },
  {
    "miRNA_name": "miR-1207-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "58 paired GC & adjacent corresponding tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0015",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: expression inn GC not  correlates with survival time of patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE tissues of 132 primary CRCs and 22 colorectal liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1470.1004",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23373973"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "Plasma samples of 543 CRC patients with stage I-IV disease",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Custom TaqMan® Array MicroRNA Cards followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poor prognosis and shorter relapse-free survival and overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27632639"
  },
  {
    "miRNA_name": "miR-122",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "GC,DM,NDM plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in Gc/DM)",
    "significance": "p<0.01( GC/DM  vs GC/NDM & HC group plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC for plasma miR-122=0.808(95%CI,0.712-0.905,p<0.01),Prognostic:  higher plasma miR-122 in GC is a favourable Prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-122*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-1224-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "99 mCRC patients, out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-1225-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 paired GC & adjacent non tumor tissues,BGC-823,MKN-28,MKN-45,AGS,MGC-803,SGC-7901,NGEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival(p=0.003)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with more aggressive tumor phenotypes including local invasion, lymph node metastasis, advanced clinical stage and distant metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26684358"
  },
  {
    "miRNA_name": "miR-1228*",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs of GC & adjacent non tumor tissues,GES1,BGC823,AGS,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23554909"
  },
  {
    "miRNA_name": "miR-1229",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-122a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 primary colorectal carcinoma tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "n = 20, p<0.05",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19607815"
  },
  {
    "miRNA_name": "miR-1231",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, CRC patients [male (n = 47), female (n = 21); median age: 57 years; colon cancer (n = 37) and rectal cancer (n = 31)] who underwent surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Significantly associated with CRC metastasis, tumor T and N stages, and tumor grade (all P < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25987767"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "67tissues,Het-1A,ECA-109,EC9706,TE1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,ECA109,TE1)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928665"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 pair of EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Elevated expression confers radiosensitivity in EC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323123"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "32 paired GC & adjacent non-tumor tissues,GES1,SGC7901,MKN28,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues,SGC7901),p<0.05(BGC823,MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25169484"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Could discriminate non-LNM from LNM with 80.0% sensitivity and 80.0% specificity and discriminate tumor Ι-II stages from tumor III-IV stages with 71.9% sensitivity and 75.0% specificity at the best cut-off value of 0.0125",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis & tumor stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "80 gastric carcinoma tissues, 18 nontumourous gastric tissues ,MKN28,BGC823,MKN45,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :expression not correlated with patients prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "miR-124 expressionwas inversely correlated with tumor size(t-test: p=0.0265 and spearmans:p=0.0083) and lymph node metastasis(t-test:p=0.0164)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24614175"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24658854"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Low expression  associated with tumor size (p=0.001), lymphatic metastasis (p=0.008) and TNM stage (p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28829503"
  },
  {
    "miRNA_name": "miR-124",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 colorectal cancers and individual-matched normal mucosa samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker: correlated with worse prognosis, both in terms of overall survival and disease-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Correlated significantly with the grade of differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22885837"
  },
  {
    "miRNA_name": "miR-124-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Plasma",
    "sample": "71 colorectal cancer patients, Plasma and FFPE samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25081869"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "22  tissues",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference in tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-1246",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum Cell-line",
    "sample": "101 ESCC serum,46 healthy serum, exosomes & donor cells of exosomes (TE1,TE2,TE4,TE6,TR11,WI38,MRC5)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC serum, exosomes)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Serum miR-1246 -diagnostic (AUC-0.754) & prognostic biomarker ,serum expression level,tumor depth,lymph node metastasis(all p<0.0001),distal metastasis(p=0.0005) are correlated with patients survival.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Serum low expression in T1/T2 than T3/T4(p=0.0024),low in without lymph node metastasis than with metastasis(p=0.0002),without distant metastasis than with metastasis(p=0.0020)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23361059"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Forty UC patients without CAC, four patients with CAC or dysplasia, eight sporadic colorectal cancer (S-CRC) patients, and 12 healthy volunteers (HV)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "methylation-specific polymerase chain reaction (MSP)",
    "marker": "Prognostic",
    "marker_details": "Potential risk marker of colitis-associated cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24825593"
  },
  {
    "miRNA_name": "miR-124a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "81 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated, Methylated in 99% tissues",
    "significance": "N/A",
    "detection_method": "methylation-specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22870149"
  },
  {
    "miRNA_name": "miR-125",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 primary CRC specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Decreased by Fold Change=3.3, p =0.005",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-1254",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Increased in bevacizumab-induced cardiotoxicity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-1258",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "116 pairs of GC & adjacent normal tissues,SGC7901,MGC803, BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(SGC7901,MGC-803,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "There was association between decreased miR-1258 expression level and increased age(p=0.042),advanced pathological tumor stage (p=0.027),positive lymphatic vessel invasion(p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28521475"
  },
  {
    "miRNA_name": "miR-1259",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=20.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  CRC tissues and adjacent normal tissues from 68 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Hypermethylated promoter-shorter overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Worse survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398444"
  },
  {
    "miRNA_name": "miR-125a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "70 paired GC & normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low expreesion related with poor prognosis(p=0.0083)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-125a-3p expression  associated with tumor size(p=0.0002),tumor invasion(p=0.0149),lymph node metastasis(p=0.018),liver metastasis(p=0.016),peritoneal dissemination(p=0.03),advanced clinical stage(p=0.0037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22322911"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "90 biopsy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23618359"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "51 GC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Association between expression level and distant metastasis was observed (P<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25231560"
  },
  {
    "miRNA_name": "miR-125a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  CRC tissues and adjacent normal tissues from 68 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Hypermethylated promoter-shorter overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "89 colorectal cancer patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-125b expression group had a significantly poorer prognosis compared to the low expression group",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "High miR-125b expression groupregulated showed a greater incidence of advanced tumor size and tumor invasion compared to the low miR-125b expression groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21399871"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 sporadic early-onset Turkish CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24746948"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Sera, 237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.806",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26693202"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Six patients with submucosal invasive CRC with lymph node metastasis and 10 patients with submucosal invasive CRC without lymph node metastasis, CRC tissues with lymph node metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis in submucosal CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28032929"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "90 biopsy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23618359"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 samples of GC & corresponding para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23128435"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 paired tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter OS & DFS ( both p<0.001) than with high expression",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Inverse correlation with invasion depth(p=0.031),clinical stage(p=0.002),Lymph node metastasis(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26504803"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expression associated with TNM stage & lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27220320"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "132 GC & 38 non cancerous gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor for GC : miR-125b expression (P=0.001), lymph node metastasis (P=0.004), distant metastasis (P=0.001) and TNM stage (P=0.005)",
    "therapy": "Chemotherapy",
    "therapy_details": "Increased miR-125b level associated with trastuzumab resistance in HER2-positive gastric cancer (P<0.05).",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with T stage (P<0.001), lymph node metastasis (P=0.001) and clinical TNM stage (P=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672982"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated (after therapy)",
    "significance": "Fold Change=2.5, p=0.05",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Higher levels of miR-125b were associated with worse response to the therapy.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-125b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.37, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-125b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study, in which peptide vaccines combined with chemotherapy were given",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.040",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-125b-2",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue Cell-line",
    "sample": "25 paired tissue samples,AGS,MKN-28,MKN-45,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0459",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-125b-2*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-125b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=0.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "FFPEtissue from the primary tumours of 560 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression associated with poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25199818"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "89 patients with mCRC, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "p<0.0001, PPV=90%, and NPV=71%",
    "detection_method": "In situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with progression free survival PFS",
    "therapy": "Chemotherapy",
    "therapy_details": "Marker for  response to first line XELOX in patients with mCRC",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22397399"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden and Denmark",
    "sample_type": "Tissue Blood",
    "sample": "Phase III Nordic ACT (I) multicentre study included 249 patients from Sweden and Denmark, Tissues from 230 patients and blood from 222 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.005",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with longer progression-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23922111"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001, 77.78% sensitivity and 68.97% specificity",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer:  downregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Plasma",
    "sample": "Blood samples (plasma)  68 metastatic colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non responders",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "Chemotherapy",
    "therapy_details": "Related to the response to chemotherapy and bevacizumab",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25584492"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 matched tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21269950"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with tumor differentiation(p=0.017),lymph node metastasis(p=0.019),tumor depth(p=0.009),TNM stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25017784"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26191164"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 pairs of primary GC & corresponding adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-126 significantly associated with lymph node metastasis(p<0.001),poor histological grade(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25027343"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC  & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428912"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 GC & corresponding normal tissues , AGS,HGC-27,BGC-823,SGC-7901,MKN-7,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26464628"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC-7901,NCI-N87,MKN-45,MKN-28,BGC-823,Snu-16,AGS,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-126 expression was associated with large tumor size(p=0.017),local invasion(p=0.006),lymph node metastasis(p=0.013),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20619534"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue samples were obtained from surgical specimens from 66 patients (36 men, 30 women)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20680522"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 pairs of CRC and adjacent nontumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facto for overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with distant metastasis, clinical TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24532280"
  },
  {
    "miRNA_name": "miR-126",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<10(-6)",
    "detection_method": "in situ hybridization (ISH)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with regional lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25592646"
  },
  {
    "miRNA_name": "miR-126*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-1260b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "120 cases of CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis and venous invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27399918"
  },
  {
    "miRNA_name": "miR-1266",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "58 paired GC & adjacent corresponding tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0288",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: higher miR-1266 exp. In GC tissues correlates with a longer survival time",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481448"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-1269",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "100 stage II CRC patients, early- and late-stage CRC tumors",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic value of miR-1269a for disease-free survival was significant (p=0.015)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Associated with relapse and metastasis of disease-free patients (logrank p=0.002).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25872451"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "33 tumor & adjacent normal tissues,TE-1,Eca 107",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27645894"
  },
  {
    "miRNA_name": "miR-127",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "86 pairs of GC & adjacent norma tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic modification)",
    "significance": "p<0.05  (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Lower miR-127 level was associated with pM or pTNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-1271",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 paired tissues,HGC27,SGC7901,MGC803,AGS,GES1",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Expression inversely correlated with tumor size (P = 0.017), tumor stage (P = 0.035), lymph node metastasis (P = 0.018), and TNM stage (P = 0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26159618"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HEEC,EC109,EC9706,TE1,EC1,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-127-3p increases chemosensitivity of EC patients to phenanthroline-dione derivative",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27590853"
  },
  {
    "miRNA_name": "miR-127-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.03",
    "detection_method": "Microarrray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,HGC27,MGC803,AGS,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25753202"
  },
  {
    "miRNA_name": "miR-1274a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-127-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-128",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-1280",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues, human colorectal cancer tissues consisted of surgically resected primary colorectal cancer specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28446464"
  },
  {
    "miRNA_name": "miR-1284",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC & adjacent normal tissues ,SGC7901,SGC7901/VCR cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26936591"
  },
  {
    "miRNA_name": "miR-1287",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissue samples and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p>0.05 (not significant)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Low sensitivity and specificity",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27251300"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "Tissues from 122 patients with surgical resection of colorectum (82 adenocarcinomas, 20 adenomas, and 20 non-neoplastic tissues)",
    "expression": "Downregulated",
    "expression_details": "Downregulated, reduced in 76% (n = 62/82) cancer tissues",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Higher expression in distal colorectal adenocarcinomas and in cancers of lower T staging",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24009195"
  },
  {
    "miRNA_name": "miR-1288",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue Cell-line",
    "sample": "90 primary ESCC & 30 non neoplastic tissues,KYSE-520,KYSE70,HACAT",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27658568"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26478435"
  },
  {
    "miRNA_name": "miR-128b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "18 tissues,GES1,SGC7901,BGC823,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,BGC823,HGC27),p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26949090"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Methylation specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Gastric Juice",
    "sample": "141 gastric juices samples from gastric cancer, gastric ulcer, atrophic gastritis, and minimal gastritis patients or subjects with normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc disease compared with benign gastric diseases",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.639(miR-129-1-3p),0.651(miR-129-2-3p)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23307240"
  },
  {
    "miRNA_name": "miR-129",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in cisplatin resistant tissues & cells)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression decreases cisplatin resistance in cisplatin resistant GC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28012924"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Out of 31 patients 13 of stage III tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change =17.7 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with stage III",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "179 primary CRC tissues, serum samples of 211 CRCs, 56 adenomas and 57 control subjects.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.718 (Adenoma v/s normal), AUC=0.830 (CRC patient v/s normal)",
    "detection_method": "miRNA array",
    "marker": "Prognostic",
    "marker_details": "Predictor for prognosis (hazard ratio (HR) = 4.51; P=0.0096) and tumor recurrence",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27502702"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "24 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Upregulation correalated with tumor differentiation,TNM(both p=0.021) & N classification(p=0.006)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25805931"
  },
  {
    "miRNA_name": "miR-1290",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC-7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "FISH,qRT-PCR,western blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with clinical stages, depth of invasion and lymph node metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26851540"
  },
  {
    "miRNA_name": "miR-1291",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "54 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with lymph node metastasis and TNM stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324125"
  },
  {
    "miRNA_name": "miR-129-1-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25008064"
  },
  {
    "miRNA_name": "miR-1292",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-129-2",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "42 pared surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with advanced clinical TNM stage(p<0.001),distal metastasis(p<0.001),lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23677061"
  },
  {
    "miRNA_name": "miR-1294",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "79 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had poorer prognosis(p=0.040)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Low expression correlated with tumor size(p=0.018),nos. of lymphatic invasion(p=0.0448),venous invasion(p=0.0211)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925090"
  },
  {
    "miRNA_name": "miR-1295b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "FFPE tissue samples of 53 CRC and 35 normal subjects",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28193082"
  },
  {
    "miRNA_name": "miR-1295b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Stool",
    "sample": "Stool samples from 40 patients with early stage (I, II) CRC and 16 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by miScript PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25519020"
  },
  {
    "miRNA_name": "miR-129-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 paired tissues,AGS,SGC7901,BGC823,MKN45,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28653880"
  },
  {
    "miRNA_name": "miR-1296-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 GC and 30 adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc and lymph node metastatic tissues)",
    "significance": "p<0.01(gc vs adjacent normal & lymph node metastatic vs non metastatic tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28099468"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-1297",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "156  pair of ESCC & healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : serum miR-1297 was an ideal diagnostic marker of ESCC,AUC on serum miR-1297 was 0.840+-0.035 in discovery grp and 0.837+-0.034 in validation grp",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27152453"
  },
  {
    "miRNA_name": "miR-129b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum,  55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Inversely corelated with advanced TNM stages",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-1303",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Overexpression of miR-1303 and downregulation of clauding was significantly associated with tumor size,location invasion,histologic type and lymph node metastasis stage in GC tissues",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24647998"
  },
  {
    "miRNA_name": "miR-1308",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "esophageal achalasis",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Biopsy of middle esophageal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28810541"
  },
  {
    "miRNA_name": "miR-130a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "SGC7901,HGC27,AGS,MKN45,N87,GES-1,41 GC & adjacent normal tissues,41 GC & 41 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(tissues),p=0.0041(serum),p=0.021(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic :AUC =0.905(tissues expression) & AUC=0.870(serum expression) and Prognostic: low tissues expression had improved OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-130a expression level were higher in patients with metastasis than in without metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26134263"
  },
  {
    "miRNA_name": "miR-130a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.4678, p=0.003971",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non reponders",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in non-responders",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25637514"
  },
  {
    "miRNA_name": "miR-130b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711782"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (Surgical specimens of cancer tissues and adjacent nontumor tissue from 36 patients)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Downregulatedregulation-poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26675712"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis), and 16 liver metastatic lesions arising from CRC]",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.040 (over all survival), p=0.015(disease free survival)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissue samples from 151 patients [135 primary lesions (109 without liver metastasis and 26 with liver metastasis), and 16 liver metastatic lesions arising from CRC].",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Overall survival p = 0.040, disease-free survival p = 0.015",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26868958"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent non-tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26298723"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Potential diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26324336"
  },
  {
    "miRNA_name": "miR-132",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "201 paired GC and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "The 5-year survival rate of the miR-132 high-expression group was significantly better than that of the low-expression group (p < 0.01)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Expression  correlated with age (p = 0.036), tumor size (p = 0.001), histological type (p = 0.003), depth of invasion (p = 0.007), venous invasion (p = 0.002), hematogenous metastasis (p = 0.022), and pathological stage (p = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28918037"
  },
  {
    "miRNA_name": "miR-1322",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissue",
    "sample": "Serum,tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(serum & tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-serum marker miR-1322 (AUC-0.847)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22315007"
  },
  {
    "miRNA_name": "miR-132-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.9894, p=0.034038",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-133",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "180 pairs of GC tissues,AGS,BGC823,MGC803,SGC7901,MKN-45,MKN-1,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival rate of high expression group was higher than low expression(P=0.003)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-133 expression was lower in T3 and T4 groups(-4.11 to -3.08) than in T1 and T2 group(-1.91 to 0.07)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25152372"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue",
    "sample": "125 resected CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-133a had a significantly lower overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Advanced TNM and Dukes staging was associated with higher miR-133a expression even though its expression was mostly lower in tumor tissues. higher expression of miR-133a was associated with the development of distant metastases.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25104873"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor samples and adjacent non-cancerous tissues from 169 patients undergoing radical resection for CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with the depth of the local invasion, poor differentiation, lymph node metastasis and advanced disease",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25170220"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "102 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22641236"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "84 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0125",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24196787"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "Chemotherapy",
    "therapy_details": "Combined downregulation predicts paclitaxel based chemosensitivity of ESCC patients",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "45 apired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26396670"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Primary GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Decreased expression is associated with lymph node metastasis in GC patients(p<0.001)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25620172"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "105 GC & adjacent non tumor  tissues,SGC7901,BGc823,MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression associated with degree of differentiation (p=0.01),local invasion(p=0.001),TNM stage(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25780292"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "18 GC & matched norma gastric  tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs GES-1 cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25815687"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "26 paired GC & adjacent normal tissues,SGC7901,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Gastric Juice",
    "sample": "204 gastric juices",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.907, p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=0.907",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27268657"
  },
  {
    "miRNA_name": "miR-133a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early Diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 50 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.028",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "31 fresh, human CRC tissues and nineteen adjacent, non-tumor tissue counterparts",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 93.55% tissues",
    "significance": "p<0.001, AUC=0.8081",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24330809"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.9819, p=0.0019298",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "6 human CRC, 2 adjacent non-tumor and 2 healthy colorectal tissue samples and  HT-29, HCT-116, SW480, SW620, LOVO cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p=0.013",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622593"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "38 CRC and corresponding non-cancerous tissues (NCTs)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.857 (p<0.0001), with 78.9% sensitivity and 81.6% specificity",
    "detection_method": "RT-qPCR, in situ hybridization (ISH)",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098895"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-combined expression of miR-133a & miR-133b",
    "therapy": "Chemotherapy",
    "therapy_details": "Combined downregulation predicts paclitaxel based chemosensitivity of ESCC patients",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25280517"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "100 pairs of GC & adjacent non-neoplastic tissues,GES1,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-133b in GC was associated with venous invasion(p<0.05),more aggressive tumor phenotype(p<0.05,stage I/II vs stage III/IV)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25433493"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,MGC803,SGC7901,MKN45,BGC823,MKN74,AGS,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23296701"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "140 patients for GC & adjacent non tumor tissues,GES1,SGC7901,NCI-N87,BGC823,AGS,KATO III,MKN45,MKN28,SNU1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues), p<0.01(MKN28),p<0.05(SGC7901,NCI-N87,AGS,KATO III,MKN45,SNU1",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-133b exp was negatively correlated with lymph node metastasis of GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24443799"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "26 paired GC & adjacent normal tissues,SGC7901,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "20 paired tissues,KATO-III,MKN-1,MKN-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues),p<0.001( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27696637"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28901466"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.33, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-133b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "27 primary and liver metastasis tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qPCR arrays",
    "marker": "Prognostic",
    "marker_details": "Associated with lower survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues ( 168 pairs of CRC specimens and adjacent noncancerous tissues) and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictor of poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26897940"
  },
  {
    "miRNA_name": "miR-134",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28260021"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8, p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Could discriminate non-LNM from LNM with 50.0% sensitivity and 100.0% specificity at the best cut-off value of 0.0901 and discriminate tumor Ι-II stages from tumor III-IV stages with 37.5% sensitivity and 100.0% specificity at the best cut-off value of 0.1122",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis & tumor stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "11 pairs of GC & adjacent normal  tissues,SGC-7901,SGC7901/VCR,MGC-803,MKN-45,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22310976"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue Cell-line",
    "sample": "59 patients GC & adjacent normal  tissues,AGS,YCC2,MKN28,KATO III,SNU 1,SNU5,SNU16,SNU216,SNU601,SNU638,SNU668,SNU719,HFE145",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.009(more down in IB than IA patient,p<0.002(more down in LN+ve than LN-ve",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-135a have advanced TNM(p=0.045) and higher rate of LN metastasis(p=0.014)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24465504"
  },
  {
    "miRNA_name": "miR-135a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "15 paired tissues, AGS, BGC-823, MKN-28, MKN-45, MGC-803, SGC-7901,HEK293",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.00015(tissues),p<0.05( gc cell lines vs HEK293)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27366092"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum, 60 patients with primary colorectal cancer, 40 patients with colorectal polyps and 50 healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.875",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Correlated with different degrees of tumour differentiation (  P = 0.029) and different tumour stages (p=0.013)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27126269"
  },
  {
    "miRNA_name": "miR-135a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs GC & para cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "realtime-PCR,microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Increase and decrease of miR-135a-5p inhibited or impaired adriamycin induced apoptosis in BGC-823 cells(p<0.05),compared with group without gene intervention",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25322930"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=26.32 by microarray and 5.06 by real ime PCR",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SW-48 colon cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated (targeted by SD-208)",
    "significance": "p=0.006",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26523217"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Positively correlated with the clinical stage, correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool Tissue",
    "sample": "40 pairs of CRC tissues, 16 pairs of advanced adenoma tissues, and 424 stool samples, including 104 CRCs and 109 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive stool marker for CRC and Adenoma patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Increasing trend across the adenoma to cancer sequence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691020"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal,gastritis,metaplasia and gastric cancer",
    "expression": "Downregulated",
    "expression_details": "Higher expression in the non-atrophic chronic gastritis and the intestinal metaplasia samples and lower values in the normal gastric mucosa and intestinal-type GAC",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  Differential expression as potential biomarker for GC Metaplasia",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal,gastritis,metaplasia and gastric cancer, H. Pyroli positive VS H. Pyroli Negative",
    "expression": "Upregulated",
    "expression_details": "Samples of H. pylori-positive non-atrophic chronic gastritis have a higher expression of hsa-miR-135b than the H. pylori-negative non-atrophic chronic gastritis samples",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  Differential expression as potential biomarker for GC Metaplasia. Samples of H. pylori-positive non-atrophic chronic gastritis have a higher expression of hsa-miR-135b than the H. pylori-negative non-atrophic chronic gastritis samples",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "66  pairs of GC & corresponding non tumor tissues,GES1,BGC823,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-135b was related with Lauren classification,tumor differentiation ,invasion,pTNM(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23328512"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=28.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-135b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Multicenter cohort of 116 patients, Tumor biopsies",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0000000000283",
    "detection_method": "microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Expression correlated significantly with disease-free and cancer-specific survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22850566"
  },
  {
    "miRNA_name": "miR-135b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-135b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-136",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "GC peritoneal metastatic parental sublines : GC-9811,GC-9811P,GC-9811P1,GC-9811P2,GC-9811P3",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression associated with worse Prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression is associated with more peritoneal metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656883"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colonic tissues derived from stage II-III colon cancer patients with (n = 3) and without (n = 3) lymph node metastasis. Lymph node positive vs. Lymph node negative.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.6-folds, p=0.036",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: to identify ptients with lymph node metastasis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulated in lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19659786"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Methylation specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "409 colorectal tissues [21 normal colonic mucosa from healthy individuals (N-N), 160 primary CRC tissues and their corresponding normal mucosa (N-C), and 68 adenomas].",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR and and in situ hybridization",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic market for early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20682795"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "tissue specimens from 146 primary rectal adenocarcinoma samples, 116 distant normal mucosa samples, 80 adjacent normal mucosa specimens, and 49 lymph node metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 84% tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940441"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "107 paired GC & matched normal gastric FFPE tissues,MGC-803, HGC-27,MKN-45,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25064845"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (CpG island methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,bisulfite pyrosequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25663388"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "100 patients tissues,HGC-27,HGC-803,SGC-7901,MKN-45,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26102366"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "154 GAC tissues after radical gastrectomy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for GC except for TNM stage",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression associated with tumor cell differentiation,N stage,TNM stage( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26545111"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 paired GC & surgical margin tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27468717"
  },
  {
    "miRNA_name": "miR-137",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tumor biopsies from 35 patients with rectal cancer before therapy and parallel tumor biopsies from 31 patients two weeks after starting preoperative capecitabine chemoradiotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated (after therapy)",
    "significance": "Fold Change=6.5, p = 0.0004",
    "detection_method": "TaqMan Micro-RNA assays after reverse transcription",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Higher levels of miR-137 were associated with worse response to the therapy.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18695884"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "205 archived ESCC,20 paired tissues,NEEC1,NEEC2,KYSE30,KYSE510,ECA109,HKESC1,KYSE180,KYSE410,KYSE140,E18,KYSE520",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCr",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had shorter survival(p<0.001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Inverse correlation with clinical stage(p<0.001),TNM(p<0.001),histological differentiation(p=0.024)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23319823"
  },
  {
    "miRNA_name": "miR-138",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "168 serum,128 ESCC and corresponding normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum/ tissue low level",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Reduced serum/tissue correlated with T stage,lymph node metastasis,TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759955"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-138-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "188 CRC samples, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with advanced clinical stage, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27248318"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "63 pairs of colon cancer and adjacent non-cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.025",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25550849"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-139-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "42 pairs of tumor and adjacent non-tumor tissues, and in serum samples of 117 patients and 90 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.9935, sensitivity of 96.6% and specificity of 97.8%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Serum",
    "sample": "111 stage II/III and 139 stage I-III CRC patients, as well as serum samples and matched primary and metastatic liver tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray, miRNAseq and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Serum biomarker for recurrence and metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28262692"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 pair tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24204738"
  },
  {
    "miRNA_name": "miR-139-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "89 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with tumor stage(p=0.007),metastasis(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25322669"
  },
  {
    "miRNA_name": "miR-140",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "20 paired tissues,HGC27,BGc823,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05( cell lines)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27353653"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty six pairs of CRC tissues and matched adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with advanced CRC stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26402430"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "99 mCRC patients, out of 99 33 patients had wild-type KRAS/BRAF and third- to sixth-line anti-EGFRmAb treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23098991"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Eighteen colorectal cancer Tissues, 174 stage III or IV CRC patients from the TCGA project",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Higher miR-140 expression is significantly correlated with better survival in stage III and IV",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25980495"
  },
  {
    "miRNA_name": "miR-140-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and China",
    "sample_type": "Plasma",
    "sample": "102 plasma samples collected from USA. independent cohort of 156 plasma samples collected from China",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic marker for metastatic colon cancer and predicts poor prognosis.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Circulating miR-141 was significantly associated with stage IV colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21445232"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HT29, T84 and LS174",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28454307"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh cancer tissues and matched adjacent non-cancerous tissue from 18 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26278151"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 187 CRC cases and 47 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Plasma miR-141 levels were higher in stage IV CRC patients than in stage I–III (P < 0.001)",
    "significance": "AUC=0.851, P < 0.001",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Differentiated stage IV CRC from stage I-III patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001, 86.11% sensitivity and 76.11% specificity",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer: upregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Cell-line",
    "sample": "KYSE890,KYSE960,KYSE70,KYSE140,KYSE590,KYSE170,KYSE190,KYSE520,KYSE450",
    "expression": "Upregulated",
    "expression_details": "Upregulated (cisplatin resistant cell lines)",
    "significance": "p=0.01(cisplatin resistant vs sensitive cell lines)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Confers resistance to cisplatin in cisplatin sensitive cell lines,order of decreasing sensitivity to Cisplatin:KYSE890>KYSE960>KYSE70>KYSE140>KYSE590>KYSE170>KYSE190>KYSE520>KYSE450",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21289630"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 H.pylori  positive & 75 H.pylori negative tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0067",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24732377"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC specimens, SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to highly methylated CpG island located Upregulatedstream or Upregulated TGF-beta signalling",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Decitabine increased miR-200c and miR-141 expression",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression of miR-141 was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 paired GC and matched adjacent normal tissues,BGC-823,HGC-27,SGC-7901,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR,microarray analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25633292"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233544"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "35 pair matched gastric neoplastic &  adjacent non neoplastic tissues,NCI-N87,MGC803,BGC823,SGC7901,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated, Upregulated in NCI-N87",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19363643"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24276755"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.pylori infected GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (H.pylori infection downregulate expression)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Knockdown miR-141 expression in 7901/DDP and 7901 cells could significantly improve cisplatin sensitivity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24628843"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "95 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor : lymph node metastasis(p=0.003),distant metastasis(p=0.001),TNM(p<0.001) & miR-141  expression",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with tumor diffrentiation(p=0.044),positive lymph node metastasis(p=0.010),distant metastasis(p<0.001),advanced TNM stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26681225"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated regulation causes selective resistance to L-OHP and EMT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-141",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "Tumor tissues, lymph nodes and serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(Lymph nodes) and p<0.05(serum)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882171"
  },
  {
    "miRNA_name": "miR-141*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-141-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 ESCC & paired adjacent normal tissues,EC109, EC9706, TE-1 and KYSE-150",
    "expression": "Upregulated",
    "expression_details": "Upregulated (5FU and oxaliplatin resistant EC9706 ,ESCC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-141-3p contributed to an acquired chemo resistance through PTEN modulation in vitro and in vivo",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27644195"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Plasma",
    "sample": "Pre-operative plasma from 61 recently diagnosed colorectal cancer patients (including 13 stage I, 41 stage II and 7 stage III patients) and 24 (age and gender-matched) healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with  histological grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "91 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-142-3p)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-142-3p expression :p=0.017(univariate),p=0.022(multivariate)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "miR-142-3p expression correlated to histological differentiation(p<0.05),good prognostic group comprised of ESCC patients with small tumor,negative lymph node metastasis or early stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21882196"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "51 paired tissues,80 GC & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic :plasma level( AUC=0.839)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-142-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "CAIRO study (ClinTrials.gov NCT00312000) of the Dutch Colorectal Cancer Group",
    "sample_type": "Tissue",
    "sample": "820 patients with advanced CRC, primary tumors and matched normal tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Progression free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26392389"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues (Cancerous colorectal tissue was collected from 16 patients and normal tissue from 9 patients), SW-480 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629019"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "12 matched tumor and normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Northern blot analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/14573789"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colorectal carcinoma and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19062714"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Frequently downregulated in the smaller adenomas",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Closely associated with the initiation of tumor development and not to progression stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "46 patients with CRC, Paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients with a higher expression of miR-143 had disease-free interval",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples of 38 CRC patients and 13 healthy individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "TaqMan miRNA assays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22273643"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 pared tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.436",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression correlated with tumor invasion: (p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21218087"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "miR-143 was associated with recurrence of metasatsis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 preoperative Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-143  expression associated with lymph node  metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Inverse correlation with tumor invasion depth,lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23276710"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "30 ESCC and 30 margin ESCC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26427659"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpressed miR-143 sensitized SGC7901/DDP cells to cisplatin(DDP)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25492481"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.058",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25656032"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19439999"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "15 schirrous type GC & 5 non scirrous type GC tissues,30 FFPE schirrous & non schirrous type GC GC,FFPE",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in schirrous type gc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression of miR-143 in GC associated with worse cancer specific mortality(p=0.0141)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283360"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "122 tissues atomic bomb survivor",
    "expression": "Upregulated",
    "expression_details": "Upregulated in high dose exposed groUpregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "GES-1,SGC7901,MGC803,MKN45,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28718369"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Indicate successful neoadjuvant chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-143",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "77 CRC patients who were identified by pyrosequencing to have wild-type KRAS and were subsequently treated with EGFR-targeted therapy with the monoclonal antibodies cetuximab or panitumumab.",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 47 out of 77 (61%) tumours",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator- low levels of miRNA-143 expression is an independent prognostic factor with respect to cancer specific survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22549179"
  },
  {
    "miRNA_name": "miR-143-145 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 patients with synchronous CRC and 7 patients with solitary CRC for microarray, 22 patients with synchronous CRC and 579 solitary CRCs,  CRCs, CRC along with the matched normal colorectal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26266366"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "80 pairs of primary ESCC 7 adjacent normal tissues,HEEC,KYSE30,KYSE70,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,KYSE-30,KYSE-70,ECA109)",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-143-3p expression had a poorer OS than those with high expression",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-143-3p correlated with advanced clinical stage(p=0.026),lymph node metastasis(p=0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27358073"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "MKN-1,MKN-7,AGS,SGC7901,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616567"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC &  normal tissues(42 each),GEs1,SGC7901,HGc27,MGC803,Ags,MKN45,BGC823",
    "expression": "Downregulated",
    "expression_details": "Upregulated (in H.pylori infected GC compared to H.pylori negative GC),Downregulated (GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low expression In lymph node positive than in negative & stage III- IV thgan in I-II (both p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.pylori positive & negative GC(42)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in H.pylori infected GC compared to H.pylori negative GC),Downregulated (GC tissues than in normal) & GC cell lines",
    "significance": "p<0.001(tissues & cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high H.pylori infection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low expression In lymph node positive than in negative & stage III- IV thgan in I-II (both p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404925"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-143-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "MKN-1,MKN-7,AGS,SGC7901,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616567"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Saliva Plasma",
    "sample": "Saliva",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24369245"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "India",
    "sample_type": "Tissue Serum",
    "sample": "19 EC & 19 normal serum,12 pre neoplastic, 35 neoplastic & matched distant non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.010(tissues),p=0.015(serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- serum level in EC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27748283"
  },
  {
    "miRNA_name": "miR-144",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Blood",
    "sample": "Tissues and peripheral blood samples from 96 gastric cancer patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Tissue and serum miR-144 levels were both associated with clinical stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800316"
  },
  {
    "miRNA_name": "miR-144*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "75 Fecal specimens were collected from patients who underwent colonoscopy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 74% and a specificity of 87% (n=75, p < 0.0001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker for CRC detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21863218"
  },
  {
    "miRNA_name": "miR-144-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with depth of invasion (P = 0.030), tumor size (P = 0.047), lymph node metastasis (P = 0.047), and TNM stage (P = 0.048)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28111340"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.9",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "SW620 , colon mucosae, 32 cases of colon cancer and 18 cases of nontumorous colon mucosae",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=2.7, p < 0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23714355"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "EMT positive tissues, 45 patients with colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.023",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lymphovascular invasion",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "fecal samples from 80 CRC patients and 51 normal controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Australia",
    "population": "Australia",
    "sample_type": "Tissue",
    "sample": "12 matched tumor and normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Northern blot analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/14573789"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Frequently downregulated in the smaller adenomas",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Closely associated with the initiation of tumor development and not to progression stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples of 38 CRC patients and 13 healthy individuals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "TaqMan miRNA assays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22273643"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0004",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "31 samples of tumor and paired normal mucosa obtained from 31 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change >15 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "113 colon adenomas, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Decreased with higher histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 202 patients (117 males and 85 females) undergoing surgical resection for CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25019299"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, 32 CRC patient",
    "expression": "Differential Expression",
    "expression_details": "Differed in clinical stage",
    "significance": "p<0.05; odds ratio = 4.21; 95% CI of odds ratio = 1.17 to 15.13)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25896668"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT-8, HT-29, SW480, SW620, LoVo, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0098",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25973017"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "45 CRC tisues",
    "expression": "Upregulated",
    "expression_details": "Upregulated in EMT positive Cancer",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Marker for EMT",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "CRC tissues and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with  lymph node or distance metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572146"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 pared tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression correlated with tumor invasion (p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21218087"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "High mature miR-145 associated with  recurrence of metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 EC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "The combined expression of miR-143 and miR-145 was significantly associated with the risk for esophageal cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-145 expression associated with lymph node  metastasis(p= 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22457808"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23276710"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "40 tissues,5 ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24356567"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 FFPE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-miR-145 AUC:0.74",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 paired ESCC & corresponding normal tissues,HEEC,Eca109,EC1,KYSE150,KYSE158",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27771733"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.007",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25656032"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "160 pairs of collected clinical samples included 80 unclassified gastric cancer samples, 40 infiltrative gastric cancer samples and 40 expanding gastric cancer samplesnfiltrative and expanding gc",
    "expression": "Downregulated",
    "expression_details": "Downregulated in infiltrative as compared to expanding gc",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26010149"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "43 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19439999"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "89 GC & 89 normal gastric mucosa tissues,GES-1,AGS,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc & especially in metastatic gc tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lower expression in metastatic than in non metastatic GC tissues(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23233482"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "26 paired GC & adjacent normal tissues,SGC7901,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24613927"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Forty patients with locally advanced rectal cancer. patients were treated with neoadjuvant chemoraditherapy 5Fu",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Patients with a low intratumoral post-therapeutic expression of miR-145 had worse response to neoadjuvant therapy compared to patients with a high expression",
    "tumor_size": "",
    "tumor_size_details": "Significant correlation between miR-145 expression and tumor regression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21567082"
  },
  {
    "miRNA_name": "miR-145",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-145*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Out of 31 patients 3 of stage IV tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=23.8 folds",
    "detection_method": "microRNA PCR system (GeneCopoeia, USA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with stage IV",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24743265"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue GEO Dataset",
    "sample": "ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28832500"
  },
  {
    "miRNA_name": "miR-145-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic indicator for OS (p = 0.011).",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis, metastasis stage, and distant metastasis (all p < 0.05).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27460730"
  },
  {
    "miRNA_name": "miR-1469",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "129 patients with ESCC who underwent esophagectomy and esophagogastrostomy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-1469 expression had significant poorer disease free survival(p=0.004) and OS(p=0.029)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Low miR-1469 expression was significantly associated with tumor invasion depth(p=0.026),lymph node metastasis(p<0.001),pathological tumor stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588716"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "43 colonic cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in non relapsed",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low expression of miR-146a was associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Tumor-size",
    "tumor_size_details": "Associated with poor tumor differentiation, tumor size and clinical stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24670457"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "78 samples, differential expression in metastases compared to primary tumor",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.02, p=0.032",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Localization",
    "tumor_size_details": "miR-146a is potential biomarkers for colorectal tumor localization",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 tissues,EC109,TE8,TE2,HEEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC and EC cell line)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression was associated with metastatic property and stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26508028"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "62 pairs of ESCC & adjacent paracancerous tissues,115 FFPE,154 ESCC & 154 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic & Prognostic : miR-146a expression level is an ideal prognostic and diagnostic biomarker of ESCC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-146a tissues level was significantly reduced with increased T stage(p=0.037) and TNM stage(p=0.004) ,serum miR-146a was negatively associated with T stage (P=0.002",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26794279"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "43 patients tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : OS time with higher miR-146a expression was longer than low expression(p=0.011)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Low expression miR-146a was associated with increased tumor size(p=0.06),poor differentiation(p=0.010)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21347720"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "20 GC & matched non tumor adjacent tissues,BGC-823,MKN-45,HGC-27,AGS,SGC-7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori infection increases expression)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22020746"
  },
  {
    "miRNA_name": "miR-146a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "37 gastric adeno carcino & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22992343"
  },
  {
    "miRNA_name": "miR-146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-146a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Seventy pairs of samples from CRC Tissues for IHC and 20 for real time PCR, HT29, HCT116, RKO, SW480, LoNo, FHC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28186967"
  },
  {
    "miRNA_name": "miR-146b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.9",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-146b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0045",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-147b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.24, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-148",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-148 in EAC compared to ESCC)",
    "significance": "p=0.0014(miR-148 in EAC vs ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-148 expression have shorter DFS(p=0.0145)  & shorter OS (P=0.0016) in EAC, low miR-148 level have shorter OS(p=0.0014) in ESCC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-148-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "TCGA Dataset,GEO Dataset,Tissue,Cell-line",
    "sample": "TCGA & GEO datasets,13 CDDP resistant & 92 CDDP sensitive GC tissues,BGC823,BGC823CDDP,SGC7901,SGC7901CDDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated in CDDP resistant cell lines & CDDP resistant GC tissues",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker for CDDP resistance in GC",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-148-3p sensitizes GC cells to CDDP",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Expression level  negatively correlated with tumor size, clinical stage, T classification, and CDDP resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28965855"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Colorectal adenoma (n = 21) and CRC (stage I-IV, n = 159), formalin-fixed paraffin-embedded tissue samples",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic classifier in patients with stage III CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low expression correlated with advanced pT stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "273 CRC specimens from stage II/III patients treated with 5-fluorouracil-based adjuvant chemotherapy and stage IV patients subjected to 5-fluorouracil and oxaliplatin-based chemotherapy.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "In stage III and IV CRC, low miR-148a expression was associated with significantly shorter disease free-survival (DFS) and poor overall survival (OS)",
    "therapy": "Chemotherapy",
    "therapy_details": "In stage III and IV CRC, low miR-148a expression was associated with a worse therapeutic response",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23056401"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue Serum",
    "sample": "Tissues and Serum from 55 early relapsed patients and 55 nonearly relapsed patients, stage II stage and III colorectal cancer",
    "expression": "Upregulated",
    "expression_details": "Overexpressed in non-early relapsed samples",
    "significance": "N/A",
    "detection_method": "Microarray followed by validation",
    "marker": "Prognostic",
    "marker_details": "Lower levels associated with significantly shorter disease-free survival rates and poorer overall survival rates.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23933284"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Colorectal adenoma (n = 21) and CRC (stage I-IV, n = 159) FFPE Tissues, HT29 and WiDr",
    "expression": "Downregulated",
    "expression_details": "downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Independent prognostic classifier in patients with stage III CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26389729"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 patients tissues,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression in cancer tissues of patients with lymph node metastasis, vascular invasion and TNM stage III(-IIII( was down-regulated more obviously(P<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25341915"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 advanced primary gastric tumors & adjacent non tumor  gastric tissues,AGS,BGC-823,SGC7901,SNU-16,GES-1,BGC-803",
    "expression": "Downregulated",
    "expression_details": "Downregulated, relatively Upregulated in Ags,BGC-823,SGC-7901 compared with GES-1",
    "significance": "p=0.005(tissues)",
    "detection_method": "Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21552422"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 GC & corresponding non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Downregulated miR-148a  associated with TNM stage (p=0.0049) and lymph node metastasis(p=o.0003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21994419"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 GC & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Lower mIR-148a was associated with lymph node metastasis,N stage and blood vessel invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23873106"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "20 GC & 5 non neoplastic tissues & 61 pair  tissues,MKN1,HCS-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(gc vs non neoplastic tissues in n=61",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : lower miR-148 exps. Had worse prognosis(log-rank test,p<0.0001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-148a significantly correlated with advanced clinical stage,lymph node metastasis and poor clinical outcome",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24283384"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 GC & 33 normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- miRNAs are potential biomarker for GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "52 paired tissues,80 GC & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.842)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "41 paired tissues,SNU-1, SNU-16, AGS, NCI-N87, KATOIII, SGC-7901, BGC-823, MKN-45 , MKN-28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression more lymph node metastasis(p=0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27518872"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-148a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-148b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "bisulphite sequencing PCR and methylation-specific PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-149 was associated with lower 5-year survival rate, an independent prognostic factor for overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression of miR-149 was associated with a greater depth of invasion,",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22821729"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic Predictor: correlated with longer overall and disease-free survival (DFS)",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients treated with fluoropyrimidines and high levels of miR-149 had longer overall survival",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "78 cases of CRC tissues,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with lymph node or distant metastasis and advanced TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25613903"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CAFs ans NFs of GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25916550"
  },
  {
    "miRNA_name": "miR-149",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "44 GC & matched adjacent tissues,GES1,MKN45,GC9811,AGS,SGC7901,MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Decreased miR-149 expressioncorrelates with lymph node metastasis(p=0.046),TNM stage(p=0.0011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23144691"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "239 patients for real time PCR and 185 patients for Insitu hybridization",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and In-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had low miR-150 expression had shorter survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients whose tumours had low miR-150 expression had worse response to adjuvant chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22052060"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "78 samples (23 normal colon mucosa, N; 31 primary colon carcinoma, T; and 24 liver metastases, M), obtained from 46 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23987127"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue Plasma",
    "sample": "Tissue, Plasma, 97 subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma (FC = -1.29, p-value = 0.013) and cancer tissue (FC = -2.55, p-value = 4.104e-08)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "108 paired curative surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRt-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-poor prognosis for low expression(univariate analysis)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with tumor invasion depth(p=0.039),lymph node metastasis(p=0.035),lymphatic invasion(p=0.005),venous invasion(p=0.006),clinical stage(p=0.018)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23013135"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20067763"
  },
  {
    "miRNA_name": "miR-150",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.48, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-150*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulated in colorectal cancers with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-151",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-151-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27191259"
  },
  {
    "miRNA_name": "miR-151-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27191259"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "CRC cell lines and tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Inverse correlation with advanced tumor-node-metastasis (TNM) stage (P < 0.01) and lymph node metastasis (P < 0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26820128"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 101 patients with colorectal cancer and matched normal",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Tumor-size",
    "tumor_size_details": "Low expression correlated with increased tumor size and advanced pT stage.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20422307"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,AGS,BGC823,MKN28, SGC7901,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25119599"
  },
  {
    "miRNA_name": "miR-152",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "202 colorectal cancer and adjacent colorectal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expression associated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27784461"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis,5 year overall and disease free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-153 levels were prominently downregulated in the tumor tissues with lymph node metastasis than without (p=0.012)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25678802"
  },
  {
    "miRNA_name": "miR-153",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC & adjacent non tunmor gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26232914"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, 169 pairs of CRC specimens and adjacent noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer overall survival (P = 0.006)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Significantly associated with large tumor size, positive lymph node metastasis, and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26048406"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28800791"
  },
  {
    "miRNA_name": "miR-154",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 paired GC and adjacent normal gastric tissues,GES1,SGC7901,MKN1,AGS,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927076"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated or high",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "therapy": "Chemotherapy",
    "therapy_details": "Re-elevated in patients not sensitized to chemotherapy",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Mouse model and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "real-time fluorescent quantitative PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Gradually elevated with the formation of colitis-associated colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24989910"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "110 POCD patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictive biomarkers for POCD",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27872469"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "156 CRC patients, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-155 expression were significantly worse than those of patients with low miR-155 expression",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-155 expression was significantly correlated with lymph node metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.005, Fold Change=2.3",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 patients who underwent colorectal cancer resection without pre-operative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expression of miR-155 significantly correlated with an advanced TNM stage, lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23588589"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Low plasma miR-155 level as Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of tiisues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24551280"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "AGS,SNU-16,KATO III,MKN28,SGC-7901,MKN-45,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426647"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 GC & corresponding normal  tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24969405"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Inverse correlation  with tumor size & pathological stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26955820"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.46, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Taqman miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-155",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Eighty-four pairs of colon cancer specimens and their corresponding non-tumor adjacent tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Upregulated in the recurrence and metastasis groupregulated",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24888652"
  },
  {
    "miRNA_name": "miR-155-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=9.5344, p=0.003666",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "Tissues, serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic, Prognostic- serum level",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low serum miR-15a level more frequently occurred in ESCC patients with advanced TNM,Tand N stage(all p=0.01),poor tumor differentiation(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27802201"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 pairs of primary GAC & adjacent non-tumor tissues,GES-1,MKN-1,MKN7,MKN28,MKN45,SNU1,SNU16,AGS,NCI-N87,MGC803,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "2 1 paired normal & gastric tumor tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0239",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-15a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0278",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls, To distinguish Stage IV CRC from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-15b and  sensitize SGC7901/VCR cells to VCR induced apoptosis",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-15b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-15b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line Plasma",
    "sample": "Cell lines,tissues,plasma sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28560431"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "143 primary CRC tissues and 18 corresponding normal colonic mucosa from patients who had undergone surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low-miR-16 had lower 5-year overall survival than those with high-miR-16",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Associated with tumor differentiation, lymph node metastasis, L category, V category, TNM stage, and tumor recurrence of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24045965"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 non-cancerous colorectal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free survival (DFS) and overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27930363"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired normal & gastric tumor  tissue",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p=0.2514",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901/VCR,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-16 sensitize SGC7901/VCR cells to VCR induced apoptosis",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18449891"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180 GC patient after surgery for microarray preparation,paracancerous normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "tissue microaaray,miRNA-locked nucleic acid ISH",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-16 (HR 2.26; 95 % CI 1.51-3.40; P < 0.001) predicted shorter OS, while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242), lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.according to multivariate",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-16",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-16-1",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 pairs of primary GAC & adjacent non-tumor tissues,GES-1,MKN-1,MKN7,MKN28,MKN45,SNU1,SNU16,AGS,NCI-N87,MGC803,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25743273"
  },
  {
    "miRNA_name": "miR-16-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray profiling,qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "TNM stage IV:AUC=0.832 for miR-16-5p, Poorly diffrentiated: AUC=0.801",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.9, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6, p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Positive correlation of miR-17a with lymph node metastasis(p=0,035),clinical stage(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 paired GC & corresponding non cancer normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "40 GC,32 benign gastric disease(BGD) & 36 healthy sera",
    "expression": "Downregulated",
    "expression_details": "Downregulated (order of decreasing level of miR-17 in serum:healthy<BGD<GC",
    "significance": "p=0.000(Gc vs healthy),p=0.002(BGD vs healthy),p=0.001(Gc vs BGD)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC of 0.879 with 80.6% sensitivity and 87.5% specificity for discriminating GC patients from controls , AUC of 0.717 with 90.6% sensitivity and 57.5% specificity for discriminating GC patients from BGD patients and  AUC of 0.725 with 62.9% sensitivity and 81.2% specificity for discriminating BGD patients from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression of miR-17  was  associated with patients age(p<0.05) but  not  with tumor differentiation ,TNM stage or lymph node metastasis(p>0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25561770"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "38 patients with colorectal, gastric or pancreatic cancer, FFPE Tumours",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - associated with a higher risk of disease progression and risk of death",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21743960"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "FFPE samples from 25 patients, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Candidate molecular markers of cetuximab resistance",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20881268"
  },
  {
    "miRNA_name": "miR-17*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma of 25 patients with CRC and 20 healthy controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0005",
    "detection_method": "MicroRNA profiling and qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-17-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.037",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lymphovascular invasion",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE specimens from CRC tissue and the surrounding non-tumour tissues obtained from 240 patients who underwent surgical resections",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients whose tumours had high miR-17-5p expression had shorter overall survival rates",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients with high expression of miR-17-5p showed a better response to adjuvant chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23250421"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "295 patients, who underwent tumor resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "In late stage CRC patients, high miR-17-5p expression levels were associated with a worse prognosis, especially for patients who had received chemotherapy",
    "therapy": "Chemotherapy",
    "therapy_details": "Induces drug resistance, miR-17-5p was negatively related with chemosensitive status in CRC patients",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24912422"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8.4896, p=0.001783",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-17-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "28 patients GC & adjacent  normal  tissues,SNU-601,SNU-668,AGS,MKN-28, HeLa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: expression not associated wth patients OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression of miR-17-5p was associated with differentiartion degree of GC (P=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24801601"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 colon tumor and 48 paired normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Patients expressing high levels of miR-17 showed reduced overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22065543"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 patients with synchronous CRC and 7 patients with solitary CRC for microarray, 22 patients with synchronous CRC and 579 solitary CRCs,  CRCs, CRC along with the matched normal colorectal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26266366"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues from 13 cases of colorectal cancer and 4 normal colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-92a expression group had greater lymphatic invasion and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22452939"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Human ESCC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21271217"
  },
  {
    "miRNA_name": "miR-17-92 cluster",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "30 paired tumor & non tumor gastric samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "MIR17HG was conversely associated with the size of tumoral specimens in early stages (stages I and II). Association between presence of metastasis and lower expression of MIR17HG.",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26837962"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissue and non-cancer liver tissue were obtained from patients with colorectal cancer. 72 CRC patients and 69 normal (control) patients for survival analysis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Positive with late liver metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26750720"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "162 CRC patients who underwent resection of primary CRC",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression group had a significantly poorer prognosis than the low expression group",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23023298"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "80 patients with wild type KRAS CRC undergoing treatment with the EGFR-targeting monoclonal antibodies cetuximab and panitumumab for metastatic CRC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Pyrosequencing",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low miR-181a expression was associated with poor progression free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low miR-181a expression level was associated with poor differentiation of CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24098024"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "105 tissues,HEEc,KYSe150,KYSE410,OE19,ECA109,EC9706",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for OS and recurrence free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Upregualation correlated with lymph node metastasis,advanced tNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25230784"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 paired GC & adjacent normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lower level of miR-181a were associated with the pM and pTNM stage in GC patients",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25706394"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901,MGC803,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22581522"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression miR-181a in GCT associated with positive lymph node metastasis(p=0.042)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22971574"
  },
  {
    "miRNA_name": "miR-181a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "3 normal gastric tissues & 3 GC cell lines SGC7901,MGC803,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24531888"
  },
  {
    "miRNA_name": "miR-181a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "40 pairs of GC & adjacent non tumor  tissues,GES1,SGC7901,MGC803",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-181a-5p upregulation  correlated with vascular invasion(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23886199"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Sessile serrated adenomas (SSA) without cytologic dysplasia vs. Hyperplastic polyp (HP),  18 HPs, 19 SSAs without cytologic dysplasia and 20 normal colonic mucosal specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.01-fold; p < 0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19547998"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues collected from 106 black and 239 white patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker only for Black patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "97 CRC and normal tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 65 out of 97 samples",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Closely related to TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26935905"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/VCR",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-181b expression reduced BCL2 protein level and sensitized SGC7901/VCR to VCR induced and CDDP induced apoptosis",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20162574"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10  pairs of GAC & adjacent normal tissues,SGC7901,BGC 823,MGC-803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22539488"
  },
  {
    "miRNA_name": "miR-181b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "12 GC & corresponding adjacent non neoplastic tissues,GES1,AGS,HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22901205"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "63 stage II CRC Tissues, FFPE tissues, Seven patients with recurrence and 50 patients were recurrence-free",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA chip followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Recurrence predictor",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28036302"
  },
  {
    "miRNA_name": "miR-181c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "30 patients tissues and plasma of GC,gastric ulcer,chronic gastritis each",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC tissues and plasma)",
    "significance": "p=0.000(in GC tissues and plasma compared to gastric ulcer and chronic gastritis)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23803080"
  },
  {
    "miRNA_name": "miR-181c-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray,qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of miR-181c-3p  associated with poor prognosis(p<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572270"
  },
  {
    "miRNA_name": "miR-181d",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "148 pairs of colorectal cancer and adjacent noncancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-182 expression predicted poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Significantly correlated with large tumor size, positive regional lymph node metastasis, and advanced tumor-node-metastasis stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23474644"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "in-situ Hybridization",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with T-stage, lymph node metastasis, distant metastasis, and Dukes' stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25031782"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "20 tubular adenomas, 50 colorectal carcinoma (CRC), and 40 CRC liver metastases, 50 Controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated : increased progressively",
    "significance": "In primary CRCs (5.3-Fold Change; p<0.0001), and CRC liver metastases (7.5-Fold Change; p=0.005)",
    "detection_method": "in situ hybridization and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 51 CRC patients and controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.2, p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25115394"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "10 pairs of GAC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22325466"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-182",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "116 malignant colorectal adenocarcinoma specimens and 60 paired non-cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : predicts poor overall survival (p=0.007)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24615484"
  },
  {
    "miRNA_name": "miR-182-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-1826",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-1827",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical tissues from 94 patients with CRC.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with advanced clinical stag, lymph node metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24150523"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "Plasma from 118 CRC patients and 61 healthy , CRC tissues and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.829",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS) and lower overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Associated with lymph node metastasis, distant metastasis, higher pTNM stage (III-IV), and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25629978"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22891887"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "32 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25211657"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "65 GC & matched adjacent normal tissues,GES-1,MGC-803,MKN28,SGC7901,AGS,HGC27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(gc cell lines), p<0.001(gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-183 had lower survival rate(P=0.020)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-183 expression levels were significantly associated with increased tumor type(P=0.003),presence of distant metastasis(P=0.018) and increased tumor-node-metastasis stage(P=0.019)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25295122"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "52 pairs of paraffin embedded GC & adjacent  normal tissues,MGC-803,SGC-7901,BGC823,MKN45,MKN28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low expression is associated with poor prognosis(p=0.008)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Levels of miR-183 expression were associated with lymph node metastasis and pathological TNM stage (P=0.005 and P=0.007, respectively).",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25337200"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Stage II tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : shorter survival in low expression grp(p<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression was  associated with histological differentiation(p<0.05),lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22851079"
  },
  {
    "miRNA_name": "miR-183",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-183-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "23 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.016",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24025511"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "28 ESCC and 35 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-185;AUC was 0.73(95% CI  0.604-0.855)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316588"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES-1,SGC7901,BGC823,MKN28,MGC803,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : low miR-185 level correlates with shorter survival(p<0.0001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-185 suppresses tumor metastasis in GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24352663"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "25 patients GC & normal  tissues.GES1,SGC7901,BGC823,MGC803,NCI-N87,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-185 enhances the sensitivity of GC cells to chemotherapy(cisplatin or doxorubicin)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763054"
  },
  {
    "miRNA_name": "miR-185",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 50 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21573504"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood Tissue Stool",
    "sample": "Blood, tissue, stool;  39 patients with Colorectal Neuroendocrine tumor , blood and stool from 25 patients with hemorrhoids or other non-neoplastic diseases.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885189"
  },
  {
    "miRNA_name": "miR-186",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "64 surgical fresh tissues, ECA-109,KYSE30,Het-1a",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Inverse correlation between miR-186 expression level and differentiation grade(p=0.013),lymph node metastasis(p<0.001) and TNM(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26568291"
  },
  {
    "miRNA_name": "miR-186*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.35, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-187",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Associated with depth of invasion (P = 0.005), tumor size (P = 0.024), lymph node metastasis (P = 0.048), and TNM stage (P = 0.035)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27864146"
  },
  {
    "miRNA_name": "miR-188-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "HR=1.538; p = 0.010",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.48",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Twenty-five CRC tissue samples and adjacent normal colon tissue samples , cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26398009"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "miR-18a overexpression group had a poorer clinical prognosis than the low expression group (P=0.07)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.4, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4, p<0.04",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs, 199 polyps and 198 normal controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "array followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Plasma",
    "sample": "10 ESCC &11 normal tissues,106 ESCCplasma,54 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues,cell lines plasma),down in postoperative than preoperative (p=0.0076)",
    "significance": "p=0.002(tissues),p=0.0121(cell lines),p<0.0001(plasma),AUC for plasma=0.9449",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23579215"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Positive correlation of miR-18a with tumor stage(p=0.025)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23322197"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Plasma Cell-line",
    "sample": "21 paired GC & adajcent normal FFPE  tissues,104 GC  & 65 healthy  plasma,preoperative and postoperattive plasma,MKN28,MKN45,MKN74,NUGC4,HGC27,KATO III,WI38",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in gc tissues,plasma,preoperative plasma",
    "significance": "p=0.0286(gc vs normal tissues),p<0.0001(gc  vs healthy plasma),p=0.0002(preoperative  vs post operative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24626859"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "ISH",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173586"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-18a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.47 by microarray and 8.44 by real ime PCR",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-18b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "Plasma of rectal cancer patients (n = 42)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Reduced expression during chemoradiotherapy was found to be significantly associated with postoperative lymph node negativity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-190",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-190b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0264",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 pairs of GAC  & matched normal gastric tissues, MGC803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(cell line)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21947487"
  },
  {
    "miRNA_name": "miR-191",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "75 GC & adjacent normal tissues,57 GC & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-191 in serum & tissue)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: serum miR-191 is a potential GC diagnostic marker(ROC=0.0849,95%CI:0.78-0.92)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "miR-191 level correlates with tumor size(p<0.01 ,stage IV vs stage II and p<0.05 stage IV vs stageIII) and metastasis (p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-191-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Associated with increased tumor sizes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.00001(miR-192 BE vs healthy esophagus),p<0.05(miR-196a)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 tissues,SHEE,Kyse150,KYSE510,EC9706,TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression correalated with pathological stage and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26339371"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulation associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981590"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "118 GC & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Tumor-size",
    "tumor_size_details": "Expression of miR-192 was significantly lower in the pT4 stage of gastric cancer than in pT1, pT2 and pT3 stages (p = 0.026) and low miR-192  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 )",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "GC,DM,NDM plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in Gc/DM)",
    "significance": "p<0.01( GC/DM vs GC/NDM & Hc group  plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC for plasma miR-192=0.732(95%CI,0.625-0.841,p<0.01),Prognostic :  plasma miR-192 level not associated with OS  in GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24481716"
  },
  {
    "miRNA_name": "miR-192",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "113 colon adenomas, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Decreased with higher histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-192-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-193-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26753960"
  },
  {
    "miRNA_name": "miR-193a-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "KYSE150,KYSE410",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "miR-193a-3p regulate chemoradiation resistance in EC cells via PSEN1 gene, overexpression of miR-193a-3p increases radioresistance and chemoresistance of ESCC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26743123"
  },
  {
    "miRNA_name": "miR-193a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "304 formalin-fixed, paraffin-embedded specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0060",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Downregulated regulation associated with poorer survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25232258"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "OE21,OE33,KYSE450,OE19",
    "expression": "Upregulated",
    "expression_details": "Upregulated (chemosensitive cell line)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "OE21,OE33(5FU chemosensitive),KYSE450,OE19(comparatively chemoresistant to 5FU)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26878873"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC and BE",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "22 EC & 14 BE & their corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation of promoter mediated silencing of miR-193b in EC and BE  tissues)",
    "significance": "p=0.001(EC tissues vs normal),p=0.002(BE vs normal)",
    "detection_method": "qRT-PCR,MSP,BSP  analysis",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27176876"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 pairs of GC & matched ANTTs  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high fold change of down regulated miR-193b had significant shorter survival time compared to low fold change of down regulated miR-193b",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Down expression of miR-193b was significantly correlated with  Lauren type,differentiation ,UICC,stage,invasion and metastasis of GC(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-193b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27071318"
  },
  {
    "miRNA_name": "miR-193b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0226, p=0.03595",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum,  55 patients with CRC and 55 control subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Inversely corelated with advanced TNM stages",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318304"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "30 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated at tumor invasion front",
    "significance": "Fold Change=6.5, p = 0.0001",
    "detection_method": "Microaray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Downregulated at liver invasion front",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Associated with increased tumor sizes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 healthy volunteers and 227 patients with advanced colorectal adenoma, FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Sensitivity and specificity were 76.1% and 77.2% in prospective cohort",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Low expression is predictor of Recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24691499"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 normal colorectal mucosa cases, 40 colorectal adenomas cases and 40 CRC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Tumor-size",
    "tumor_size_details": "Associated with large tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25285168"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HEEpic,ECA109,TE1,TE6,TE12,TE14,TE8",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(TE6,TE12,TE14),p<0.05(TE1,ECA109,TE8)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27480251"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 pair of gastric tumor & non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-194 is significantly associated with tumor size,location invasion and TNM",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25412959"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "119 patients tissues,SGC7901,MGC-803,BGC-823",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (cell lines),no difference  in tissues",
    "significance": "p<0.001( cell lines),not significant in tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Lower miR-194 expression tends to have larger tumor size(p=0.002),more advanced pT stage(p=0.028) and miR-194 have significant lower expression in Borrmann IV than in I,II,III group(p=0.019), Lower expression in male than in female(p<0.034)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21845495"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fifty pairs of gastric cancer and adjacent noncancerous tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24748184"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "43 paired tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27810403"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "25 paired tissues,SGC7901,NCI-N87,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27874950"
  },
  {
    "miRNA_name": "miR-194",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "Diffuse type gastric cancer(DGC), plasma-50 DGC and healthy cobtrol",
    "expression": "No Significant Difference",
    "expression_details": "No alteration",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- AUC-0.512,plasma miR-194 level is not a biomarker for DGC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27909811"
  },
  {
    "miRNA_name": "miR-194-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 pairs ESCC tissues,9 pairs dysplasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC)",
    "significance": "p<0.05(in ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24025765"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 pairs tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Negatively correlated with TNM(p=0.008),lymphatic metastasis(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400770"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES1,AGS,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "53 paired tissues,80 GC & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.765)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "Tissues,62 GC & 36 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05( tissues & serum)",
    "detection_method": "QF-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Negative correlation with the infiltration depth, the extent of differentiation, the clinical staging and lymph node metastasis (all p <0.05), but not correlated with tumor locations (p >0.05).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27097947"
  },
  {
    "miRNA_name": "miR-195",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Two colorectal cancer cell lines and 85 colorectal cancer and paired normal patient samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlates with poor prognosis  reduced expression of miR-195 was an independent predictor of overall survival.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21390519"
  },
  {
    "miRNA_name": "miR-195-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-195-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "11 paraffin tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated with progression of EA",
    "significance": "N/A",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19342367"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-196a had positive correlation with progression from intestinal metaplasis to adenocarcinoma",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "TE-1,EC-109",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27621035"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue Saliva",
    "sample": "Tissues, saliva",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(tissues)",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095062"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 pairs of GC & matched ANTTs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: overall survival time for low fold change of upregulated miR-196a was significantly lower than that with high fold change of upregulated miR-196a",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Overexpression of miR-196a was significantly associated with poor differentiation(p=0.022)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25374225"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66 GC & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25474430"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 GC & adjacent normal tissues,MGC803,MKN-28,SGC7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissue and cll lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher miR-196a expression was correlated with shorter OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Higher miR-196a expression was associated with tumor size,a higher clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22343731"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "72 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22420029"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 GC & 33 normal samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- both miRNAs are potential biomarker for GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24527072"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "109 GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196a have poorer 5 year survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma),p=0.004(preoperative vs postoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic & Diagnostic :Circulating miR-196a exhibited higher diagnostic capacity than combined miR-196a/b or miR-196b alone",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "miR-196a was closely associated with grossly infiltrative type (p < 0.001), larger tumours (p < 0.001), histological type (p = 0.015), depth of invasion (p < 0.001), serosal invasion (p < 0.001), lymph node status (p < 0.001), lymph node metastasis (p < 0.001), distant metastasis (p < 0.001), pathological stage (p < 0.001/), liver metastasis (p < 0.001/), peritoneal seeding (p < 0.001), vascular invasion (p = 0.001), lymphatic invasion (p < 0.001), and perineural invasion (p < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420607"
  },
  {
    "miRNA_name": "miR-196a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 126 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.726",
    "detection_method": "with laser capture microdissection and quantitative real-time PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "For discriminating chemoresistant colon cancer",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.71",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "63 surgically resected tissues and paired normal",
    "expression": "Upregulated",
    "expression_details": "Upregulated in  40/63 (63.5%)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Correlate with tumor stage and associated with the absence of lymph node invasion (N0)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27902469"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "South Korea",
    "sample_type": "Tissue",
    "sample": "12 pairs of & non cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.007",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: poor prognosis(p<0.001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24222951"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "109 GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: upregulation of miR-196b have poorer 5 year survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24933454"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Plasma",
    "sample": "98 GC & 126 healthy plasma,",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC & preoperative plasma)",
    "significance": "p<0.001(gc vs healthy plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic& Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "miR-196b was closely associated with grossly infiltrative type (p <0.001), larger tumours (p <0.001), histological type (p =0.018), depth of invasion (p < 0.001), serosal invasion (p <0.001), lymph node status (p<0.001), lymph node metastasis (p <0.001), distant metastasis (p <0.001), pathological stage (p/<0.001), liver metastasis (p<0.001), peritoneal seeding (p = 0.001), vascular invasion (p <0.001), lymphatic invasion (p < 0.001), and perineural invasion (p <0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27420608"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=9.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-196b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-196b*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=10.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-196b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "34 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Genechip-microarray analysis,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28053808"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-115",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 EC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (good prognostis compared to poor prognosis patients",
    "significance": "p=0.043",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117314"
  },
  {
    "miRNA_name": "miR-197",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/5FU",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in 5FU resistant SGC7901/5FU)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression enhances 5FU sensitivity in SGC7901/5FU cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26151540"
  },
  {
    "miRNA_name": "miR-1973",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.14, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (poor prognosis )",
    "significance": "p<0.05 ( poor vs good prognosis samples)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24175778"
  },
  {
    "miRNA_name": "miR-198",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 paired GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognosis-poor survival(p<0.001) in low expression group",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "miR-198 level was associated with tumor size (p = 0.009), tumor depth (p = 0.005), lymph node metastasis (p = 0.03), and clinical stage (p = 0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852230"
  },
  {
    "miRNA_name": "miR-1995p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 pairs of primary CRC samples and their corresponding liver metastasis tissues (8 pairs of fresh frozen and 48 pairs of paraffin-embedded specimens)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Higher in primary tumors than in matched liver metastases (p=0.007), high in stage III patient without metastasis (p=0.028)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with long overall survival (p=0.01)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Higher in primary tumors of patients with stage III CRC without liver metastases than in CRC patients with liver metastases",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26259252"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 colorectal cancer cases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic facctor for survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Contributed to more advanced lymphatic invasion, lymph node metastasis, liver metastases and late TNM stage in colorectal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292866"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Post-operative serum Vs. pre-operative serum, 30 paired serum samples, 84 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.016",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with deep wall invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25269744"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "52 GC & matched non-tumor  tissues,GES-1,MKN-45,BGC-823,MKN-28,AGS,SGC-7901,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001( tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-199a-3p high expression group had inclination towards TNM stage(P=0.037),invasion depth(P=0.08)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25448600"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "210 GC & 110 healthy plasma(qRT-PCR)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker,ROC- 0.837 with 80% sensitivity and 74% specificity",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22956063"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 GC post & pre operative plasma & 70 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential diagnostic marker(AUC=0.818,sensitivity=76%,specificity=74%,accuracy=75%)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23733518"
  },
  {
    "miRNA_name": "miR-199a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES1,AGS,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(AGS),p<0.01(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24065659"
  },
  {
    "miRNA_name": "miR-199a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "34 matched GC & adjacent normal tissues,MKN45,MKN28,SGC7901,BGC823,HGc27,AGS,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Higher miR-199a-5p expression level was associated with increased likelihood of lymph node metastasis and later TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24655788"
  },
  {
    "miRNA_name": "miR-199b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of CRC metastatis tissues and primary CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with longer median survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated to late TNM stage and distant metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27145368"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.3",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Surgical tissue specimens from 11 CRC patients and 275 formalin-fixed, paraffin-embedded CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26302825"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0339",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 colorectal cancer tissue samples were obtained from 5 patients with liver metastasis and 20 patients without distance metastasis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.06",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Downregulated in colorectal cancer with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21174058"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from drug-responsive and drug-resistant patients, n=72 for validation",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, Sensitivity=66.7%, specificity=63.9% and AUC=0.679.",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Predicts resistance to FOLFOX chemotherapy in advanced colorectal cancercases",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460313"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs of GC & matched adjacent non neoplastic tissues,SGC7901,NUGC-3 ,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Relative expression of miR-19a increased in patients with lymph node metastasis or with stage I and II were higher than patients without lymph node metastasis or stage III(p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25400827"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 GC & adjacent normal tissues,SGC7901,NUGC-3,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Relative more expression in patients with lymph node metastasis or with stage I/II disease than in patients without lymph node metastasis or stage III disease",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25914465"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "MDR cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (MDR cell lines)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23603256"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "GES-1,MGC803,BGC823,MKN28,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23621248"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: independent prognostic factor associated with OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Exprression of miR-19a remote metastasis(p<0.001) ,  TNM stage(p<0.001),lymph node metastasis(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-19a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.4, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls, serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC=0.830",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "30 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated at tumor invasion front",
    "significance": "Fold Change=7.7 at the tumor invasion front (p = 0.0001)",
    "detection_method": "Microaray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for colorectal liver metastasis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Downregulated at liver invasion front",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21722265"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Positive correlation of miR-19b with tumor size(p=0.005),lymph node metastasis(p=0.040),clinical stage(p=0.011)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "MDR cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (MDR cell lines)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23603256"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 & adjacent normal  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression of miR-19b  associated with remote metastasis(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24675462"
  },
  {
    "miRNA_name": "miR-19b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Low expression associated with adverse clinicopathological characteristics including poor differentiation, large tumor size and advanced TNM stage.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27572553"
  },
  {
    "miRNA_name": "miR-19b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19b-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.6, p=0.021",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-19-b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA, Twenty CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-19b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray profiling,qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "TTNM III stage:AUC=0.822 for miR-19b-3p . Poorly diffrentiated: AUC=0.791",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25897338"
  },
  {
    "miRNA_name": "miR-20",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Tissue Stool",
    "sample": "Tissues, faecal; Forty pairs of primary CRC and its adjacent normal tissues and Faecal samples from 595 subjects (198 CRCs, 199 adenomas, and 198 neoplasm-free controls).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissues p=0.0065, faecal<0.0001, AUC=0.83",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosis: screening",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26621842"
  },
  {
    "miRNA_name": "miR-200",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Sweden",
    "sample_type": "Tissue",
    "sample": "60 FFPE  primary colorectal tumors, normal colon mucosa, and matched liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "in situ hybridization and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low miR-200 expression in colorectal liver metastases was associated with bad prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Downregulated in metastatic compared to non metastatic CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24376848"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "TCGA Dataset",
    "sample": "Cohort of 111 patients and 217 patients of the Cancer Genome Atlas data set",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "microarray followed by in-situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker - low miR-200a expression was associated with poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24504363"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients treated with fluoropyrimidines and high levels of miR-200a and miR-200c had longer overall survival",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostric",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "18  EBV-asssociated GC & 18 EBV negative GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0107",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20484038"
  },
  {
    "miRNA_name": "miR-200a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-200a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Higher in stage III–IV CRC patients than in controls (P < 0.001 for both) and stage I–II CRC patients (P = 0.006 and P < 0.001, respectively)",
    "significance": "AUC=0.74",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished stage I-IV CRC from healthy controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "144 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.05",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "High plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "88 tissues,7 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-200b correlated with lymph node metastasis and advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "18  EBV-asssociated GC & 18 EBV negative gc",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20484038"
  },
  {
    "miRNA_name": "miR-200b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-200b level correlate with advanced TNM(p<0.05),lymph node metastasis (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated or high",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-200C",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor and peritumoral tissues of 101 colon cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Significantly correlated with the TNM stage, lymph node metastasis, and invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24682933"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "EMT positive tissues, 45 patients with colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Forty eight snap frozen clinical colorectal samples (24 colorectal cancer and 24 paired normal patient samples)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0017",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with patient survival (p = 0.0122).  The patients with higher  miR-200c expression had a shorter survival time",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18079988"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001, Fold Change=3.1",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Serum",
    "sample": "3-phase study using FFPE tissue and serum from 446 colorectal specimens,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker for CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Higher in stage IV than in stage I-III CRCs: Predictor for lymph node metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23982750"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "L-OHP-resistant SW620 cells, SW620 cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated regulation causes selective resistance to L-OHP and EMT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25757925"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Tissue",
    "sample": "45 CRC tisues",
    "expression": "Downregulated",
    "expression_details": "downregulated in EMT positive Cancer",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with degree of tumor differantiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26335822"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA Dataset",
    "sample": "255 CRC tumor samples from The Cancer Genome Atlas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "For survival p<0.01",
    "detection_method": "TCGA data",
    "marker": "Prognostic",
    "marker_details": "Related to overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28567416"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Chemotherapy surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-200c)",
    "significance": "p=0.0196",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-up 200c(p=0.037),up miR-21(p=0.048),down miR-145(p=0.023)",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-200c expression correlated with response to chemotherapy(p=0.009 for clinical response &p=0.007 for pathological response)",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-200c expression associated with tumor depth(p<0.001),lymphatic invasion(p=0.0220),vessel invasion(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21248297"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.017",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC specimens, SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (due to highly methylated CpG island located Upregulatedstream or Upregulated TGF-beta signalling",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-200c and miR-141 expression was inversely correlated with disease free survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Decitabine increased miR-200c and miR-141 expression",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression of miR-200c was inversely correlated with TNM stage,tumor invasion depth,tumor embolus",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25502084"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired normal & gastric tumor tissue",
    "expression": "No Significant Difference",
    "expression_details": "No significance difference",
    "significance": "p=0.1752",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26894855"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Blood",
    "sample": "52 patients & 15 healthy blood",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.018(blood)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC-ROC was 0.715(p=0.012),sensitivity=65.4%,specificity=100%,accuracy rate=73.1%.Prognostic : Increased miR-200c level had poor OS(9 vs 24 months;p=0.016),PFS(4 vs 11 months;p=0.044)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Increased miR-200c expression levels correlates with no. of lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22954417"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 pairs of Gc & matched adjacent tissues,GES1,MGC803,BGC823,MKN28,SGC7901,HGC27,AGS,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-200b/c correlate with short survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-200c level correlate with advanced TNM(p<0.05),lymph node metastasis (p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23995857"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum levelof miR-200c",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with tumor grade(p=0.01) & TNM stage(p=0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26662382"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 GC and paired normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28113080"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 paired GC and distal normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28955960"
  },
  {
    "miRNA_name": "miR-200c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues from 127 surgically resected patients with stage I-III CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prognostic predictor: associated with longer overall survival,",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients treated with fluoropyrimidines and high levels of miR-200a and miR-200c had longer overall survival",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24510588"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-200c-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Prognostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "NCBI GEO",
    "sample_type": "GEO Dataset",
    "sample": "Nine samples from responders and 29 from non-responders in GEO Dataset, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-202",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 ESCC & matched adjacent non cancerous tissues,HEEC,ECA109,KYSE510",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27045085"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431272"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV).",
    "expression": "Upregulated",
    "expression_details": "Higher in stage III–IV CRC patients than in controls (P < 0.001 for both) and stage I–II CRC patients (P = 0.006 and P < 0.001, respectively)",
    "significance": "AUC=0.757",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Separated stage III-IV CRC patients from stage I-II",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues of 212 patients with gastric or colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Tumor-size",
    "tumor_size_details": "Low expression of miR-203 was correlated with tumor size (p = 0.015) and pT stage (p = 0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21063914"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues collected from 106 black and 239 white patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-203 was associated with poor survival of whites with stage IV colorectal cancers, but in blacks it was an indicator of poor survival of patients with stages I and II colorectal cancers",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23719259"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "72 pairs of CRC tumor tissues and their corresponding adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with an advanced clinical tumor-node-metastasis stage, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27376958"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues of 122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with distant metastasis (DM), lymph node metastasis (LNM), and TNM stage (P < 0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue Serum",
    "sample": "Short-term survivors compared to long-term survivors, Samples from 100 patients were used in the tumor cohort, and samples from an additional 50 patients were used in the serum cohort.",
    "expression": "Upregulated",
    "expression_details": "Overexpressed",
    "significance": "p=0.010",
    "detection_method": "next-generation sequencing followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictor of short term survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27935861"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "145 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.007",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "High plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.00001( miR-203 BE vs healthy esophagus)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22094011"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-203 in EAC)",
    "significance": "p<0.0001(miR-203 in EAC vs control mucosa)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-203 have shorter DFS in EAC (p=0.026)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs of H.pylori positive & negative tumor & normal tissues,SGC7901,AGS,MKN45,BGC-823,BGC-803,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori positive normal & tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25373785"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "130 GC & 22 healthy control serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in stage IV than in I &III)",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Low miR-203 expression levels were significantly associated with T stage, male sex (P = 0.018), lymphatic invasion (P = 0.0004), venous invasion (P = 0.0057), high tumor depth (P < 0.0001), lymph node metastasis (P < 0.0001), liver metastasis (P = 0.0058), peritoneal metastasis (P = 0.0001), and distant metastasis (P < 0.0001) and early recurrence",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26233325"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0299",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-203",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "122 CRC patients (with non-tumor tissues as controls) and those from 30 healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "TaqMan® MicroRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with distant metastasis (DM), lymph node metastasis (LNM), and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27714672"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=8.5246, p=0.0000345",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203a or hypermethylation of the miRNA\nshowed significantly poorer 5-year survival rates",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-203a  associated with TNM stage,pathological diferentiation,UGIC family history,LN metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-203a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (proximal promoter methylation)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic- stge III and stage IV low expression in GCA patients had poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low expression in stage III & stage IV GCA",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27791400"
  },
  {
    "miRNA_name": "miR-203b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "119 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-ESCC patients with reduced expression\nof miR-203b showed significantly poorer 5-year survival rates",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-203b associated with TNM stage,pathological diferentiation,UGIC family history,LN metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26577858"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs of H.Pyloro positive & negative tumor tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori postive tumor tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24984017"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Rome and Italy",
    "sample_type": "Tissue",
    "sample": "84 gastric tumor & matched peritumoral tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower miR-204 had worst survival(p=0.017)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23152059"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "24 GC & matched normal tissues,AGS,BGC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-204 expr. Was lower in metastasis group than in non-matastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23768087"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 GC and matched nontumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26729198"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "115 GC 7 40 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in GC plasma samples),Upregulated(after treatment)",
    "significance": "p<0.01( for gc vs normal & before treatment vs after treatment plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis (P = 0.016), tumor differentiation (P = 0.001), and TNM stage (P = 0.005).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173244"
  },
  {
    "miRNA_name": "miR-204",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "54 GC & 54 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "ISH",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-204 level was significantly associated with no lymph node metastasis (P = 0.003) and early tumor stages (stages I-II; P = 0.048).",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28133610"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "272 paired colorectal cancer and Normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "therapy": "Chemotherapy",
    "therapy_details": "Increases sensitivity to oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25294901"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-204-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "Prospectively in 36 pairs of samples of CRC tissue and adjacent noncancerous tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with lymphatic metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24935592"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Cell-line",
    "sample": "ESCc cell line-OE21,TE5,TE8,TE10,TE11,Het-1a,tissues",
    "expression": "No Significant Difference",
    "expression_details": "No difference",
    "significance": "Not significant in tissues",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21426561"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-205 in ESCC positively associated with lymph node(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC =0.85(95% CI:0.79-0.93;sensitivity=76%,specificity=84%",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC and EAC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "17 paired EAC & adjacent normal tissues & 22 ESCC ,22 EAC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in EAC compared to normal & ESCC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : decreased level of miR-205 in tumor tissues correlates with poor OS in EAC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26711784"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "120 FFPE tissues,KYSE30,KYSE450,KYSE30/RR,KYSE450/RR",
    "expression": "Upregulated",
    "expression_details": "Upregulated (KYSE30/RR,KYSE450/RR,tumor tissues)",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: ESCC patients with high miR-205 expression had poorer overall survival than with low mir-205 expression",
    "therapy": "Radiotherapy",
    "therapy_details": "SP1 mediated transcriptional activation of miR-205 promotes radioresistance through PTEN",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-205 expression was positively associated with tumor differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27974696"
  },
  {
    "miRNA_name": "miR-205",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 pair GC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-205 expression level was significantly correlated with the progress of tumor invasion (p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24763883"
  },
  {
    "miRNA_name": "miR-205-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.1074, p=0.005377",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissue compared to control tissue",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Downregulation associated with poorer overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26406866"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "220 self pair of GC & adjacent non-cancer tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Independent Prognostic factor",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression is significantly associated with great depth of invasion,positive lymph node and distant metastasis and advanced TNM stage of human GC(all p<0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25960238"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 GC & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26186594"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Sample Cell-line",
    "sample": "30 GC samples,GES1,SGC7901,MKN28,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Lower miR-206 expressionSignificantly correlated with patients differentiation grade and TNM stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23348698"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 GC  & adjacent normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Shorter overall survival(p=0.02)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Low miR-206 expr. Had greater extent of lymph node metastasis(p=0.01),venous invasion(p=0.008),hematogenous recurrence(p=0.01),worse stage(p=0.03)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23751352"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "35 patients paired  tissues,SGC7901,BGC823, MGC803,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Cisplatin docetaxel treatment suppressesgc cell movement via regulating miR-29c-mediated catenin-δ axis",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Reduction of miR-206 expression was significantly associated with lymphatic metastasis,local invasion and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24855559"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "20 pairs of primary GC tumors & lymph noide metastasis ,MKN28-M,MKN28-NM,SGC7901-M,SGC7901-NM,GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in lymph node metastasis)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25653235"
  },
  {
    "miRNA_name": "miR-206",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "150 GC & 150 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic:AUC=0.89,sensitivity=78%,specificity=86%, Prognostic : low serum level(OS & DFS both p<0.001), Recurrence vs non recurrence AUC=0.85",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Low expression associated with deep local invasion (P = 0.007), positive lymphatic metastasis (P = 0.009), and advanced TNM stage (P = 0.001),higher recurrence rate(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27614739"
  },
  {
    "miRNA_name": "miR-208",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 pair tissues,NEEC,KYSE410,KYSE30,KYSE510,KYSe520,EAC109,TE1,KYSe410,KYSe180,Ec18,HKESC1,108CA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(ESCC cell lines  vs NEEC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25023649"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.6",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "Blood samples from 100 CRC patients and 79 cancer-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261602"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.6, p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers. feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 patients with primary CRC who underwent surgery without preoperative treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of low survival rates",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24737193"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "56 paired GC & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25115392"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "28 GC & adjacent normal tissues,GES1,SGC7901,MKn45,NUGC3",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines),p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-20a promoted chemoresistance(cisplatin,docetaxel) of GC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23924943"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "Plasma ,tissues,SGC7901/DDp,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in cisplatin resistant cell line",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26286834"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "GC & healthy Plasma,gc FFPE tissues,normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP,preoperative plasma,gc FFPE )",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27357419"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Pre and post operative serum samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (postoperative serum)",
    "significance": "p<0.01( 55 paired pre-postoperative),p<0.05( 15 paired pre-postoperative serum)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: miR-20a serum level",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Serum level correlated with  differentiation degree,lymph node metastasis,age,tumor stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28413641"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=16.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "Plasma, n=42",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Reduced expression during chemoradiotherapy was found to be significantly associated with postoperative lymph node negativity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25990502"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-20a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-20a*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.41",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-20a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,  11 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with survival: For Survival p=0.024",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue Stool",
    "sample": "Tissue and Fecal samples from 20 CRC patients and 20 age/sex-matched healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-20a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-20b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "38 tumor & adhjacent normal tissues,Het-1A,TE-1,Eca-109,EC9706,KYSE-150,SKGT-5",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues,TE-1),p<0.01(EC9706,KYSE150,SKGT-5)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27701465"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "Paired tumor and normal mucosa samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Associated with poor response to adjuvant chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21099344"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "764 patients diagnosed with stage II colon cancer, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "In situ hybridisation",
    "marker": "Prognostic",
    "marker_details": "Patients expressing high levels of miR-21 had significantly inferior recurrence-free cancer-specific survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23011541"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 156 patients were treated at Japanese",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0008",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival in both the stage II/III Japanese cohort",
    "therapy": "Surgery",
    "therapy_details": "High miR-21 was associated with poor therapeutic outcome",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Significantly higher in T4 cases than T1, T2, and T3 cases, higher in node positive than node negative colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "FFPE Tissues from 301 patients who had undergone surgical excision of CC. Rectal cancer patients were excuded. Of 301, 145 patients were German",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.047",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor survival in stage II German cohhort",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24122631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "32 patients who underwent primary tumor resection and received palliative chemotherapy for unresectable metastatic CC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "For pFS (p=0.0109) and OS (p=0.0675)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Associated with reduced progression-free survival (PFS) and overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798874"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S,  CRC tumours of patients that had undergone adjuvant 5-FU treatment (n = 11)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Treatment with antagonist sensitized 5FU resistant CRC",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "RKO cells",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Mediate drug resistance to 5-FU",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26418978"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer liver metastasis; formalin-fixed paraffin-embedded (FFPE) tissue samples of primary colorectal cancer, liver metastasis and healthy tissues of 29 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with liver metastasis in colorectal cancer",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26845148"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "24 patients <40 years of age with colorectal carcinoma, and 45 patients > or =40 years of age served as controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.005",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Associated with early onset in young patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19047896"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Thirty-four endoscopically resected colorectal polyps and 39 surgically excised colorectal tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Locked nucleic acid in situ hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19509156"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Sessile serrated adenomas (SSA) without cytologic dysplasia vs. Hyperplastic polyp (HP),  18 HPs, 19 SSAs without cytologic dysplasia and 20 normal colonic mucosal specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.82, p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19547998"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0289",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples from 8 healthy volunteers and 29 samples collected via fecal occult blood testing from subjects with normal colonoscopies, colon adenomas, and CRCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20551304"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "46 patients with CRC, Paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "patients with a higher expression of miR-21 had disease-free interval",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20620599"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "130 stage II colon and 67 stage II rectal cancer specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Correlated significantly with shorter disease-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21069438"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosttic/Screening marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 42 patients with colorectal cancer (CRC)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity=80% and Specificity=88.2% for response to therapy",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Associated with chemotherapeutic response",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Correlated with advanced clinical stage and poor cell differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22289545"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Positively correlated with the clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma from 20 CRC patients and 20 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "90% specificity and sensitivity",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "316 patients, 193 prospectively recruited patients with colorectal cancer,",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 186 CRC patients, 60 postoperative patients, 43 advanced adenoma patients, and 53 control subjects.  And tissues from  166 matched primary CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic marker - high miR-21 expression was associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "High miR-21 expression significantly associated with tumor size, distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23704278"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "Tissues from 195 colorectal cancer patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "DNA sequencing and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis: patients with APC mutation/high miR-21 had poorer overall survival rates than those with APC mutation/low miR-21, APC wild-type/high miR-21 and APC wild-type/low miR-21",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23773491"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Blood",
    "sample": "Blood samples were collected from 102 CRC patients undergoing surgery with curative intent.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent predictor of survival: increase in miR-21 expression was associated with a 50% reduction in the risk of mortality",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Lower expression levels of serum miR-21 were associated with higher local recurrence and mortality.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23970420"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples (N=224) from CRC patients including 116 consecutive patients of Localized-CRC  and 108 consecutive patients of metastatic CRC. mCRC vs. LCRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Non invasive marker for metastatic colorectal cancer: upregulated-regulated in mCRC when compared with L-CRC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24653631"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "Serum of 40 patients with colorectaladenocarcinoma and 40 control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with clinical stages of tumors",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25178939"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor tissue, paired normal tissue, Mesenteric Vein blood and Peripheral Vein blood of 57 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated in MV than PV",
    "significance": "p=0.014",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter disease-free survival (DFS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25569638"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "Tissue sections, 277 consecutive patients with T3-4a colorectal cancer treated with R0 surgical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.019",
    "detection_method": "in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter recurrence-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25609245"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.706",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Russia",
    "sample_type": "Blood",
    "sample": "34 EDTA stabilized peripheral blood samples and 34 saliva samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Plasma: p = 0.0001, sensitivity and specificity of 65 and 85% in the plasma; Saliva: p = 5e-12,  Sensitivity=97% and Specificity=91% in the saliva.",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27910062"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma Tissue",
    "sample": "326 CRC patients, plasma exosomes, primary tumor tissues, and liver metastasis tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan miRNA assays",
    "marker": "Prognostic",
    "marker_details": "Prediction of recurrence and poor prognosis in CRC patients with TNM stage II, III, or IV",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28376502"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "20 matched normal & ESCC tissues,TE6,TE8,TE10,TE11,TE12,TE14,KYSE30",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCr,ISH",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression in lymph node metastasis & venous invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19276261"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20428818"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "18 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21104017"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Mature miR-21  in ESCC positively associated with lymph node(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21453382"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "38 paired tissues,TE1 to TE15 cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues) ,highest in TE1 and lowest in T9 among cell lines",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High expression in T3 or T4 than in T1 or T2(p=0.0333)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21475818"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (whole spectrum of preneoplastic/neoplastic lesion)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21883657"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in ESCC serum,low in postoperative than in pre,reduce expression in CT responders)",
    "significance": "p<0.001(ESCC serum vs healthy),p=0.003 (postoperative vs preoperative and responder)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "Chemotherapy",
    "therapy_details": "Serum miR-21 act as response marker for chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22354855"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "50 preoperative plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-21 plasma level as prognostic indicator",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Esophageal Cancer",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "174 solid tumors serum,39 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22638884"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "21 ESCC & 21 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Expression had no significance with CRT",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-21 expression was ssociated with metastasis(p<0.05),not significant with cell differentiation,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22799367"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Exosomes of ESCC & benign disease serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression correlated with advanced tumor stage classification,positive lymph node status,metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23224754"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Saliva Plasma",
    "sample": "32 EC and 16 healthy saliva supernatant",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.003",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic- miR-21 saliva supernatant level: AUC-0.762,sensitivity-84.4%,specificity-62.5%",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant correlation with cancer stage,differentiation & nodal metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23464420"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23504349"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "64 ESCC serum,27 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0030",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- serum miR-200c level",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-200c  associated with poor response to chemotherapy(p=0.0211)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23838916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "42 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0007",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24039846"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 invasive ESCC tissues,30 normal biopsy",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "stem loop RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expressiond  significantly associated with tumor status,lymph node metastasis & clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24221338"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Ec",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Saliva Plasma",
    "sample": "150 saliva,plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma miR-21:sensitivity-96%(stageI),64%(stage II),97%(stageI+IIEC) & specificity(44%,84%.56% respectively for stages), saliva miR-25 :sensitivity-90%,88%,89% respectively for stages and specificity 64% for all stages",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24968850"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 pairs tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25400316"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-21  in EAC)",
    "significance": "p=0.0004(miR-21 in EAC vs normal)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Austria",
    "sample_type": "Tissue",
    "sample": "36 tissues,FFPE",
    "expression": "Upregulated",
    "expression_details": "Upregulated (after neoadjuvant CT)",
    "significance": "p=0.27",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Expression upregulated after CT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25950983"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "76 tissues,TE13",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "T3/T4 patient had higher exoression than T1/T2(p=0.000),lymph node metastasis had higher expression than without(p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26345812"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC and EAC",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "195 FFPE of GEC(129 ESCC,61 EAC,5 stomach)",
    "expression": "Upregulated",
    "expression_details": "High levels of miR-21 significantly correlated with shortened DSS",
    "significance": "HR 1.76 (95% CI 1.05-2.97",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic- miR-21 independent prognostic factor in EAC for DSS but not in ESCC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "Serum ,tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.011(miR-21 serum),p=0.019(miR-21 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Elevated expression of miR-21 reduced the sensitivity of RT",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-21 expression was correlated with infiltration depth,vascular invasion,lymph node metastasis(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma Tissue",
    "sample": "Plasma and surgical resesction",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0409(tissues between low and high response grp),p=0.0029(plasma of low response grp and healthy),p=0.0433(plasma of high response grp and healthy)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Circulating miR-21 is an independent predictive biomarker for chemoresistance in ESCC",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508093"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "Tissues, serum,Kyse170,Eca109",
    "expression": "Downregulated",
    "expression_details": "Downregulated (miR-21 in kyse170,Eca109 with zinc in media)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : high expression level of miR-21 had poor OS(HR2.15,95%CI 1.16-3.97)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-21 expression was associated with pathogenic sites (P = 0.037): high levels of miR-21 were correlated with upper sites but not with gender (P = 0.229), age (P = 0.722), pathological type (P = 0.191), TNM stage (P = 0.618) and Postoperative metastasis (P = 0.349)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC tissues, normal gastric & H.pyloro infected tissuesSGC7901,MKN-45,MKN28,AGS,GES-1, H.Pylori infected gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(gc tissues vs normal),p<0.05(H.pyloro infected vs normal gastric tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired GC & adjacent normal tissues,",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression( AUC =0.7944)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Elevated plasma level in Stage I (p<0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "50 GC & healthy serum and PBMCs",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001 and miR-21 AUC in:serum=0.912, pBMCs=0.898",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  miR-21 AUC in serum=0.912,in PBMC=0.898",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Marker for diagnosis of early (stage I) and late GC (stage IV), Not associated with clinicopathological features",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26063956"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "32 pateints for GC & paired adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: AUC=80.3",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 pairs GC & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18507035"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 GC & normal tissues,GES-1,AGS,SGC7901,MKN28,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated (due to H.pylori infection)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18794849"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 patients(gc & adjacent normal tissues),GES-1,CRL-5971, CRL-5974, BGC-823,AGS,SGC7901,MKN45,HTB-103,MKN28,CRL",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High miR-21 expression was associated with degree of differentiation of tumor tissues(p=0.004),local invasion and lymph node metastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22267008"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "39 GC & 40 normal stromach tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC tissues)",
    "significance": "p=0.02",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22464652"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC patients tissues  without lymph node metastasis (n = 56), GC patients with lymph node metastasis (n = 30), and normal controls (n = 72)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(lymph node metastasis than non )",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic : AUC=0.79,Prognostic : overall survival rate with high miR-21 expression was lower than low expression (p<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High miR-21 exprresion was associated with histological type(p<0.001),T stage(p<0.001),lymph node metastasis(p<.001),pTNM (p<0.05) in univariate amd pTNM(p=.001),lymph node metastasis (p=.001) in multivariate analysis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22792096"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC= 0.7944",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Plasma miR-21 (p=0.003) level was increased in StageI GC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "69 preoperative GC plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic : prognostic factor(p=0.0133,HR=13.4(95% CI=1.72-104.4)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High plasma miR-21 had vascular invasion(p=0.0311)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267156"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated (SGC7901/DDP)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-21 confers cisplatin resistance in Gc cells by regulating PTEN",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23466500"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Pre-operative and post-operative paired plasmas from 42 patients with primary GCs",
    "expression": "Downregulated",
    "expression_details": "Downregulated (post operative plasma of GC)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Plasma miR-21 expression was highly associated with differentiation degree and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24460332"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic :high miR-21 related with lower OS rate, diagnostic: AUC-0.75,sensitivity-0.70,specificity-0.78",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 FFPE paired sample",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Associated with tumor size,TNM stage,lymph node metastasis presence(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26847916"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Colombia",
    "sample_type": "N/A",
    "sample": "N/A",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28489839"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Taqman miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissues, 92 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity=77.6%, Specificity=86.6%, NPV=6%, and PPV=92%",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Correlated with tumor grade after preoperative chemoradiotherapy (P = 0.013) and with pathological response (P = 0.013)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25953218"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "44 paired samples of tumoral and non-tumoral colon tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated to shorter overall survival of CRC patients",
    "therapy": "Chemotherapy",
    "therapy_details": "Silencing miR-21 when combined with chemotherapeutics (5-FU, L-OHP, and SN38), contributed to the decrease of cell viability.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22476768"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR, TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 primary CRC specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3, p =0.025",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Related to TNM stage and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19921579"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "156 CRC patients, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "Prognostic",
    "marker_details": "The overall and disease-free survival rates of patients with high miR-21 expression were significantly worse than those of patients with low miR-21 expression",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Significantly associated with venous invasion, liver metastasis and tumor stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21412018"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.802, p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non-invasive diagnostic marker for early detection of CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-21",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Tunisia",
    "sample_type": "Tissue",
    "sample": "25 pair-matched colon cancer tissues and normal colon mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7, p = 0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24800242"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Tissue Cell-line",
    "sample": "Tumours of patients that had undergone adjuvant 5-FU treatment (n = 11) , Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Hypoxia biomarker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "27 primary and liver metastasis tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qPCR arrays",
    "marker": "Prognostic",
    "marker_details": "Associated with lower survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25075017"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "82 tissues,HE3,HEEpiC,KYSE150,KYSE170,KYSE180",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21044961"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "22 ESCC & 15 healthy  serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25069478"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "Tissue",
    "sample": "19 Hp positive & 16negative gastric specimen,20 normal & tumor biopsies",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in Hp postive gastric specimec and gc biopsies",
    "significance": "p=0.0066(H.pylori positive vs H.pylori negative specimen)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25187177"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 15 patients with colon cancer",
    "expression": "Upregulated",
    "expression_details": "Re-elevated or high",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Re-elevation associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "Re-elevation associated with local recurrence and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24310813"
  },
  {
    "miRNA_name": "miR-210",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 193 CRC patients at the time of surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Correlated with large tumor size, lymph node metastasis, advanced clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24632577"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "miR-211 expression level (P = 0.01) was effective on overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Lymphovascular invasion (P = 0.011), perineural invasion (P = 0.009)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26152286"
  },
  {
    "miRNA_name": "miR-211",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & corresponding normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues & cell lines except AGC),p<0.01(AGS)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823713"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "MSI vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "Tissue Cell-line",
    "sample": "32 pair of Gc and corresponding normal stomach tissues,MKN7,MKN45,MKN74,NUGC3,NUGC4,KATO-III,GC14,TGBC 11TKB",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray analysis,q qRT-PCR, end point RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/20020497"
  },
  {
    "miRNA_name": "miR-212",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "71 paired GC & adjacent normal tissues,SGC-7901,MKN-45,AGS,MKN-28,BGC-823,MGC-803,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in methylated tumor groUpregulated and downregulation is due to promoter hypermethylation)",
    "significance": "p=0.03(methylated vs unmethylated tumors),p=0.35(no significant difference between methylated & unmethylated non-tumor group)",
    "detection_method": "qRT-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "Prognostic: methylated tumor had longer OS than unmethylated",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Hypermethylation of miR-212 was significantly associated with tumor depth, lymph node, UICC staging and peritoneal dissemination,",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26693054"
  },
  {
    "miRNA_name": "miR-21-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal miRNA (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "99 CRC patients (44 with and 55 without liver metastases)",
    "expression": "Downregulated",
    "expression_details": "Dowregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with an unfavorable prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24616020"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-214 expression significantly correlated with pathological grade,tumpr stage,lymph node metastasis and miR-101 expression associated with tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-483 & miR-214 expression predict less chemotherapy effect",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 EC & adjacent non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26807179"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-214  positively correlated with poor tumor differentiation (p=0.004),tumor invasion(p=0.013) and lymph node metastasis(p=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27619677"
  },
  {
    "miRNA_name": "miR-214",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "120 GC & adjacent non tumorous tissues,GEs1,BGc823,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,BGC823),p<0.05(SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-214 overexpr.  correlated with poor prognosis(p=0.03)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High miR-214 expre is significantly associated with invasion(p=0.01),metastasis(p=0.05),TNM(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23834902"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "34 paired normal and colon (stage II and III) tumor specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR and immunohistochemistry",
    "marker": "Prognostic",
    "marker_details": "prognostic biomarker in stage II and III colon cancer -  high levels of miR-215 expression closely associated with poor patient's overall survival.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21752725"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor samples from 71 white patients with stage II colon cancer",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.023",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker: high-risk groupregulated had significantly shorter disease-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27247088"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "107 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Associated with increased tumor sizes",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22969930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "205 stage II, III, and IV colorectal cancer specimens",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Significantly associated with progression free survival (PFS) and/or overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28881738"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulation associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981590"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "118 GC & adjacent non tumor tissues, MGC-803,BGC-823,SGC7901",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (in cell lines only),no difference in tissues",
    "significance": "p<0.01(cell lines),p>0.05(gc vs adjacent normal tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Low miR-215 expression  associated with increased tumor sizes(p=0.003),advanced Borrmann type tumors(p=0.015 and p=0.044)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22205577"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "51 pairs of GC & adjacent non malignant  tissues,GES1,SGC7901,BGC823,NCI-N87,AGS,HGC27,MGC803,MKN28",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05 (tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: potential biomarker(AUC=0.824,95% CI is 0.699-0.947)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-215 expression level was correlated with progression of tumor invasion(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23981575"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "77 paired tissues,AGS,BGC823,HGC-27,MGC803,MKN45,NCI-N87,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Higher expression in advance GC( stage III/IV,p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26716895"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue",
    "sample": "50 paired tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression level correlated with progression of tumor invasion & TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28485164"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,AGS, SGC-7901, NCI-N87, GES-1, MKN-45 ,BGC-823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with the progression of tumor invasion and tumor-node-metastasis (TNM) stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28689850"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-215",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissues were retrospectively collected from 125 stage II/III colorectal cancer patients, which contained 60 patients who relapsed and 65 patients who did not relapse within 3 years after surgery",
    "expression": "Downregulated",
    "expression_details": "downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predictive marker for relapse",
    "therapy": "Chemotherapy",
    "therapy_details": "Patients with high expressions of miR-215 could benefit from 5-fluorouracil-containing adjuvant chemotherapy",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Low expression of miR-215 was significantly correlated with a high probability of 3-year relapse",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23532818"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.3418, p=0.017928",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls, serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC=0.830",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "43 tissues below 40 years age",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in  recurrence groUpregulated)",
    "significance": "p=0.03( recurrence vs nonrecurrence)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Recurrence-predictor of recurrence in young GC patients whose tumors contain a high proportion of intratumoral stroma.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26824898"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Urine",
    "sample": "50 GC patients urine",
    "expression": "Upregulated",
    "expression_details": "Expression level reduced following surgical removal of GC tissues",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28915598"
  },
  {
    "miRNA_name": "miR-21-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Training (n = 27) and a validation (n = 16), rectal tumor biopsies prior to nCRT",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "Sensitivity and specificity of 78% and 86%",
    "detection_method": "deep sequencing followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25496125"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue (n=50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.038",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with shorter overall survival p=0.032",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Significantly associated with poor tumor differentiation (P = 0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26016795"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "83 GC & paired normal tissues,SGC7901,HGC27,BGC823,BGC803,MKN28,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(in human gc tissues),p<0.05(in gc cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with large tumor size(p=0.004),poor differentiation(p=0.008),distant metastasis(p=0.027) and advanced TNM stage(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25869101"
  },
  {
    "miRNA_name": "miR-217",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 GC & adjacent non-tumor gastric tissues,SGC-7901,HGC-27,MGC-803,MKN-45,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26098560"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 63 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "Chemotherapy",
    "therapy_details": "Enhanced 5-FU cytotoxicity by targeting enzyme thymidylate synthase",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26442524"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 189 cases and 30 healthy subjects and sera from 30 CRC patients and 30 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold-change=0.27, p < 0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis - significant association between low miR-218 expression and worse survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with TNM stage, lymph node metastasis (LNM) and differentiation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24294377"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 tissues,NEEc,ECA109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Increases ESCC cells chemosensitivity to cisplatin and suppresses tumor growth",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Negative correlation between TNM stage,lymph node metastasis,tumor depth(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25482044"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum(106 EC &60 healthy)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC:0.833",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Lower expression in lymph node metastasis,poorer differentiation and later stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25812647"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "33 pairs tissues,HEEC,EC109,TE1,EC9706,KYSE150",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,TE1,KYSE150),p<0.001(EC109,ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Lower expression in stage III than in stage I &II",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25999024"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Eca9706,Eca9706-CisR",
    "expression": "Downregulated",
    "expression_details": "Downregulated (Eca9706-CisR)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-218 increases sensitivity to cisplatin in esophageal cancer cells via targeting survivin expression",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28352763"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 noncardia gastric cancer tissues, in 10 H. pylori-infected and 8 uninfected normal gastric biopsies,",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in H.pylori infected tissuse & gc tissues)",
    "significance": "p<0.01( in gc vs paired normal tissues & H.pylori  positive vs normal tissues)",
    "detection_method": "microarray analysis, Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/19890957"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired GC & adjacent normal tissues,",
    "expression": "Downregulated",
    "expression_details": "Downregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma expression(AUC=0.7432)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Decreases plasma expression in Stage- II,III & IV (p<0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "AGC tissues before and after CRS and HIPEC,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-218 increased Gc cell chemosensitivity to cisplatin in vitro and inhibited gastric cell tumor growth in vivo (p<0.05)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170221"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Positive correlation between expression & tumor invasion & metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25694126"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 GC tissues & non tumor mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression was associated with TNM stage(p=0.0010),lymph node metastasis(p=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20300657"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.7432, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC=0.7432",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "68 GC & 56 healthy serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.026",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: decreased miR-218 expression was independent prognostic marker for overall survival /(p=0.035)in addition to presence of tumor metastasis (p=0.005) and high tumor grade(p=0.000)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Serum miR-218 significantly associated with GC metastasis(P=0.003),tumor stage(P=0.018),tumor grade(P=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944481"
  },
  {
    "miRNA_name": "miR-218",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "112 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression associated with tumor differentiation (P < 0.001), depth of tumor invasion (P = 0.006), and TNM stage (P < 0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27323107"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (20 patients) and cell line (HT-29 (P<0.001), Caco-2 (P<0.001), DLD-1 (P<0.001), SW480 (P<0.001) and SW620 (P<0.001) )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26238082"
  },
  {
    "miRNA_name": "miR-219-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "15 patients for GC & adjacent matched normal tissues,GES-1,MGC-803, BGC-823, MKN-45, and SGC-7901,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27983934"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 patients with primary colorectal cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.002",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Reduced miR-22 had a poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression of miR-22 correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22492279"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "118 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 76%",
    "significance": "Fold Change=4 i.e. 76% had reduced expression by 4 folds",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Correlated with relapse free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28422727"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 ESCC, 100 normal epithelium",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRt-PCr",
    "marker": "Prognostic",
    "marker_details": "prognostic-positive corralation between expression & survival patients who received rsdiotherapy(p<0.05)",
    "therapy": "Radiotherapy",
    "therapy_details": "High miR-22 expression sensitizes ESCC cells to irradiation",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with stages of clinical classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23188185"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "89 GC & 41 normal stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "ISH (TMA)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-22 levels were inversely correlated with the tumor stage (P=0.03) and lymph node metastasis (P=0.001).",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25323629"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 pairs of GC & matched normal tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23529765"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 pairs of GC & adjacent norma mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: shorter overall survival(p=0.03)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-22 expr. Had grater extent of lymph node metastasis(p=0.02),distant metastasis(p=0.01),worse stage(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23786758"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901,MKN28,NUGC-3,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,SGC7901),p<0.05(MKN28,NUGC-1)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495805"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "61 paired tissues,Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with aggressive phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26610210"
  },
  {
    "miRNA_name": "miR-22",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "193 colorectal cancer patients, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28347238"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 103 CRC patients and 37 healthy normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non invasive marker for diagnosis and prognosis, prognostic factor for poor overall survival in CRC patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20880178"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 pairs of CRC tissues and 595 stool samples (198 CRCs, 199 polyps and 198 normal controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "array followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive marker for detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233396"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Slovak Republic",
    "sample_type": "Blood",
    "sample": "Peripheral blood of 71 patients and 80 matched healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 80% and specificity of 74% (p<0.0001)",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27798914"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "4 pairs of EAC cell lines & corresponding 5FU resistant variant,14 pairs of EC tumors & surrounding normal",
    "expression": "Upregulated",
    "expression_details": "Upregulated (5FU resistant cell lines & in EAC tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501171"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "32 patients for GC & adjacent normal gastric tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.012",
    "detection_method": "qRT-PCR",
    "marker": "diagnostic",
    "marker_details": "Diagnostic: AUC=93.3",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26209976"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 pairs of Gc & adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression Showed significant correlation with advanced tumour-node-metastasis,local invasion and lymphatic metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22613407"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.Pylori infected tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26364844"
  },
  {
    "miRNA_name": "miR-221",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "4 pair of GC & non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28618968"
  },
  {
    "miRNA_name": "miR-221-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "AGS,BGC-823,SGC-7901,GES-1,HGC-27,18 H.pylori positive & 12 negative tissues,30 GC & corresponding normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in GC & H.pylori positive tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22321642"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "114 gc,36 chronic atrophic gastritis and 56 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "iSH (TMA)",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic: AUC of 0.850 with 66.1% sensitivity and 88.3% specificity,Prognostic: increased miR-222 level have reduced disease free survival(p=0.016) and overall survival(p=0.012)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High level was significantly correlated with clinical stage (p<0.001),lymph node metastasis(p=0.009)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25129310"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.Pylori infected tissues)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26364844"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "200 GC patientstissues (112 H.pylori infected & 88 H.Pylori negative),88 healthy tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001( gc tissues vs normal)",
    "detection_method": "RT-qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27994199"
  },
  {
    "miRNA_name": "miR-222",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "4 pair of GC & non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28618968"
  },
  {
    "miRNA_name": "miR-222-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.6624, p=0.025468",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,  fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue Plasma Stool",
    "sample": "Tissue, stool, and plasma;  62 tissue, 447 stool, and 398 plasma samples were collected from CRC patients and healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum samples from 88 CRC patients, Exosomal miRNA",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive Diagnostic Marker: downregulated after surgical resection",
    "therapy": "Surgery",
    "therapy_details": "Downregulated after surgical resection",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24705249"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Singapore",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=17.5, AUC=0.939, p<0.01, sensitivity=76.5% and specificity=96.4%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 62 patients undergoing radical resection",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with TNM stage and lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270282"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue, 24 pairs of CRC tissues and adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25867276"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "109 resected  tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-high expression poorer prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Expression level associated with gender(p=0.008),tumor size(p=0.042),depth of tumor invasion(p=0.030)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22108521"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "FFPE samples of BE-HD,HGD,EAC,NSE",
    "expression": "Upregulated",
    "expression_details": "Upregulated (Upregulated during BE-dysplasia-EAC sequence)",
    "significance": "p=0.003(BE-ND vs matched NSE tissues),p=0.001(HGD vs NSE),p<0.001(EAC vs NSE)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23757351"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissue",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissue & serum)",
    "significance": "p=0.009(tissue miR-223)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum miR-223",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "Gastroesophageal Carcinogenesis",
    "continent": "Europe",
    "population": "N/A",
    "sample_type": "Tissue Plasma",
    "sample": "280gastroesophageal biopsy,30 plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-223 overexpression was significantly associated with the score of intestinal metaplasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28395057"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "70 GC patients(43 Hp infection & 27 without) & 70 healthy(31 Hp infection & 39 without) plasma, 8 paired GC & adjacent normal tissues,",
    "expression": "Upregulated",
    "expression_details": "Upregulated (distinguish GC patients with or without Hp infection from healthy controls).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic:  plasma expression(AUC=0.9089)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Higher plasma expression in Stage I(p<0.01)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "38 Hp +ve GC & 27 Hp -ve GC tissues,15 normal Hp +ve & 12 Hp-ve normal gastric tissues,SGC7901,AGS,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive normal gastric & Gc tissues & cell lines)",
    "significance": "p<0.001(gc tissue with H.pylori postive vs negative and H.pylori postive vs negative normal gastric tissues and H.pylori postive vs negative SGC7901 ,MKN45 cells)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis of GC in H.pylori positive tissues",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "High expression of miR-223 associated  with large tumor size (p = 0.006), high metastasis (p = 0.002), and poor TNM staging (p = 0.03)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25036956"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "NCI-N87 parent cell,NCI-N87 trastuzumab resistant cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-223 reduced sensitivityto trastuzumab drug",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25159729"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs ofgc & adjacent non tumor tissues,SGC7901,SGC7901/DDP,BGC-823,BGC-823/DDP",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulation of miR-223 significantly increases the sensitivity of 7901/DDP cells to DDp(cisplatin)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25888377"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue Cell-line",
    "sample": "50 GC & 50 healthy plasma,tissues,cells,GES-1,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-plasma expression level(AUC=0.812,sensitivity=70%,specificity=80%)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26629240"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 pairs of GC  & matched normal tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21628394"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "22 GC & matched normal gastric mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.000",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-223 upregulation correlated with lymph node metastasis(p=0.086),metastasis (p=0.002),advanced pathological stage(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22270966"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "60 GC & 60 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated, (plasma levels of miR-223 were significantly higher in GC patients with helicobacter pylori (Hp) infection than those without (P = 0.014), and significantly higher in healthy control subjects with Hp infection than those without (P = 0.016).",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : AUC:0.9089",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Plasma miR-223(p<0.001)  increased in StageI GC patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22860003"
  },
  {
    "miRNA_name": "miR-223",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-223-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7.44",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,  fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "115 colorectaladenocarcinomas and 66 adjacent non-cancer mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong prognosticator, predicts short-term relapse and poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25420464"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy and  UK and  Romania and  Austria",
    "sample_type": "Tissue",
    "sample": "85 CRC samples, CRC tissues from patients with and without metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Shorter overall survival and shorter metastasis free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25804630"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "103 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression associated with advanced clinical TNM stage and pathological grade( both p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26245343"
  },
  {
    "miRNA_name": "miR-224",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC and metastasis positive tissues) &HIF-1α Upregulatedregulates miR-224 expression)",
    "significance": "p<0.01( gc vs adjacent non-tumor tissues),p<0.05(metastatis vs non metastatic)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28173803"
  },
  {
    "miRNA_name": "miR-2392",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28512191"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "92 cases of colon carcinomas were collected with both the tumor and paired normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated in 87.0% (80/92)",
    "significance": "N/A",
    "detection_method": "In-situ hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Upregulation of miR-23a was associated with an advanced clinical stage and depth of invasion,  higher in the tumors with lymph node metastasis than those without",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22455847"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24997345"
  },
  {
    "miRNA_name": "miR-23a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "160 pair of GC tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Co-expression of both miRNAs (miR-23a and miR-23b) in GC tissues was significantly associated with advanced TNM stage(p<0.001),presence of lymph node metastasis(p=0.008),great depth of invasion(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma samples,  96 blood samples were obtained from patients that underwent tumor resection for CRC, 48 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001, AUC=0.842, sensitivity=84.38%; specificity=77.08%",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Shorter recurrence-free survival time and poorer overall survival rate",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Associated with clinical stage, tumor depth, distant metastasis and tumor recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28101227"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "160 pair of GC tissues & normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: combined expression of miR-23a and miR-23b confers poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Co-expression of both miRNAs (miR-23a and miR-23b) in GC tissues was significantly associated with advanced TNM stage(p<0.001),presence of lymph node metastasis(p=0.008),great depth of invasion(p=0.02)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25674252"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "TCGA Dataset",
    "sample": "Stomach adenocarcinoma samples from TCGA Dataset",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26041881"
  },
  {
    "miRNA_name": "miR-23b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "138 GC & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic :AUC-0.80, Prognostic :independent predictor of  OS(p=0.015) &  disease free survival(p=0.004))",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with T stage, distant metastasis, and differentiation",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26835790"
  },
  {
    "miRNA_name": "miR-23b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "24 chemoresistant & 24 chemosensitive patients,SGC7901,SGC7901/vincristine",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/VCR & chemoresistant gc patients)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression had poorer OS",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-23b-3p dramatically enhanced the sensitivity of SGC7902/VCR to 5-FU,VCR,CDDP",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression correlated with distant metastasis(p=0.005)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25996293"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "239 FFPE tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: miR-24 independent predictor for exposure group",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "63 GC & adjacent non tumor  tissues,Ges-1,BGC823,MKN28,KATOIII,SGC7901,NCI-N87,,AGS,MKN45,SNU-1,SNU-16",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low-expression group exhibited significantly lower tumor differentiation (P = 0.021)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24886316"
  },
  {
    "miRNA_name": "miR-24",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "122 tissues atomic bomb survivor",
    "expression": "Upregulated",
    "expression_details": "Upregulated in high dose exposed groUpregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "High miR-24 expression is independent predictor for exposure status",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045155"
  },
  {
    "miRNA_name": "miR-24-2*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 CRC patients who underwent radical resection, Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicators for overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with  local invasion, lymph node metastasis and clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25502080"
  },
  {
    "miRNA_name": "miR-24-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "182 colorectal adenocarcinoma specimens and 86 paired non-cancerous colorectal mucosae",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-24-3p expression predicts poor disease-free survival (DFS) and overall survival (OS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27939727"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.027",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "186 patients who underwent surgery matched adjacent normal tissues and 18 normal tissues from normal controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent prognostic factor",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with tumor invasion, lymph node metastasis, distant metastasis and the TNM stage of colorectal cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24293092"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "22 normal epithelia,24BE,22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with lymph node metastasis status & TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22450326"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated ( in tissues & serum)",
    "significance": "p=0.008(tissue miR-25)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-25 serum associated with lymph node metastasis(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Plasma",
    "sample": "Tissues, preoperative,postoperative and healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC tissues,Upregulated in preoperative compared to healthy plasma,down in postoperative compared to preoperative plasma)",
    "significance": "p=0.0157(ESCC tissues),p=0.0093(ESCC cell lines),p<0.0001(preoperative vs healthy plasma),p<0.0005( postoperative vs preoperative plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25117812"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma Tissue",
    "sample": "Plasma & Primary GC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high plasma concentration had poor prognosis.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High plasma and primary tissues expression in TNM ( stage III or IV) & lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25043310"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "GAC & healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25824045"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25944166"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901,MKN28,MKN45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,SGC7901,MKN45),p<0.05(MKN28)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24078004"
  },
  {
    "miRNA_name": "miR-25",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-25-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands and  Germany",
    "sample_type": "Tissue",
    "sample": "Metastasized and nonmetastasized tumors N = 43",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Next generation sequencing followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Independent prognostic factor",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Twenty-five patients who had undergone esophagectomy with lymph node dissection for EA",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Downregulation related with tumorigenesis and metastasis of EA",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23108995"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 paired ESCC  & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (not related with DNA methylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MSP,BSP-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28476684"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC-7901/DDP,SGC-7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC-7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MTS method",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Sensitizer in chemotherapy(cisplatin) for GC",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458859"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "40 pairs of GC & matched adjacent tissues,MKN 28,SGC7901,AGS,MGC803,MKN45,BGC823,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24015269"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "50 paired tissues,80 GC & 80 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001(tissues),p<0.001(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma level (AUC=0.882)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27010210"
  },
  {
    "miRNA_name": "miR-26a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor OS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27529338"
  },
  {
    "miRNA_name": "miR-26a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Plasma",
    "sample": "Plasma, Plasma samples from 61 colorectal cancer patients and 24 normal subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.013",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26413249"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany and Greece",
    "sample_type": "Tissue Serum",
    "sample": "Ulcerative Colitis-associated Carcinogenesis, 25 fresh-frozen colon biopsies and corresponding serum samples of 6 UC and 15 non-UC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26083618"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "27 ESCC & paired adjacent non tumor tissues,ESEC,TE1,TE2,ECA109,KYSE30,KYSE140,KYSE150,KYSE410,KYSE510",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues,EC cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27347306"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 paired ESCC  & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (not related with DNA methylation)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR,MSP,BSP-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28476684"
  },
  {
    "miRNA_name": "miR-26b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue",
    "sample": "106 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0318",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression is correlated with advanced tumor stage and lymph node metastasis.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27078844"
  },
  {
    "miRNA_name": "miR-27",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-27 level in metastatic group were higher than those in the non metastatic group",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018270"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "25 ESCC with lymph node metastsis,normal ESCC tissues,NECC,TE1,TE13,ECA109,EC9706,KYSE140,KYSE30",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.025(ESCC tissues with nodal involvement vs normal)",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24154848"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "Het-1A,TE10,TE11,TE1,ECA109",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25436011"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 pairs of GC & adjacent non tumor tissues tissues( 4 pairs for microarray & 4 for semiquantitative RT-PCR",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,semiquantitative -PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18789835"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "67 GC & matched adjacent non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-27a inhibitors alone or in combination with Perifosine suppresses growth of GC cells(AGS,MGC803)",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High expression associated with poor tumor histological grade (P=0.037)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23175237"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue Plasma",
    "sample": "73 paired tissues,35 GC & 35 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic & Diagnostic-plasma miR-27a level",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26523130"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 paired GC and matched adjacent tissues,MGC-803, HGC-27, BGC-823, AGS , SGC-7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High expression associated with advanced clinical stage(p=0.002),advanced T stage(p<0.001),advanced N stage(p=0.026), advanced M stage(p=0.004)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28327189"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "273 tissues,MGC803,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with lymph node metastasis,tumor diggerentiation & TNM( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28401000"
  },
  {
    "miRNA_name": "miR-27a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-27a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1788, p=0.007623",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-27a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "18 GC tissues,GES1,HGC27,AGS,GC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26781754"
  },
  {
    "miRNA_name": "miR-27b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "48 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0133",
    "detection_method": "qRt-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26460960"
  },
  {
    "miRNA_name": "miR-28-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-29",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tumor & adjacent tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic :high miR-29 related with higher OS rate, diagnostic: AUC-0.73 ,sensitivity-0.70,specificity-0.68",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26509997"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues from 90 CRC cases, HCT116, Caco2, HT29, SW620 and SW480",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28209128"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR,northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20485139"
  },
  {
    "miRNA_name": "miR-296",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Eight patients were enrolled in the phase II clinical trial of Sunitinib and Capecitabine in first-line treatment of metastatic colon cancer, Serum samples were collected from patients prior to drug administration",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Progostic",
    "marker_details": "Patients with shorter survival and poor clinical outcome exhibited a decrease in the level of miR-296",
    "therapy": "Chemotherapy",
    "therapy_details": "Loss of miR-296 may be one of the mechanisms for primary resistance of colorectal cancer to chemotherapy, poor response to treatment with Sunitinib and Capecitabine",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22892985"
  },
  {
    "miRNA_name": "miR-298",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "20 GC & 20 normal gastric  tissues,GES-1,MGC-803,SGC-7901,MKN-45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Bufalin inhibited cell proliferation and promoted cell apoptosis by down regulating miR-298",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26064232"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 sample pairs of CRC tissue and adjacent noncancerous tissue",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "Sensitivity=68% and Specificity=78% (p=0.001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28469363"
  },
  {
    "miRNA_name": "miR-299-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27007598"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Israel",
    "sample_type": "Tissue",
    "sample": "110 patients, 51 (46%) with stage I and 59 (54%) with stage II disease, FFPE Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.028",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-29a was associated with a longer disease-free survival (DFS)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "miR-29a associated with risk of recurrence in patients with stage II",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22426940"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Feces,  fecal samples from 80 CRC patients and 51 normal controls.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26756616"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.844",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "114 participants including 58 metastatic patients and 56 non-metastatic CRC patients. Serum from 38 CRC patients with liver metastasis and 36 CRC patients without metastasis. For validation - CRC patients without (n=20) and with liver metastasis (n=20)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.803, At a cutoff value of 0.155, the sensitivity was 75% and the specificity was 75% in discriminating metastatic from non-metastatic patients",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - novel noninvasive biomarker for early detection of CRC with liver metastasis.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Upregulated in liver metastatic patients compared to non metastatic",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22018950"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p= 0.001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Sera, 237 serum samples from 160 patients with early colorectal neoplasms (148 precancerous lesions and 12 cancers) and 77 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.741",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26038573"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "146 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.703, p=0.005",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "High plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC clinical samples,HGC27,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "166 GC & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.02",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "115 pairs of GC & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "26 samples of gastric cancer without metastasis, 20 samples of gastric cancers with metastasis, and 15 samples from healthy donors",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(GC with and without metastasis)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24209632"
  },
  {
    "miRNA_name": "miR-29a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tumor tissue and in adjacent normal tissue from 40 patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Taqman miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Potential association with tumor N stage (lymph node metastasis) and Dukes stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25040971"
  },
  {
    "miRNA_name": "miR-29a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.1147, p=0.00046",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-29a-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 pairs of GC & adjacent non cancer  tissues,SGC-7901,AGS,MCG803,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.012(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25889078"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue and Plasma",
    "sample": "Tissue and Plasma, CRC specimens (tumor and\nadjacent nontumor colon tissues) from 200 patients who had\nundergone resection and 400 Healthy controls",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "Tissue AUC=0.883, plasma AUC=0.743. sensitivity of 61.4% and a specificity of 72.5%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26466603"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "202 colorectal cancer tissues and adjacent colorectaltissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27346400"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 pairs tissues,98 surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25866219"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC clinical samples,HGC27,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "166 GC & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "115 pairs of GC & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29b-2*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non-responders",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-29b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-29b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.951, p=0.013832",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 paired tissues,KYSE150,KYSE410,KYSE450,KYSE510,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21551130"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC and ESCC",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "62 tissues ( ESCC,EAC,normal epitehlial mucosa)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to ESCC)",
    "significance": "p=0.0446(miR-29c in EAC vs ESCC)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25928282"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 ESCC and 50 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic-AUC = 0.72(95% CI:0.62-0.82 :sensitivity=68%,specificity=68%)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26554762"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC clinical samples,HGC27,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25428377"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "166 GC & matched normal gastric  tissues,Ges-1,MGC803,HGC27,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher miR-29c level were correlated with longer disease free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-29c downregulation was correlated with more extensive venous invasion(p=0.02) and more aggressive tumor phenotype(p=0.05)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25634213"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Brazil",
    "sample_type": "Tissue",
    "sample": "Gastric tissues derived from normal,chronic gastritis,intestinal metaplasia and GAC",
    "expression": "Downregulated",
    "expression_details": "Higher in normal gastric mucosa samples, and decreased progressively in non-atrophic chronic gastritis, intestinal metaplasia and intestinal-type GAC samples",
    "significance": "p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: Differential expression as potential biomarker for GC Metaplasia",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26877610"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.000",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885198"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Tokyo and Japan",
    "sample_type": "Tissue",
    "sample": "53 GC &  matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.005( early GC vs corresponding non tumor),p<0.0005(  advanced GC vs corresponding non tumor )",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "mIR-29c was significantly activated by celecoxib in GC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23001726"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "12 paired GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0002(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23442884"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "115 pairs of GC & adjacent non cancerous tissues,SGC7901,HGC-27,MGC803,BGC823,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-29c in GC was significantly associated with a more extensive venous invasion ( P = 0.05) and a more aggressive tumor phenotype ( P < 0.05, stage I/II versus III/IV)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24130168"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "4 pairs of GC & adjacent normal f&2 additional normal for NGS and 24 pairs for qRT-PCR validation tissues,SNU601,SNU668,AGS,MKN28,HSC45,NM",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003(24 pairs of GC vs adjacent normal tissues)",
    "detection_method": "NGS,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24870620"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-29c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China residing in Taiwan",
    "sample_type": "Serum",
    "sample": "Serum samples from 61 CRC patients with primary CRC at UICC stages II/III (41 non-early relapsed and 20 early relapsed patients) before they received surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.012",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Circulating miR-29c increased in early relapsed patients than control and non-early relapsed",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23840538"
  },
  {
    "miRNA_name": "miR-3",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-300",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer (CRC) tissues compared to adjacent colorectal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with lymphatic metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779716"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "30 pairs of GC & matched non tumor tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Overexpression is associated with tumor size,invasion depth,lymph node metastasis,TNM",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23832550"
  },
  {
    "miRNA_name": "miR-301a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-301a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=6.3519, p=0.019431",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-301b",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.02",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-302a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "50 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with tumor differentiation(p=0.010),lymph node metastasis(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24438167"
  },
  {
    "miRNA_name": "miR-302b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 FFPE",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773691"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 139 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27173217"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "Eighty fresh-frozen tumor tissues samples and paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Inversely associated with advanced stage and lymph node metastatic status",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28528497"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 platinum received tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (chemosensitive)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-30a overexpression had higher DDP sensitivity than knockdown",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27212164"
  },
  {
    "miRNA_name": "miR-30a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 drug treated GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (chemoresistant tissues & SGC7901/DDP)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Low expression decreases chemosensitivity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27876712"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "43 GC & 10 normal gastric tissues,GES-1,AGS, HGC27, BGC823 , SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28672911"
  },
  {
    "miRNA_name": "miR-30a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "3 samples each of cancer, adenoma, and normal mucosa tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA deep sequencing",
    "marker": "Diagnostic",
    "marker_details": "Early diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27022275"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "37 paired EC and adjacent normal tissues,HEEC,ECA109,EC9706,TE-1,TE-8",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,TE-1),p<0.05(ECA109,EC9706,TE-8)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-30b was strongly correlated with poor overall survival I patients with EC (p<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Decreased miR-30b expression was correlated with invasion classification (p<0.01),lymph node metastasis(p<0.01),pathological stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28189678"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "21 paired GC & adjacent non tumor tissues,HGC27,AGS,BGC-823,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(cell lines),p=0.002( tissues)",
    "detection_method": "qRT-PCR, Northern blot",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25170877"
  },
  {
    "miRNA_name": "miR-30b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "23 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0016(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression correlated with lymph node metastasis(p=0.021)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309359"
  },
  {
    "miRNA_name": "miR-30b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "51gc tissues,AGS,BGC-823",
    "expression": "Downregulated",
    "expression_details": "Downregulated (by DNMT1 methylation regulation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,MSP,BGS",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "In tumor expression level of miR-30b-5p was profound correlated with lymph node metastasis(p=0.019)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24913034"
  },
  {
    "miRNA_name": "miR-30c-1*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Colon cancer: DLD-1, HCT116 and HT29; rectal cancer: HT55, SW837 and VACO4S",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Treatment with antagonist sensitized 5FU resistant CRC",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28207045"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-30d",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Reduced expression of miR-30d occurred more frequently in ESCC patients with positive lymph node metastasis ,moderate-poor differentiation ,advanced tumor node metastasis stage than those with negative features",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28184915"
  },
  {
    "miRNA_name": "miR-30e-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Tissues from 30 CRC patients and 30 individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microfluidic array followed by validation",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "More upregulated in stages III and IV compared with stages I and II",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22868372"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "721 CRCs, 381 serrated lesions and 251 non-serrated adenomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.009, 335.0",
    "detection_method": "miRNA Array analysis, qRT-PCR and Pyro sequencing",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic Marker, associated with BRAF and KRAS mutations, High miR-31 expression was related to cancer-specific mortality",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24242331"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues, 50 submucosally invasive colorectal cancer specimens, along with the corresponding non-tumoral mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26173758"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Plasma",
    "sample": "147 patients in a prospective CRC cohort study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.717, p=0.001",
    "detection_method": "Taqman qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "High plasma miRNA levels were associated with increased recurrence risk",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28809863"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "45 paierd tissues,523 serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(serum),77.8%(tissues)",
    "detection_method": "qRt-pCr",
    "marker": "Prognostic",
    "marker_details": "Prognostic & diagnostic-serum miR-31 level",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21658006"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EAC",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissue and Cell line OE33 P and OE33 R cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated (radioresistant cell)",
    "significance": "P < 0.01",
    "detection_method": "TaqMan Low Density arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Low expression had poor response to neoadjuvant CRT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22706599"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19598010"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "40 tissues ,MGC-803, MKN-45, AGS, SGC- 7901,GES1",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.001(tissues),p<0.05( cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-31 was associated with poor tumor differentiation, lymph node metastasis, advanced T stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27174918"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression associated with lymphovascular invasion & TNM-III & IV(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904131"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "78  GC tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-31 expression was associated with lymph node metastasis ,poor pT and pN stage and invasion ability into lymphatic vessels",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656284"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=18.2, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "FFPE biopsies from 78 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.71, p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predicted worse overall survival",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Predicted poor pathological response to neoadjuvant CRT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27271609"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "98 primary CRC specimens, along with the corresponding normal mucosa specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Positively related to advanced TNM stage (p = 0.026) and deeper invasion of tumors (p = 0.024)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19242066"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "102 tissue specimens of varying stages.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004",
    "detection_method": "miRNA profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with aggressive mucinous phenotype",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21739196"
  },
  {
    "miRNA_name": "miR-31",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "316 patients, 193 prospectively recruited patients with colorectal cancer,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23121918"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "N/A",
    "expression_details": "Associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers of cetuximab response in wt-RAS mCRC patients",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-31-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Paris",
    "sample_type": "Tissue",
    "sample": "87 patients for training set and validation set of 19 FF and 26 FFPE prospectively collected samples from patients with mCRC treated with anti-EGFR antibodies",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "For Training set 1: p=0.01, for training set 2: p=0.02",
    "detection_method": "Genome miRNA profiling on Illumina Human v2 microRNA Expression Beadchips",
    "marker": "Prognostic",
    "marker_details": "Associated with prognosis",
    "therapy": "Chemotherapy",
    "therapy_details": "Marker for Response to EGFR therapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Market for the identification of patients with wild-type KRAS metastatic colorectal cancer who are more likely to respond to anti-EGFR therapy.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24771647"
  },
  {
    "miRNA_name": "miR-3144-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3151",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-31-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "28 patients of wt-RAS mCRC treated with cetuximab and 24 patients of wt-RAS mCRC treated with panitumumab, formalin fixed paraffin embedded (FFPE) tumor samples",
    "expression": "N/A",
    "expression_details": "Associated with time to progression",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers of cetuximab response in wt-RAS mCRC patients",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26497852"
  },
  {
    "miRNA_name": "miR-3163",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3177",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-3180-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 colorectalcarcinoma samples, 35 corresponding cancer-adjacent tissue samples, 27 colorectal adenoma samples, and 16 normal tissue samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "patients with high miR-32 expression had a poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High miR-32 levels were significantly associated with lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24123284"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "Tissues, plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26471298"
  },
  {
    "miRNA_name": "miR-32",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=12.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Correlated with the probability of recurrence-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-320",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Samples of primary CRC, normal adjacent tumor tissue, and liver metastasis tissues were collected from 62 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Downregulation of miR-320 was associated with liver metastasis in colorectal cancer.",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22134529"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "113 colon adenomas, Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "Affymetrix miR v. 1.0 microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Increased with higher histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24791633"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "21 paired GC & adjacent matched non tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28713899"
  },
  {
    "miRNA_name": "miR-320a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.47, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320c",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320d",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-320e",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tissue, 237 stage II–IV CRC patients treated with 5-FU-based chemotherapy, as well as in normal colonic mucosa from 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Stage III colon cancer, 95% confidence interval (CI)=1.14-1.42; p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Poorer DFS (HR)=1.65; 95% CI=1.27-2.13; P=0.0001) and OS (HR=1.78; 95% CI=1.31-2.41; P=0.0003) in stage III CRC patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26035698"
  },
  {
    "miRNA_name": "miR-324-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic - Higher expression associated with decreased progression-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-326 is associated to clinical stage ,tumor depth,lymph node metastasis and distant metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26359764"
  },
  {
    "miRNA_name": "miR-326",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27733214"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty-three fresh CRC and matched normal colorectal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-328 overexpression reversed drug resistance",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22453125"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "EC109,EC9706",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Significant",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26773497"
  },
  {
    "miRNA_name": "miR-328",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "54 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25479940"
  },
  {
    "miRNA_name": "miR-329",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "20 pairs of GC & adjacent non tumor gastric tissues,D197MGC-803,SGC-7901,MKN-45,HGC-27,GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25654811"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "35 pairs tissues,Het-1A,EC109,KYSE150",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.005(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045986"
  },
  {
    "miRNA_name": "miR-330-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "40 paired tissues,MGC-803, MNK-45, SGC-7901, HGC-27,GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic regulation)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27904681"
  },
  {
    "miRNA_name": "miR-330-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "CRC tissues than and adjacent non-tumorous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27633518"
  },
  {
    "miRNA_name": "miR-331",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-331-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "GES-1,AGS,MKN45,KATO-III,BGC-823,NCI-N87,SNU-16,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20510161"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.9",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Plasma",
    "sample": "196 plasma samples from 123 patients newly diagnosed with sporadic colorectal neoplasia (63 with CRC and 60 with AAs) and 73 healthy individuals (controls)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "genome-wide miRNA expression profiling followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23267864"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "67 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression associated with higher histological grade(p=0.003),lymph node metastasis(p=0.002),tumor stage(p=0.005),clinical stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25337272"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "81 tumor  & adjacent non-tumor tissues,SGC7901,MKN45,MKN28,BGC823,MGC803,Ges-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,MSP,BSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-335 methylation level was significantly associated with lymph node and peritoneal metastasis ,poor pT stage",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25520857"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "Poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression is associated with higher clinical stage and lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "70 GC & paired matched adjacent tissues,SGC7901,BGC823,MGC-803,GES-1,AGS",
    "expression": "No Significant Difference",
    "expression_details": "Downregulated (cell line),no significant difference between gc & adjacent normal tissues",
    "significance": "p<0.01(SGC7901,MGC-803,BGC-823),tissues(p=0.7)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-335 asssociated with lymph node metastasis(p<0.001),poor pT stage(p<0.05),poor pN stage and invasion of lymphatic vessels",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21822301"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "74 GC patients (31 patients with recurrence and 43 patients without recurrence).tissues,plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated (reccurence GC grp)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Prognostic and Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22802949"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "231 pared GC &  adjacent non tumor tissues,SGC-7901, MKN-45, BGC-823, AGS, and GES-1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (hypermethylation)",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR,MS-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic: high expression associated with better DFS,p=0.013(Kaplan -Meir)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Low expression  associated with tumor size (P = 0.030), venous invasion (P = 0.027), peritoneal dissemination (P = 0.027), lymph node metastasis (P = 0.033), poor pT stage (P = 0.040), poor pN stage (P = 0.038), poor TNM stage (P = 0.005), and invasion into lymphatic vessels (P = 0.041)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28239297"
  },
  {
    "miRNA_name": "miR-335",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.7, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-337-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 normal gastric & 90 GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27259238"
  },
  {
    "miRNA_name": "miR-338",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "41 GC & 24 adjacent normal mucosal  tissues,SGC7901,HGC27,AGS,MKN45,N87,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24736504"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 CRC, adjacent nontumorous tissues and 2 human CRC-derived cell lines (SW-480 and SW-620)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Northern blotting",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-338-3p was associated with unfavorable outcome in disease free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Negatively related to advanced TNM stage and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24824250"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "20 pairs of GC & adjacent non-tumor tissues,NCI-N87,AGS,MKN-45,MKN-28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low m-RNA expression of miR-338-3p in advanced stage(III-IV) than in early stage(I-II)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25945841"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "53 pairs of GC & matched adjacent normal tissues,GES-1,BGC823,AGS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24375644"
  },
  {
    "miRNA_name": "miR-338-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 tumor & matched normal tissues,Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617808"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "TE-4,TE-4R",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in TE-4R cell compared to TE-4)",
    "significance": "N/A",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "miR-338-5p is downregulated in radioresiatant ESCC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28883406"
  },
  {
    "miRNA_name": "miR-338-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori negative cancer tissues)",
    "significance": "p<0.01",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-339",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26391641"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands and  Germany",
    "sample_type": "Tissue",
    "sample": "Metastasized and nonmetastasized tumors N = 43",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "Next generation sequencing followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Independent prognostic factor",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25315964"
  },
  {
    "miRNA_name": "miR-339-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression level inversely correlated with pathological differentiation & distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26352175"
  },
  {
    "miRNA_name": "miR-33a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27609581"
  },
  {
    "miRNA_name": "miR-33b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "150 pairs of GC and adjacent matched normal tissues,MGC-803,HGC-27,SGC-7901,MKN-45",
    "expression": "Downregulated",
    "expression_details": "Down-regulation due to Hypermethylation",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR,MSP,q-MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low level associated with pM stage (p = 0.038, metastasis vs non metastasis) and pTNM stage (p = 0.006, stage I vs IV; p = 0.002, stage II vs IV; p = 0.038, stage III vs IV)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26729612"
  },
  {
    "miRNA_name": "miR-34",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue Plasma",
    "sample": "Tissue (public dataset of 40 CRC samples and paired normal tissues), Plasma (validation cohort of 97 subjects)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Tissue Fold Change=1.71, p=8.50e-6; plasma - FC = 1.90, p-value = 0.001)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguished groups of patients with polyps from those with advanced cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25924769"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "64 tissues,HEEC,EC109,ECA9706,EC1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues,EC109,ECA9706)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26316084"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26722508"
  },
  {
    "miRNA_name": "miR-340",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "80 tissues,SGC-7901, AGS, MKN-45, MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: for OS(p=0.001) & DFS(p=0.045)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "High expression  associated with poor histological features (P=0.025), large tumor size (P=0.003), advanced TNM stage (P=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27374211"
  },
  {
    "miRNA_name": "miR-342",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "42 colorectal cancers, 9 colorectal adenomas and 16 samples of grossly normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated, Methylated in 86% of colorectal adenocarcinomas and in 67% of adenomas",
    "significance": "N/A",
    "detection_method": "PCR",
    "marker": "Screening",
    "marker_details": "Methylation is an early event in colorectal carcinogenesis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "Methylation is an early event in colorectal carcinogenesis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18264139"
  },
  {
    "miRNA_name": "miR-345",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for progression free survival and  associated with shorter survival",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-345 expression was associated with lack of response to treatment with cetuximab and irinotecan.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "94 primary colon cancer samples with and without liver metastases,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.003",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Predicts distant metastasis of colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23243217"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0002",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "109 pair-matched human colorectal cancers and the corresponding normal mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.001, Fold Change=2.2",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22562822"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Blood",
    "sample": "Blood samples from 63 colorectal cancer patients and 45 controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22648208"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Colorectal cancer patients with recurrence (40 cases) and without recurrence (40 cases) within 3 years after radical operation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Independent factor for colorectal cancer recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23355243"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool Tissue",
    "sample": "Stool samples and Tissue samples from 82 CRC patients, Control samples from 40 healthy individuals",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "76.8 % sensitivity and 93.6% specificity of the miR-34a methylation test for detecting CRC using stool samples.",
    "detection_method": "Methylation specific PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Abnormal DNA methylation of miR-34a was correlated with lymph metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573638"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "15 CRC, 15 Polyps",
    "expression": "Upregulated",
    "expression_details": "Upregulated in polyps",
    "significance": "p<0.05",
    "detection_method": "Gene Chip and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422210"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.42",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "No significant association with prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25954903"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "111 ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level had a significant impact on OS of patients (p=0.006), expression of miR-34a (P = 0.018), tumor\ndifferentiation (P = 0.021), and TNM stage (P = 0.003) were independent prognostic factors for\npatients with ESCC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low miR-34a level was significantly associated with tumor differentiation(p=0.013),lymph node status(p=0.038),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26782413"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "8 pairs of ESCC & adjacent non tumor tissues,ECA-109,TE1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DNA methylation of miR-34a promoter)",
    "significance": "N/A",
    "detection_method": "qRT-PCR, MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26944831"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/24981249"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray",
    "marker": "prognostic",
    "marker_details": "Poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression is associated with higher clinical stage and lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26318298"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "GES1,MGC803,HGC27,NCI-N87,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23264087"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated (SGC7901/DDP)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-34a overexpression improve sensitivity of GC cell against cisplatin based CT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24068565"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "41gc( 25 metastatic & 16 non metastatic) & 41 normal adjacent tissues, MKN,AGS,GEs1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Decreased miR-34a expression is associated with GC metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24837198"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 Gc & 20 normal gastric tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Negative correlation with depth of invasion & lymph node metastasis(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26238271"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "76 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator of GC(p=0.0027, according to multivariate)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Applying the prognostic value of miR-34a expression to tumor node metastasis (TNM) stage system showed a better prognostic value in patients with gastric cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26415802"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464633"
  },
  {
    "miRNA_name": "miR-34a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901,SGC7901/DDP",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DDP resistant tissues & SGC7901/DDP",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27513895"
  },
  {
    "miRNA_name": "miR-34a*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-34a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1307, p=0.004859",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours, p=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non-invasive faecal-based screening marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.27",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Significant poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "88 tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.004(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High expression in advanced stage 2,3 &4 than in 0 & 1(p=0.039)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22966364"
  },
  {
    "miRNA_name": "miR-34b/c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "111 CRC tumors",
    "expression": "Downregulated",
    "expression_details": "Downregulated, Methylated in 101 of 111 (90%) CRC tumors",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18519671"
  },
  {
    "miRNA_name": "miR-34b/c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "68 CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated, Methylated in 93% tissues",
    "significance": "N/A",
    "detection_method": "methylation-specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22870149"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "82 of primary colorectal and 28 fecal specimens",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Hypermethylated in 97.5% of  tumours, p=0.0110 and 75% fecal specimens",
    "detection_method": "methylation-specific PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non-invasive faecal-based screening marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21610744"
  },
  {
    "miRNA_name": "miR-34c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (USA and Asia)",
    "population": "USA and Hong Kong",
    "sample_type": "Tissue",
    "sample": "Tissue (Pairs of primary colon tumor and adjacent non-tumor tissues came from 159 patients and 113 patients from Hong kong)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=1.25",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Significant poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25894979"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.1593, p=0.008549",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-34c-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Sample Cell-line",
    "sample": "Paclitaxel resistant GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in paclitaxel resistant gastric cancer sample)",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression of miR-34c-5p increased the chemosensitivity of Paclitaxel resistant GC cells",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23423488"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues (60 pairs of CRC and non-tumor samples )",
    "expression": "Downregulated",
    "expression_details": "Downregulated IN 51 of 60 patients",
    "significance": "Fold Change=3.08, p=0.004",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Correlated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-361-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Normal gastric mucosa,BGC-823,MKN-45,AGS,SGC-7901,HGC-27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25965817"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "40 resected colorectal cancer tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25773836"
  },
  {
    "miRNA_name": "miR-362",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "184 GC ,169 normal gastric & 10 pairs of GC & adjacent normal tissues,NGEC,BGC823,HGC27,MGC803,MKN28,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001(gc vs normal gastric tissues),p<0.05(10 paired gc vs adjacent normal tissues, BGC823,HGC27,MGC803,MKN28,SGC7901)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24495516"
  },
  {
    "miRNA_name": "miR-3622a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-362-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-363-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 GC & adjacent normal tissues,SGC-7901,AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26709677"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-3651",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh ESCC & FFPE tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:- OS & DFS both p=0.001(multivariate analysis),low expression poorer OS & DFS p=0.004 and 0.001 respectively(Kaplan Meier)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Tumor-size",
    "tumor_size_details": "Expression  had negative correlation with T stage(p=0.022),tumor length(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26210449"
  },
  {
    "miRNA_name": "miR-3651-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-3656",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "35 ESCC & adjacent normal tissues,46 ESCC & 46 healthy serum",
    "expression": "Upregulated",
    "expression_details": "Upregulated (sera,tissues of ESCC),Downregulated ( after chemotherapy)",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic : miR-367 is a potential prognostic biomarker,serum miR-was associated with OS(independent prognostic marker)",
    "therapy": "Chemotherapy",
    "therapy_details": "Expression down after chemotherapy",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Serum miR-367 was closely correlated with differentiation grades,clinical stage and tumor metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26777997"
  },
  {
    "miRNA_name": "miR-367",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 patients tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Downregulation of miR-367 was significantly correlated with differentiation level,TNM stage and metastasis of GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25489984"
  },
  {
    "miRNA_name": "miR-370",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721824"
  },
  {
    "miRNA_name": "miR-371-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy.",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-371b-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum (20 patients with colon adenoma, 20 patients with colon cancer and 20 healthy subjects )",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "144 CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "independent prognostic factor - associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with synchronous liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22456107"
  },
  {
    "miRNA_name": "miR-372",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissue",
    "sample": "Serum and tissues in CRC and colorectal precancerous lesions (CPL) patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05, AUC=0.854, 81.9 % and 73.3 %.",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Worse overall survival period (p<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with tumor node metastasis (p=0.012)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26179262"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "63 ESCC & adjacent non tumor tissues,63 ESCC & 39 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(tissues,plasma)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-373 expression level in tumor tissues closely associated with differentiation,tumor status and lymph node metastasis(all p<0.05),miR-373 expression in plasma correlated with tumor status and lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073718"
  },
  {
    "miRNA_name": "miR-373",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "15 gastric adenocarcinoma & 15 matched normal tissues,AGS,GES1,HGC25",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24179536"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.34",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China and Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "46 paired tissues,NEEC,Eca109,Kyse30,kyse140,Kyse180,Kyse410,Kyse510,kyse520",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26252180"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "18 pairs of GC & adjacent non cancer tissues,MKN45,HGC27,BGC823,SGC7901,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25554419"
  },
  {
    "miRNA_name": "miR-374a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=21.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-374b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 tumor tissues and 28 paired adjacent normal mucosal tissues,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Stage II:  Fold Change=-2.519 p= 0.018; Stage III=-2.924 p=0.049;  AUC 0.724, sensitivity 71.43%, specificity 71.43%, and p=0.004",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26045793"
  },
  {
    "miRNA_name": "miR-374b",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-374b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-374b-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC-7901,MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25516656"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma of ulcerative colitis and colitis associated cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0061",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312900"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma",
    "sample": "Cancer tissues (n=88) and matched plasma samples (CRC, n=88; control, n=40)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25255814"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 pairs of human colorectal cancer tissues and their corresponding noncancerous tissues (NCTs)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Predicted tumor metastatic potential",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27276676"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Africa",
    "population": "Egypt",
    "sample_type": "Serum",
    "sample": "Serum of 86 patients with CRC and 36 age- and sex-matched controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42±0.27",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28374902"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter  hypermethylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21533613"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "N/A",
    "detection_method": "qRT-PCR,MSP",
    "marker": "Prognostic",
    "marker_details": "Prognostic- expression correlated with poor OS(p=0.048),DFS(p=0.0006)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression associated with advanced stage(p=0.003),distant metastasis(p<0.0001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21813472"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "50 preoperative plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic-  low miR-375 plasma level",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22519435"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22752059"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,archived sample",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "MISH,qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had poore oS(p=0.040)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression correlatedwithlymph node metastasis(p=0.04),TNM stage(p=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23301089"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissue",
    "sample": "20 pairs tissues,94 healthy serum,194 ESCC serum",
    "expression": "Downregulated",
    "expression_details": "Downregulated (tissue & serum)",
    "significance": "p=0.006(tissue miR-375),p=0.007(serum miR-375)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-serum  miR-375",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24390317"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "85 tissues",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expressioon associated with lymphatic vessel invasion(p=0.0352)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25501018"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC and EAC",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "195 FFPE of GEC(129 ESCC,61 EAC,5 stomach)",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high miR-375 not correlated with increased survival in both EAC & ESCC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26481465"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "Serum ,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023(miR-375 in serum),p=0.013(miR-375 in tissues)",
    "detection_method": "qRT-PCR(serum),ISH(tissues)",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Elevated expression of miR-21 reduced the sensitivity of RT",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-375 expression level was correlated with TNM stage,vascular invasion,lymph node metastasis( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27508050"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Cell-line",
    "sample": "25 ESCC & 13 normal esophageal tissues,TE8,TE9",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27779648"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "Tissues, serum,Kyse170,Eca109",
    "expression": "Upregulated",
    "expression_details": "Upregulated (miR-375 in Kyse170,Eca109 with Zinc in media than media without zinc)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic :  high levels of miR-375 had improved OS(HR0.47,95%CI 0.26-0.87)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant correlation",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27885434"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, ECA109,HEEC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR,microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28069583"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue  Cell-line",
    "sample": "10 paired ESCC & non tumor tisssues,EC109,Het-1A",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28599478"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "39 pair of GC & matched normal gastric tissues(30 metastatic positive & 9 metastasis free tissues)",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in metastasis positive gc tissues)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25055044"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in Hp negative GC)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "H.Pylori positive & negative GC tissues,tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (LPS from H.Pylori 26695 downregulates miR-375 expression)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25307786"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,SGC7901/DDP(resistant) cells",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26893657"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Oita and Japan",
    "sample_type": "Tissue",
    "sample": "22 GC & 5 normal control tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (DNA methylation & histone deacetylation)",
    "significance": "p<0.001",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20215506"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "48 paired GC & matched adjacent non tumor  tissues,GES-1,MGC0803,SGC7901,AGS,BGC-823,HGC-27",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "miRNA microarray, qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20548334"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "BGC-823,MGC803,SGC7901,AGS,N87,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "miR-375 desensitizes cells to ionizing radiation and etoposide",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23835407"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 pairs of GC & normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (especially in ERBB2 +ve tissues",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24926380"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "Genechip-microarray analysis,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-375 was found to be associated with low T-stage cancers (T1+T2) and differentiated histologic grade",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28053808"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.21, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-375",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "95 pairs of colorectal cancer tissues and non-tumor adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22377847"
  },
  {
    "miRNA_name": "miR-376a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues from 53 CRC patients and matched matched normals",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0294",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Higher expression positively correlated with shorter survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High expression positively correlated with advanced lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25422250"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "30 pairs of ESCC & adjacent normal tissues,serum,7cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(serum ,tissues)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : miR-377 tissues and serum expression levels were positively correlated with patient survival",
    "therapy": "Chemotherapy and Chemoradiotherapy",
    "therapy_details": "Downregulation of miR-377 expression was correlated with poor chemoresponse(5FU and cisplatin), high serum level inversely associated with chemoradiotherapy resistance",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Higher serum miR-377 expression was inversely asssociated with pathologic tumor stage,distant metastasis,residual tumor and chemoradiotherapy resistance",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28288140"
  },
  {
    "miRNA_name": "miR-377",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "102 pairs of tumor & normal gastric tissues,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001(tissues), p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic: higher expression had  poorer overall survival  and shorter time of reccurence",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Recurrence",
    "tumor_size_details": "Higher expression correlated with distant metastasis (P=0.034), TNM stage (P=0.030) and early recurrence (P=0.044)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25998046"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.33",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarrray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Blood",
    "sample": "Peripheral blood from 65 patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated in non relapsed",
    "significance": "p=<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic and Prognostic - Decreaesd in plasma of non-relapsed patients 4-6 months after surgery",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Decreaesd in plasma of non-relapsed patients 4-6 months after surgery",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24423916"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES1,AGS,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated (promoter methylation)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23333942"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "16 gastric MALT lymphoma & 12 chronic gastritis",
    "expression": "No Significant Difference",
    "expression_details": "No difference in gastric MALt lymphoma vs chronic gastritis",
    "significance": "Not significant",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28031239"
  },
  {
    "miRNA_name": "miR-378",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.25, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-378*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.27",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-378*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue (surgical specimens of cancer tissue and adjacent normal mucosa from 32 patients with colorectal cancer)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05; odds ratio = 4.6; 95% CI of odds ratio = 1.25 to 16.84",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression of miR-378a-3p and miR-378a-5p was significantly associated with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25896668"
  },
  {
    "miRNA_name": "miR-378-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues and Cell line: LoVo, CaCo2, SW1116, SW480, HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 44/47 tissues, 93.6%",
    "significance": "p<0.001",
    "detection_method": "quantitative reverse transcriptase PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25977643"
  },
  {
    "miRNA_name": "miR-378a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Pretreatment cancer tissues in a phase I study and cancer tissues in a phase II study, in which peptide vaccines combined with chemotherapy were given",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.009",
    "detection_method": "Microarray followed by Revese transcription PCR",
    "marker": "Prognostic",
    "marker_details": "Negatively associated with overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28859241"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "Tissue,  54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=−2.0464, p=0.013107",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-378a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.025",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 11 Patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26462034"
  },
  {
    "miRNA_name": "miR-378a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 pairs of FFPE archived CRC and adjacent normal colorectal mucosal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic Marker - patients having lower expression had shorter survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24412052"
  },
  {
    "miRNA_name": "miR-378c",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.25, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "N/A",
    "expression_details": "Radiosensitivity trend: TE1>ECA109>EC9706>KYSE30>KYSE150>KYSE450",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Negative correlation between miR-381 expression and radioresistant capacity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25628936"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "60 paired GC and matched adjacent tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression of miR-381 was associated with lymphatic metastasis (P=0.031) and advanced TNM stage (III+IV, P=0.003)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28927144"
  },
  {
    "miRNA_name": "miR-381",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.32, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-382",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "46 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated (poor outcome groUpregulated)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:-miR-382 level had reverse correlation with poor outcomes,p<0.001(Kaplan Meier)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26078564"
  },
  {
    "miRNA_name": "miR-383",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "40 paired intestinal type GAC & adjacent tumor free tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28243881"
  },
  {
    "miRNA_name": "miR-384",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 cases of fresh primary CRC biopsies and their paired adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated in 83.0% (83/100) CRC patients",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with the invasive depth, lymph node and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27769041"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SW480 and SW1116 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Correlated with tumor size and local invasion",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26084278"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "90 pairs of GC & corresponding non tumor tissues( 52 lymph node positive & 38 lymph node negative),HGC-27,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc with  lymph node positive)",
    "significance": "p=0.01(gc vs normal),p=0.00",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-409-3p low expression  associated with TNM stage(p=0.01),lymph node metastasis(p=0.00)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22179828"
  },
  {
    "miRNA_name": "miR-409-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES-1,MKN45,SGC7901,NCI-N87,AGS,,MKN28,SNU-16,SNU-1,KATO III",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22388101"
  },
  {
    "miRNA_name": "miR-410",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, HGC-27,MKN-45,SGC7901,MGC803,GES",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lower level associated with lymph node metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25136862"
  },
  {
    "miRNA_name": "miR-412-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−2.4",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 GC ,pericarcinoma & normal gastric tissues,MGC-803, BGC-823,SGc-7901,HGC-27,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25041019"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "16 GC & 18 non tumor tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19802518"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Gastric Juice",
    "sample": "Gastric juice",
    "expression": "Downregulated",
    "expression_details": "Upregulated (tissues),Downregulated (gastric juice)",
    "significance": "p<0.001(gastric cancer  juices vs benign gastric diseases)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tisssues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues),Downregulated (gastric juice)",
    "significance": "p=0.001(mucosa biopsies)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: ROC -0.767(95% CI=0.684-0.850)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22926798"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "50 GC & 50 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823741"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qPCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "No correlation between miR-421 level and age, sex, tumor size, location, invasion depth, TNM stage, differentiation stage and metastasis,but correlatrd with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26823855"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "107 paired tissues, AGS, MKN-28, MKN-45, NCI-N87, HGC-27, SNU-16,SGC-7901,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low expression had longer OS (p=0.006) & time to relapse (p=0.007)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27016414"
  },
  {
    "miRNA_name": "miR-421",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "125 patients (78 men, 47 women) with histologically confirmed colorectal adenocarcinoma undergoing surgery",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "TaqMan MicroRNA Array and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469014"
  },
  {
    "miRNA_name": "miR-422a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "102 CRC tissues and paired normal mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic factor",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with local invasion lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27350737"
  },
  {
    "miRNA_name": "miR-423-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum Tissue",
    "sample": "67 serum,119 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-tissues expression of miR-423-3p",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28254439"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma, 223 patients with colorectal related diseases (111 cancer carcinoma, 59 adenoma, 24 colorectal polyps and 29 inflammatory bowel disease) and 130 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Potential marker for early CRC diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26297223"
  },
  {
    "miRNA_name": "miR-423-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in serum of stage I-II CRC patients",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-424",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Six specimens, including colonic cancerous and para-cancerous ones",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.55",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20132431"
  },
  {
    "miRNA_name": "miR-424",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.8, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-424-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-424-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "32 pairs of ESCC 7 adjacent normal paraffin embeded blocks,EC9706,Eca109,EC-1,SHEE",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27628042"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Plasma Cell-line",
    "sample": "Tissues, plasma,cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (tissues,plasma),decreasing order of miR-425 expression in cell lines-YES2<KYSE410<KYSE450<KYSE70<KYSE150<KYSE 510<Colo680N<KYSE410<KYSE30",
    "significance": "p=0.0315(tissues),p=0.047(plasma)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : plasma miR-425 is a novel biomarker for ESCC diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26674378"
  },
  {
    "miRNA_name": "miR-425",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum Cell-line",
    "sample": "75 GC & adjacent normal tissues,57 GC & 58 healthy serum,HGC27,MGC803,MKN45,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(miR-425 in tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24603541"
  },
  {
    "miRNA_name": "miR-425-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "136 CRC VS. 90 Normal Controls, serum samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC=0.830",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28177881"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC-7901,MKN-28,MKN-45,BGC-823,AGS,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26136868"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "SGC7901,MKN28,MKN45,BGC823,AGS,GES1",
    "expression": "Upregulated",
    "expression_details": "Upregulated (GC cell lines)",
    "significance": "N/A",
    "detection_method": "qRt-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26136868"
  },
  {
    "miRNA_name": "miR-425-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, GES1,BGC-823,AGS,HGC27,MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28537672"
  },
  {
    "miRNA_name": "miR-4269",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "41 paired GC & adjacent normal samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.006",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28759040"
  },
  {
    "miRNA_name": "miR-4282",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27120047"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues, 110 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Associated with tumor size, lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23111103"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "5 CRC Tissues for microarray, 141 cases of CRC for real time PCR and 103 cases of CRC for TMA",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR and tissue microarrays",
    "marker": "Prognostic",
    "marker_details": "Over-expression of miR-429 was correlated with poor prognosis for CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Downregulated in stage II and stage III clinical progression",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24237355"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "78 CRC tissues, 45 serum specimens from CRC patients, tissues from 116 patients receiving 5-FU treatment",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic indicator for chemo-response to 5-FU therapy",
    "therapy": "Chemotherapy",
    "therapy_details": "Prognostic indicator for chemo-response to 5-FU therapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27654003"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "32 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis(p=0.015),differentiation(p=0.003),TNM stage(p=0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23999873"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "88 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.037",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-429 significantly correlated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24064224"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26513239"
  },
  {
    "miRNA_name": "miR-429",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "44 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27042104"
  },
  {
    "miRNA_name": "miR-4299",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "AUC=0.810",
    "detection_method": "with laser capture microdissection and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Discriminating chemoresistant colon cancer",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "miR-431",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.896, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic",
    "marker_details": "To distinguish Stage IV CRC from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-4316",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Poland",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 56 patients and 70 healthy individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0025,  Specificity=76.8% and Sensitivity=75%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28405738"
  },
  {
    "miRNA_name": "miR-4317",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "17 GC & adjacent non tumor stomach tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28880489"
  },
  {
    "miRNA_name": "miR-432*",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.1",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-432-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Tokyo",
    "sample_type": "Tissue",
    "sample": "84 ESCC tumors",
    "expression": "Upregulated",
    "expression_details": "Upregulated in 65.5% samples",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Overexpression decreases sensitivity of ESCC to chemotherapy drug cisplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28760781"
  },
  {
    "miRNA_name": "miR-4326",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "3 normal gastric & 24 malignant  tissues,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-433",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "86 pairs of GC & adjacent norma tissues,HGC27,MGC803,SGC7901,MKN45",
    "expression": "Downregulated",
    "expression_details": "Downregulated (epigenetic modification)",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Lower miR-433 level was associated with pM or pTNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23880861"
  },
  {
    "miRNA_name": "miR-4463",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 20 patients with colon adenoma, 20 patients with colon cancer  and 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-4478",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Stool",
    "sample": "Stool samples from 40 patients with early stage (I, II) CRC and 16 healthy controls",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by miScript PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25519020"
  },
  {
    "miRNA_name": "miR-4478",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "FFPE tissue samples of 53 CRC and 35 normal subjects",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28193082"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Gastric cancer tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26852749"
  },
  {
    "miRNA_name": "miR-448",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "81 tissues,GES1,NCI-N87, MKN87, SNU16, SGC7901, AGS, MKN28, and MKN45",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expression associated with poor histological diffrentiation & distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26989077"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66 GC & adjacent non-tumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25202363"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "12 pairs of GC & adhacent normal gastric  tissues and SGC7901,NEGC",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25871967"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24248414"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 pairs of GAC & adjacent matched normal  tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24260067"
  },
  {
    "miRNA_name": "miR-449a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "SGC7901,NCI-N87,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(SGC7901,MGC803)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26576674"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue  Cell-line",
    "sample": "Tissues and cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic:low expression related with low survival rate",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-449c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Low expression correlated with low survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26141986"
  },
  {
    "miRNA_name": "miR-4506",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-450a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Asociated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with poor differentiation and advanced TNM classification",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27494869"
  },
  {
    "miRNA_name": "miR-450b-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Singapore",
    "sample_type": "Stool",
    "sample": "Fecal samples from 17 CRC patients and 28 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=102, AUC= 0.971, p<0.01, sensitivity=88.2% and specificity=100.0%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker (Phase II study)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24841830"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "26 pairs of ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.008(serum),p=0.043(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27896643"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Serum",
    "sample": "39 ESCC & 39 normal serum,exosomes",
    "expression": "Upregulated",
    "expression_details": "Upregulated (serum,exosomes)",
    "significance": "p=0.008(serum),p=0.043(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27896643"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "107 paired tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues),p<0.05(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Positive correlation with lymphatic metastasis,clinical stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26464660"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "180gc patient after surgery for microarray preparation,paracancerous normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "tissue microaaray,miRNA-locked nucleic acid ISH",
    "marker": "Prognostic",
    "marker_details": "Low expression of miR-451 (HR 2.01; 95 % CI 1.36-2.96; P < 0.001) predicted shorter OS, while tumor status (HR 1.59; 95 % CI 0.73-3.48 P = 0.242), lymph node metastasis (HR 1.41; 95 % CI 0.71-2.82; P = 0.326) and tumor size (HR 1.53; 95 % CI 0.92-2.55; P = 0.099) were not.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27605261"
  },
  {
    "miRNA_name": "miR-451",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "GC samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27780852"
  },
  {
    "miRNA_name": "miR-451a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "South America",
    "population": "Chile",
    "sample_type": "Tissue Cell-line",
    "sample": "25 paired gastric  cancer tissue samples,AGS,MKN-28,MKN-45,",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0003",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26458815"
  },
  {
    "miRNA_name": "miR-452",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-4539",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-455",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression  correlated with the clinical stage, lymph node metastasis and tumor invasion in gastric cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28714005"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "ESCC specimen",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : higher expression had shorter overall and disease free survival (p<0.05),miR-455-3p expression was independent prognostic factor(p<0.001)",
    "therapy": "Chemotherapy",
    "therapy_details": "Antagonizing miR-455-3p  inhibits chemoresistance and aggressiveness in ESCC",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "miR-455-3p level of ESCC cells were positively correlated with clinical stage(p<0.001),TNM classification(p<0.001),histological differentiation(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28633632"
  },
  {
    "miRNA_name": "miR-455-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Improved outcome in the CAPEOXBEV cohorts and showed a significant interaction with bevacizumab effectiveness",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-455-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "82 paired tissues,MKN45,SGC7901,MGC803",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27451075"
  },
  {
    "miRNA_name": "miR-4775",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "544 pairs of FFPE normal and CRC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "High levels predicted poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis Recurrence",
    "tumor_size_details": "High-risk factor for CRC metastasis and recurrence",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28095858"
  },
  {
    "miRNA_name": "miR-4787-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-483",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "104 resected tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "Chemotherapy",
    "therapy_details": "High miR-483 & miR-214 expression predict less chemotherapy effect",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23721345"
  },
  {
    "miRNA_name": "miR-483-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated (ESCC cell lines )",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "miR-483-3p  inhibit cells sensitivity to chemotherapy drugs",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26801660"
  },
  {
    "miRNA_name": "miR-483-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "80 pairs of ESCC & adjacent normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : upregulated miR-483-5p expression was significantly associated with poor survival of ESCC patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-483-5p was positively correlated with TNM stage,lymph node metastasis,T stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28211800"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−1.2",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 24 mCRC patients (12 responders and 12 non-responders) before onset and after four cycles of 5-FU/oxaliplatin, validation chohort of validation cohort of 150 patients and 130 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non reponders",
    "significance": "p=0.008",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Upregulated in non-responders",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24119443"
  },
  {
    "miRNA_name": "miR-484",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Blood",
    "sample": "Blood samples of 53 CRC patients of I-IV stage pre therapy and 50 controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated in serum of stage III-IV patients",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25807655"
  },
  {
    "miRNA_name": "miR-485-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 pairs of GC & adjacent normal tissues,MCG-803,MKN-28,MKN-45,SGC-7901,BGC-803,BSG-823,BGC-823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(gc vs normal tissues,SGC7901,BGC-803,BSG-823,BGC-823),p<0.05(MCG-803,MKN-28,MKN-45)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression related to advanced clinical features",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26807169"
  },
  {
    "miRNA_name": "miR-485-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "132 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Positively correlated with larger tumor size (p = 0.003), deeper invasion depth, (p = 0.005), positive lymph node metastasis (p = 0.039), advanced tumor-node-metastasis (TNM) stage (p = 0.017)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27160123"
  },
  {
    "miRNA_name": "miR-486-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarrray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Phase I study (UMIN clinical trial registration no. UMIN000004948) and phase II trial, 16 patients, Treatment eith HLA-A*2402 restricted peptides peptide cocktail and oxaliplatin-based chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.023",
    "detection_method": "Microarray",
    "marker": "Prognostic",
    "marker_details": "Biomarkers for prediction of the efficacy of vaccine treatment for patients with metastatic CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28789351"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "35 paired  ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27882172"
  },
  {
    "miRNA_name": "miR-486-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "GAC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "miRNA-LNA ISH",
    "marker": "Prognostic",
    "marker_details": "Prognostic: Low or unchanged miR-486-5p expression (P = 0.002), tumor stage (P = 0.001), tumor status (P = 0.001), node status (P = 0.001), tumor size (P = 0.004), and depth of tumor invasion (P = 0.013) were significant negative prognostic predictors for overall survival in patients with GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25793394"
  },
  {
    "miRNA_name": "miR-487b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Primary, non metastatic and liver metastatic lesions (n=34)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression of miR-487b was associated with better prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28000854"
  },
  {
    "miRNA_name": "miR-488",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues ,gc cell lines,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression negatively correlated with advanced TNM stage in GC",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26738864"
  },
  {
    "miRNA_name": "miR-489",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "36 paired tissues,MGC-803, SGC-7901, AGS, MKN45, MKN28,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725907"
  },
  {
    "miRNA_name": "miR-490-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-491",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "99 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression correlated with tumor depth(p=0.033),stage & metastasis(both p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26279431"
  },
  {
    "miRNA_name": "miR-491-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-491-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "22 pairs of GC & matched adjucent non tumor tissues,SGC-7901, MKN45, BGC823, AGS,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28358374"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSI comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.2",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-492",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC and corresponding adjacent tissues 247 patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "prognostic factor for progression-free and overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25270723"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "37 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Associated with lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25480402"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Cinobufacin treated BGC823 cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "miRNA microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24606447"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low level correlates with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24612089"
  },
  {
    "miRNA_name": "miR-494",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-495",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, DES1,SGC7901,MKN28,HFE-145",
    "expression": "Downregulated",
    "expression_details": "Downregulated (gc tissues,SGC7901,MKN28)",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "Cell line HCT8, LOVO, Ls-174, HCT116 and HT29 and tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26840372"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues,GES1,MKN28,BGC823,SNU-1,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(GC tissues and cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: low miR-497 expression was associated with shorter overall survival(P<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-497 low expression was significantly associated with lymph node metastasis rate(p=0.006),local invasion(p=0.015)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24845562"
  },
  {
    "miRNA_name": "miR-497",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "80 paired GC samples,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR,MSP",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28586056"
  },
  {
    "miRNA_name": "miR-497-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Correlated with the probability of recurrence-free survival",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-498",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "N/A",
    "population": "N/A",
    "sample_type": "Tissue Cell-line",
    "sample": "93 ESCC & non neoplastic tissues,5 cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28188753"
  },
  {
    "miRNA_name": "miR-500",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 GC & adjacent matched normal gastric tissues,NGEC-1,NGEC-2,mKN28,MGC803,BGC823,HGC27,SGC7901",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Independent Prognostic factor: shorter overall survival(p<0.001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression  correlated with clinical stage (p < 0.001), TNM classification (T: p < 0.001; N: p = 0.018; M: p = 0.001), and histological differentiation (p = 0.028) in GC patients",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25595906"
  },
  {
    "miRNA_name": "miR-5000-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-5009-3p",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Cell-line",
    "sample": "Cell line and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28054337"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "49 EC and 12 normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25750296"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "EC9706,HEEC",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EC9706)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26580839"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "28 paired ESCC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26617801"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "71 pair tumor & adjacent normal  tissues,TE12,KYSE510,KYSE450,KYSE410,KYSE150,COLO680N,KYSE180,,KYSe140,YES-2,KYSE30",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0021(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28602785"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, SGC7901/DDP, SGC7901,MKN45,MGC803,BGC823,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24931256"
  },
  {
    "miRNA_name": "miR-503",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "45gc(22 metastatic & 23 without metastatic) & 31 adjacent normal mucosa tissues,SGc7901,HGC27, AGS,MKN45,MGC803,NCI-N87,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated (in gc & metastatic gc tissues)",
    "significance": "p<0.01(gc vs normal & metastasis vs non metastasis tissues)",
    "detection_method": "qPCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24944699"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Poland",
    "sample_type": "Plasma",
    "sample": "Plasma samples from 56 patients and 70 healthy individuals",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0054, Specificity=76.8% and Sensitivity=60.7%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28405738"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "100 ESCC & 40 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic : AUC for plasma level = 0.835 , Prognostic : Kaplan-Meier analysis showed that patient with high miR-506 expression had significant shorter survival time then those with low miR-506 expression",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Expression of miRNA-506 in the plasma was closely associated with lymph node status (P=0.004), TNM stage (P=0.031), and tumor length (P<0.001",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27345473"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "141 GC cases",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low miR-506 expression significantly correlated with poorely differentiated type(p=0.015)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25707493"
  },
  {
    "miRNA_name": "miR-506",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Expression associated with tumor size,lymph node metastasis,primary tumors( all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26362716"
  },
  {
    "miRNA_name": "miR-508-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "MKN1,MKN7,MKN28,MKN45,AGS,KatoIII,NCI-n87,MGC-803,SGC-7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26801246"
  },
  {
    "miRNA_name": "miR-509-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "100 GC & 64 normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27697095"
  },
  {
    "miRNA_name": "miR-510",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.5",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-511",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "12 paired GC & normal  tissues,AGS, BGC823, MGC803, HGC-27,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114950"
  },
  {
    "miRNA_name": "miR-513",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.2",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-513a-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.31, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-513b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "74 GC & corresponding non malignant tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25095979"
  },
  {
    "miRNA_name": "miR-515-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-517a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "90 pairs of CRC and matched adjacent non-tumor tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall and disease-free survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High tumor invasion, lymph node metastases, distant metastasis and advanced TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27073521"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "15 matched tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21269950"
  },
  {
    "miRNA_name": "miR-518b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-low miR-518b expression were prognostic factor for PFS",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "miR-518b expression associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22958893"
  },
  {
    "miRNA_name": "miR-518e*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26819420"
  },
  {
    "miRNA_name": "miR-519a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519b-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519c-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-519d",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Lower miR-519d expression was associated with distant metastasis, lymph node metastasis and clinical stage for patients with GC",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28861156"
  },
  {
    "miRNA_name": "miR-519e*",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-520b",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27997901"
  },
  {
    "miRNA_name": "miR-520c",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "90 paired GC & adjacent non tumor tissues,N‐87, SGC‐7901, AGS, SNU‐16, MKN‐45,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High expression reduced OS(p=0.012) & DFS(p=0.015)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expression of miR‐520c had more lymph node metastasis (P = 0.019) and advanced TNM stage (P = 0.018)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28203525"
  },
  {
    "miRNA_name": "miR-520d-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues,SGC7901",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Lower expression of miR-520d-3p was associated with tumor invasion (P = 0.0357), lymph nodes metastasis (P = 0.0272), a higher clinical stage (P = 0.0041),",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25063221"
  },
  {
    "miRNA_name": "miR-520e",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27997901"
  },
  {
    "miRNA_name": "miR-522*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-523*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-524-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "15 tissues,MKN45,SGC7901,MGC803,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26998102"
  },
  {
    "miRNA_name": "miR-526c",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Recurrence vs nonrecurrence comparison (MSS only), Thirty-one of the 37 MSS samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold (log 2)=−0.7",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-526c",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Tumor and Normal adjacent tissue of 23 CRC patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21980324"
  },
  {
    "miRNA_name": "miR-532",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28356225"
  },
  {
    "miRNA_name": "miR-532-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "60 pairs tissues,HEEc,ECA109,EC9706,TE1,TE13,kyse410",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Low expression associated with tumor grade(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26323919"
  },
  {
    "miRNA_name": "miR-542-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(GC tissues),p<0.001(cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25432696"
  },
  {
    "miRNA_name": "miR-544a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Metastatic tumor samples and CRC cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27165435"
  },
  {
    "miRNA_name": "miR-548ah-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "5-FU Treated CRC cells (HT29, HCT116 and DLD1)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25526515"
  },
  {
    "miRNA_name": "miR-548c-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori negative cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-549",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-551a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, DES1,SGC7901,MKN28,HFE-145",
    "expression": "Downregulated",
    "expression_details": "Downregulated (gc tissues,SGC7901,MKN28)",
    "significance": "p<0.05(tissues,cell lines)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22469786"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "25 colorectal cancer patients, HT-29 cells treated with celecoxib",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "Microarray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with clinical stage, lymph node and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970014"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.3, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-552",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT-15, HT-29 and LoVo cells",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "micro RNA profiling followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers of the side population",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24898979"
  },
  {
    "miRNA_name": "miR-561",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 GC & adjacent tissues,SGC-7901, HGC-27, MKN-45, MGC-803, GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated   with TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27725860"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-564",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "8 pairs of GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28588702"
  },
  {
    "miRNA_name": "miR-566",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR, TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-5692b",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "55 pairs of ESCC & adjacent non neoplastic tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray, qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic: high expression of  miR-5692b associated with poor prognosis(p<0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis TNM/Stage",
    "tumor_size_details": "Expression was significantly associated with tumor size,depth of invasion and clinical tumor stage(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26888510"
  },
  {
    "miRNA_name": "miR-5704",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from 20 patients with colon adenoma, 20 patients with colon cancer  and 20 healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28427387"
  },
  {
    "miRNA_name": "miR-573",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "miR-573 correlated with preoperative chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "14 with & 5 without postoperative tumor samples,12 ESCC & adjacent normal epithelia",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis & Relapse : OS of patients with high expression of miR-574-3p better than with low expression(p=0.004)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Higher expression of miR-574-3p was inversely correlated with tumor relapse (p=0.029)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27565418"
  },
  {
    "miRNA_name": "miR-574-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Reduced miR-574-3p expr. Significantly associated with higher level of differentiation and early stage of cancer(p<0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-575",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-577",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "3o paired tissues,Cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01(tissues)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26622688"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Blood",
    "sample": "90 controls and 88 patients with bevacizumab-induced cardiotoxicity",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.0001",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Increased in bevacizumab-induced cardiotoxicity",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24515657"
  },
  {
    "miRNA_name": "miR-579",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-582-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC tissues compared with corresponding noncancerous tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26384136"
  },
  {
    "miRNA_name": "miR-584-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "GES-1,SGC7901,AGS,MKN45,MKN28",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28827574"
  },
  {
    "miRNA_name": "miR-584-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "75 paired surgical tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "RT-pCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Expression level had nrgative correlation with tumor size larger than 3cm",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28431583"
  },
  {
    "miRNA_name": "miR-590-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "50 paired tissues,SGC-7901, MKN-28, MKN-45, BGC-823, AGS,MGC-803,GES-1",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.0003(tissues),p<0.01( cell lines except AGS)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic- low expression had higher OS than high expression(p=0.025)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "Positive association with tumor size(p=0.012),lymoh node metastasis (p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27757042"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "196 samples in TNM stage I-III, 88 selected for deep sequencing",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Localization",
    "tumor_size_details": "Associated with tumors located in the right colon relative to the left colon and rectum",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-592",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "CRC serum and tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "--",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Associated with tumor size, TNM stage and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25661360"
  },
  {
    "miRNA_name": "miR-596",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Serum",
    "sample": "Serum samples from 30 patients for validation",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p= 0.0026",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictor of recurrence of early stage colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24400111"
  },
  {
    "miRNA_name": "miR-601",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma: AUC=0.747,  Sensitivity and specificity of 80.0% and 72.4%, respectively",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Thirty-three CRC tissue samples",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26885452"
  },
  {
    "miRNA_name": "miR-610",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "3 pairs of GC & corresponding adjacent non tumor tissues,MKN45,BGC823",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22189055"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HT29 and HCT116 CRC cells and tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Negatively correlated with occurance and metastasis",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26158514"
  },
  {
    "miRNA_name": "miR-612",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "High in metastatic tissues than in non",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28656264"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "60 pair tissues,75 serum from ESCC and healthy subjects",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001(tissues,serum)",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic- low serum level(AUC-0.767+-0.040,sensitivity-81.3%,specificity-62.7%),prognostic-worse OS(p=0.018) ,PFS(p=0.035) and p=0.006(multivariate analysis)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Tissue expression reduced with T stage increase (p=0.008),low serum level associates with N stage(p=0.038)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26499784"
  },
  {
    "miRNA_name": "miR-613",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28701053"
  },
  {
    "miRNA_name": "miR-615-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "196 samples in TNM stage I-III, 88 selected for deep sequencing",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Localization",
    "tumor_size_details": "Associated with tumors located in the right colon relative to the left colon and rectum",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23824282"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues and cell line",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Lower in metastatic CRC tissues compared with non metastatic",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26333174"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Serum",
    "sample": "42 pairs of tumor and adjacent non-tumor tissues, and in serum samples of 117 patients and 90 control subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Sensitivity of 87.5% and specificity of 63.5%",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28404964"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27501502"
  },
  {
    "miRNA_name": "miR-622",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "57 pair matched gastric neoplastic & adjacent non neoplastic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Lower expression of miR-622 associated with differentiation and lymphativ metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21528065"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0049",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "Defective DNA mismatch repair (dMMR) vs. Proficient DNA mismatch repair (pMMR), tumors (n = 80) and normal colon tissue (n = 28)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19922656"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "96 pairs of primary CRC and their corresponding adjacent nontumor tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Decereased expression of miR-625 was positively associated with poor overall survival and an unfavorable prognosis for CRC patients",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Decereased expression of miR-625 was positively associated with advanced lymph node metastasis and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23861214"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "158 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCr",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression correlated with tumor depth(p=0.002),tunor stage(p=0.003),metastasis(p=0.002)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24508466"
  },
  {
    "miRNA_name": "miR-625",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic-HR=3.72,95% CI:1.36-8.78,p=0.005",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Low expression correlated with lymph node metastasis(p=0.01),distant metastasis(p=0.007),tumor differentiation(p=0.04),advanced TNM(p=0.005)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26309624"
  },
  {
    "miRNA_name": "miR-625-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue Cell-line",
    "sample": "94 mCRC patients treated first-line with XELOX",
    "expression": "Upregulated",
    "expression_details": "Upregulated in non responders",
    "significance": "Fold Change = 2.7, p = 0.011",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23506979"
  },
  {
    "miRNA_name": "miR-628-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-628-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Norway",
    "sample_type": "Tissue",
    "sample": "Eight patients were randomly selected according to gender specifications (males only) from a colorectal cancer cohort.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "High throughput sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22529906"
  },
  {
    "miRNA_name": "miR-628-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "206 patients who underwent surgery",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall surviva",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Associated with tumor invasion, lymph node metastasis, distant metastasis, and tumor-node-metastasis (TNM) stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24981248"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "44 ESCC & adjacent normal tissues,HEEc,ECA109,TE1,EC9706,KYSE70,KYSE3o",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : low miR-630 expression was correlated with poor OS in patients with ESCC(p=0.000)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-630 expression was found to be correlated with tumor range,lymphatic metastasis,pathological stge( all p=0.000)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27563011"
  },
  {
    "miRNA_name": "miR-630",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "236 gc, matched adjacent normal & 18 cases normal control tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic : independent prognostic factor for overall survival(log rank test,p<0.001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Elevated miR-630 expression was associated with T3 and T4 stage(p=0.007),positive lymph node(p<0.001),distant metastasis(p=0.002),advanced TNM(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24621930"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "66 pairs of ESCC & normal tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28108314"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24623314"
  },
  {
    "miRNA_name": "miR-638",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "64 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.0045",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage",
    "tumor_size_details": "Expression not significantly asociated with tumor location,size,stage & grading(p>0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26250158"
  },
  {
    "miRNA_name": "miR-640",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.32, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-645",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "43 pair of AGEJ & t gastric cardiac non cancer tissues,SGC7901,BGC823",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05(AGEJ tissues),SGC7901,BGC823(p<0.001)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size",
    "tumor_size_details": "Tumor size greater than or equal to 5cm group had significant increased miR-645 expression as compared to tumor size less than 5cm group(p=0.045)",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25174799"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "70 GC and adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "Low expression associated with tumor size(p=0.012), TNM stage(p=0.007)  lymph node metastasis(p=0.007) and distant metastasis(p=0.028)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28098914"
  },
  {
    "miRNA_name": "miR-647",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "109 GC patients,MGC 80-3, MKN45, SNU-5, AGS and KATOIII",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Multivariate Cox regression analysis indicated that low-level expression of miR-647 was an independent prognostic factor for predicting poor survival of GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "A strong correlation between miR-647 expression and TNM stage (p=0.0020), lymph-node metastasis (p=0.0046) and local invasion (p=0.0062)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28900514"
  },
  {
    "miRNA_name": "miR-652",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "26 healthy controls, 16 patients with large adenomas, and 45 patients with CRC.",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "AUC=0.868, p<0.05",
    "detection_method": "screening by microfluidic array technology followed by validation",
    "marker": "Diagnostic and Screening",
    "marker_details": "To distinguish polyps from controls",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24022433"
  },
  {
    "miRNA_name": "miR-655",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "34 paired tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Associated with lymph node metastasis, tumor diffrentiation,TNM stage(all p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24314023"
  },
  {
    "miRNA_name": "miR-660-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from five CRC patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Deep sequencing",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25013489"
  },
  {
    "miRNA_name": "miR-663",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HEK-293,HUVEC,GES-1,BGC-823,SNU-5,MKN-45",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20514450"
  },
  {
    "miRNA_name": "miR-663b",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-664-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Tumor samples from patients with mCRC treated with first line CAPEOX and bevacizumab , n = 121",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Improved outcome in the CAPEOXBEV cohorts and showed a significant interaction with bevacizumab effectiveness",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25329796"
  },
  {
    "miRNA_name": "miR-6826",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Overall survival (p=0.003, hazard ratio, 3.67)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers for a poor response to vaccine treatment",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-6875",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Plasma",
    "sample": "93 Plasma samples from patients prior to vaccine treatment and vaccine treated",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Overall survival (p=0.003, hazard ratio, 3.67)",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictive biomarkers for a poor response to vaccine treatment",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27878288"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "196 CRCs and 14 normal mucosae",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Overall survival p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with tumour depth, venous invasion, lymphatic invasion, lymph node metastasis, and liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27919977"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "105 ESCC & 30 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC grp and CRT resistant grp)",
    "significance": "p<0.01(healthy subjects vs. ESCC grp),p<0.05(CRT sensitive vs. CRT resistant grp)",
    "detection_method": "N/A",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnostic & Prognostic   : AUC-0.841, miR-7 serum level is an non-invasive  biomarker of diagnosis  and predicting treatment responses to concurrent chemo-radiation therapy",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "ESCC patients with higher miR-7 level were much more sensitive to CRT",
    "tumor_size": "Tumor-size Metastasis",
    "tumor_size_details": "miR-7 correlates with tumor length and status of lymph node metastasis(p<0.05)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26708917"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "85 ESCC & normal samples",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prosnostic",
    "marker_details": "Prognosis : low miR-7 expression were associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28314263"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "106 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "ISH,qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26261179"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "23 patients tissues,MGC803,MKN45,SGC7901,NCI-N87,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05(cell lines,moderetly and poorly differentiated gc tissues",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24573489"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "30 paired gs & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28693382"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=3.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-7",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "128 patients with colorectal cancer (63 cases) or adenoma (65 cases)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - more significant markers in cancers than in adenomas",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20094072"
  },
  {
    "miRNA_name": "miR-718",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 ESCC & 51 healthy plasma",
    "expression": "Downregulated",
    "expression_details": "Downregulated (ESCC plasma, Upregulated expression in postoperative plasma than in preoperative)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic : -plasma miR-718 AUC of 0.715,0.689 and 0.620 for detection of ESCC patients ,early patients with Tis-T1 or early patient with TNM 0-1 respectively",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis TNM/Stage",
    "tumor_size_details": "Plasma miR-718 expression level was inversely correlated with lymph node metastasis and TNM stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26756617"
  },
  {
    "miRNA_name": "miR-7-2*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.30, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "96 CRC tissues, HCT116 and SW480",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Correlated with poorer five year survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis Tumor-size",
    "tumor_size_details": "Correlated with tumor size, TNM stage, lymphatic metastasis and distant metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25286763"
  },
  {
    "miRNA_name": "miR-720",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Serum",
    "sample": "Serum (Venous blood samples were collected from the CRC patients (n=114) and non-cancer patients (n=32))",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Decreased after surgery. p=0.0004, and p=0.0274, respectively",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "High expression of miR-720 was significantly associated with lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26134152"
  },
  {
    "miRNA_name": "miR-744",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low expression correlated with lymph node metastasis, invasive depth and TNM staging in gastric cancer patients",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28791400"
  },
  {
    "miRNA_name": "miR-760",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Plasma: AUC=0.788, Sensitivity and specificity of 69.2% and 72.4%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive diagnostic marker for early detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22970209"
  },
  {
    "miRNA_name": "miR-765",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "HCT116 and HT-29",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "For predicting the response of CRC to preoperative chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27903980"
  },
  {
    "miRNA_name": "miR-768-5p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "20 GC & adjacent normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22683180"
  },
  {
    "miRNA_name": "miR-802",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Tissue",
    "sample": "Biopsies from 147 rectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p<0.05",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Correlation of all four with overall survival and cancer-specific survival (p < 0.05)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27092493"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "80 pairs of GC & adjacent normal gastric tissues,AGS,BGC823,MKN28,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "miRNA-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25596740"
  },
  {
    "miRNA_name": "miR-874",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "75 pairs of GC & non cancerous tissues,cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-RT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23800944"
  },
  {
    "miRNA_name": "miR-885-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "66 patients with metastatic CRC, primary tumors and their corresponding liver metastases",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p≤0.0001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27365381"
  },
  {
    "miRNA_name": "miR-886-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Blood",
    "sample": "138 patients with mCRC in 3rd line therapy with cetuximab and irinotecan in a prospective phase II study",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "TaqMan MicroRNA Array v2.0",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24940606"
  },
  {
    "miRNA_name": "miR-886-3p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=5.5, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-886-5p",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=26.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "25 CRC samples from 10 CRC patients with liver metastasis and 15 CRC patients without distant metastasis",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Expression of miR-9 in CRC with metastases was significantly higher than its Expression in CRC without metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21562850"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissue (cancer tissues and adjacent normal tissues from 38 patients)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with a poor clinical outcome",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25940709"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510,KYSE410,KYSE520",
    "expression": "Upregulated",
    "expression_details": "Upregulated except in EC109)",
    "significance": "p=0.0016(tissues),p<0.001(EC18,HKESC1,KYSE30,KYSE140,KYSE180,KYSE510),p<0.05(kyse410,KYSE520)",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Upregulation associated  clinical progression(p=0.022),lymph node metastasis(p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25375090"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "131 ESCC & 131 healthy plasma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.01",
    "detection_method": "RT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognosis : high plasma miR-9 had poor survival(p<0.001)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Tumor-size TNM/Stage Metastasis",
    "tumor_size_details": "High plasma miR-9 level were significantly associated with poor tumor differentiation(p=0.022),large tumor size(p=0.007),deep local invasion(p=0.003),lymph node metastasis(p=0.005),advanced clinical stage(p<0.001)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28587538"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "3 normal gastric & 24 malignant  tissues,SGC7901,GES-1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "microarray,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19531230"
  },
  {
    "miRNA_name": "miR-9",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "86 cases for GC & adjacent non neoplatic tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p=0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-9 expressionwas significantly lower in GC with deeper invasion(p<0.001),lymph node metastasis(p<0.001),distant metastasis(p=0.022),advanced TNM(p=0.01)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23383271"
  },
  {
    "miRNA_name": "miR-9*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-9-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Primary colon tumors (n = 50) and adjacent normal tissues (n = 50)",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR and Methylation specific PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Methylation of  miR-9-1 was associated with the presence of lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19521961"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Denmark",
    "sample_type": "Tissue",
    "sample": "Normal vs MSS comparison, 10 normal mucosa samples and 49 stage II colon cancers differing with regard to microsatellite status (MSI or MSS) and recurrence of disease.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold (log 2)=1.3",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/18676867"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma of 25 patients with CRC and 20 healthy controls.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0005, sensitivity was 89% and the specificity was 70%",
    "detection_method": "MicroRNA profiling and qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19201770"
  },
  {
    "miRNA_name": "miR-92",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "Surgically resected colorectal cancer tissues and corresponding non cancerous tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19287964"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Taiwan",
    "sample_type": "Tissue Plasma Stool",
    "sample": "Tissue, stool, and plasma;  62 tissue, 447 stool, and 398 plasma samples were collected from CRC patients and healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.907",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26848774"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC= 0.838, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue Stool",
    "sample": "Two hundred six CRC patients and 134 healthy volunteers, feces as well as frozen tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/20959518"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Finland",
    "sample_type": "Tissue",
    "sample": "Primary tumors from 55 metastatic CRC patients, including 15 with mutant and 40 with wild-type KRAS",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.04",
    "detection_method": "Microarrray and qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21922590"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Stool",
    "sample": "Stool samples were collected from 88 patients with CRC, 57 patients with colorectal polyps and 101 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001, sensitivity of 71.6% and specificity of 73.3%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Diagnosttic/Screening marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21930727"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "82 patients with colorectal carcinomas",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "High miR-92a expression had a poor overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Correlated with advanced clinical stage, lymph node metastases, and distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22772712"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "100~sera of patients with CRC and 30 sera of healthy donors",
    "expression": "No Significant Difference",
    "expression_details": "No significant difference",
    "significance": "p>0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "An evidence against usage of serum miR-17-3p, miR-29a, miR-92a and miR-135b as new biomarkers for early detection of CRC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23568010"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from 200 CRC patients, 50 advanced adenoma patients, and 80 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "AUC=0.786 , p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Non-invasive diagnostic marker for early detection of CRC, and prognostic indicator: high miR-92a expression in CRC was independently associated with poor survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23625654"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Germany",
    "sample_type": "Plasma",
    "sample": "130 CRC patients, 50 advanced adenoma patients and 244 neoplasm-free controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p= 0.004",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23690963"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Upregulation correlated with lymph node metastasis((p=0.001),TNm(p=0.049)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21148309"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "105 surgical tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Positive correlation of miR-92a with clinical stage(p=0.022)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24360091"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "miRNA-LNA in situ hybridization",
    "marker": "Prognostic",
    "marker_details": "Prognosis: high miR-92a expression, tumor stage, tumor status, node status, and tumor size were significant negative prognostic predictors for overall survival in patients with GC (P < 0.001, P < 0.001, P = 0.008, P < 0.001, and P = 0.001, respectively)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26790436"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.0, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-92a",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-92a-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in adenocarcinomas vs. adenomas, 55 patients with colorectal tumours (30 adenomas and 25 adenocarcinomas)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-92a-1",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Netherlands",
    "sample_type": "Tissue",
    "sample": "Expression in CRC vs. controls, 55 colorectal tumours (30 adenomas and 25 adenocarcinomas) and 10 controls (normal colorectal epithelium).",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=4.5, p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19672269"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "Fifty-seven patients. Tissues vs. stroma",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.0001",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "No significant association",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "No significant association",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25143946"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Stool",
    "sample": "Fecal samples (Twenty CRC patients and 20 age/sex-matched healthy volunteers)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Surgery",
    "therapy_details": "Decreased after curative surgery",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25989926"
  },
  {
    "miRNA_name": "miR-92a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-92b-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Austria and Czech Republic",
    "sample_type": "Tissue",
    "sample": "Cancerous tissue of 332 histologically confirmed colorectal cancer patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Strong predictors of survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27601590"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line",
    "sample": "HCT-8 and HCT-116",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Downregulated by 5-Fluorouracil and/or oxaliplatin",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19956872"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 paired samples of tumoral and nontumoral colon tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated closely with poor overall survival in patients with colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Low miR-93 expression was significantly correlated with advanced tumor stage, positive nodal metastasis, and positive distant metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23354160"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Mouse Model",
    "sample": "Ulcerative colitis related colorectal cancer , mouse model",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24144030"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Intercontinental (Europe and USA)",
    "population": "Italy and USA",
    "sample_type": "Tissue",
    "sample": "66 Italian patients with or without lymph nodes and/or liver recurrences, 16 American metastatic patients",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "RNA microarray and Taqman array followed by qRT-PCR, TMA and In-situ Hybridization",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Metastatic marker",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24921248"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "BE and EAC",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "22 normal epithelia,24BE,22EAC tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (EAC compared to NE & BE)",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19422085"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "Iran",
    "sample_type": "Tissue",
    "sample": "30 ESCC and 30 margin ESCC",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.034",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26427659"
  },
  {
    "miRNA_name": "miR-93",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "GC & paired normal tissues,GSRCC & non- GSRCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "miRNA-array",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26742429"
  },
  {
    "miRNA_name": "miR-935",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "Tissues, cell lines",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044823"
  },
  {
    "miRNA_name": "miR-93-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue",
    "sample": "1,894 carcinoma tissue and 1,599 normal mucosa",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Agilent Human miRNA Microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Distinguish Colorectal Carcinoma and Normal Colonic Mucosa.",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26963002"
  },
  {
    "miRNA_name": "miR-938",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-939",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Cell-line Tissue",
    "sample": "Cell lines-AGS, BGC-823, HGC-27, MGC-803, MNK-45,SGC-7901 ,GES-1,tissues-one cohort of 112 GC Patients with stage I-III disease who underwent surgery followed by adjuvant chemotherapy; and another cohort of 110 GC patients with stage IV disease who received palliative chemotherapy",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01( gc vs adjacent normal and recurrence vs non recurrence group)",
    "detection_method": "qRT-PCR,qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Promising predictive value of miR-939 expression regarding GC chemotherapy response (AUC =0.777, P < 0.001)",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28114937"
  },
  {
    "miRNA_name": "miR-9-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "100 matched tissues,HGC27,MGC803,BGC823,SGC7901,GES1",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Low expression correlated with higher lymph node metastasis incidence(p=0.004)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28418879"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Hong Kong",
    "sample_type": "Plasma Tissue",
    "sample": "30plasma initial set & 80 plasma in validation set,34 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.0001(plasma), p=0.0015( tissues)",
    "detection_method": "N/A",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: plasma-miR-940",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26456959"
  },
  {
    "miRNA_name": "miR-940",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "38 paired tissues and GES-1,SNU16,MKN87,KATOIII,SGC7901,SNU216,MKN28,MGC803,HGC27",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with poor prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "High expression correlated with advanced N stage(p=0.007)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/26317898"
  },
  {
    "miRNA_name": "miR-942",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "10 pairs tissues,TCGA data,NEEC1,NEEC2,EC18,HKESC1,TE1,KYSE520,EC9706,KYSE510,KYSE180,108CA,ECA109,KYSe410,KYSE30",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p=0.002(TCGA),p<0.05(cell lines)",
    "detection_method": "qRT-PCR,microarray(TCGA)",
    "marker": "Prognostic",
    "marker_details": "Prognostic: lower expression had longer survival time",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Expression level had positive correlation with clinical stage(p<0.001),TNM(T:p=0.005,N:p<0.001,M:p=0.004),histological differentiation(p=0.045)",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25844602"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "CRC Tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Corrrelated with prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28498456"
  },
  {
    "miRNA_name": "miR-944",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 paired GC & matched normal tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28680805"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Stool",
    "sample": "Stool from 60 individuals (20 controls, 20 with tumor-lymph node-metastatic",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic - Non invasive markers to screen for sporadic human colon cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23741026"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma samples from healthy individuals and CRC patients (stages I–IV), 187 CRC cases and 47 healthy controls",
    "expression": "Upregulated",
    "expression_details": "All CRC patients had higher miR-96 levels than did controls (P = 0.003)",
    "significance": "AUC=0.74",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "Early Diagnosis: Higher expression in stage I-II than control (p=0.003). Distinguished stage I-IV CRC from healthy controls, Prognosis-overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26863633"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "52 cases of primary CRC and corresponding normal mucosal tissue",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.05",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Correlated with liver metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22844381"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue Serum",
    "sample": "56 individuals (30 stage III CRC patients and 26 healthy individuals)",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "Microarray followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23673725"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Greece",
    "sample_type": "Tissue",
    "sample": "108 primary colorectal adenocarcinoma samples and 54 paired non-cancerous colorectal tissue specimens",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Predicts poor disease-free and overall survival",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Associated with advanced stages",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27044381"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "EC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "145 tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy and Radiotherapy",
    "therapy_details": "Induces chemo or radio resistance by downregulating RECK in EC",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25465153"
  },
  {
    "miRNA_name": "miR-96",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=9.1, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-96-5p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Eurasia",
    "population": "Turkey",
    "sample_type": "Tissue",
    "sample": "54 patients diagnosed with CRC and normal colon tissue samples of 42 healthy controls",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=29.9234, p=0.01098",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25925209"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "Colorectal Adenomas",
    "continent": "Europe",
    "population": "UK",
    "sample_type": "Plasma",
    "sample": "Plasma samples, 210 patients were included (117 with polyps, 12 with cancer, 81 healthy controls [FOBt positive])",
    "expression": "Differential Expression",
    "expression_details": "Differential expression",
    "significance": "p=0·0266",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26312830"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "40 tissues",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "p<0.01",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "Expression of miR-98 was significantly correlated with pathological grade, tumor stage and lymph node metastasis",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22867052"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Cell-line",
    "population": "Cell-line",
    "sample_type": "Cell-line",
    "sample": "TE1,ECA109,EC9706,EC9706R,KYSE30,KYSE150,KYSE450",
    "expression": "Downregulated",
    "expression_details": "Downregulated (radioresistant cell lines)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Radiotherapy",
    "therapy_details": "Upregulation of miR-98 increases radiosensitivity of ESCC cells, radiosensitivity in descending order: EC9706,KYSE30,KYSE450,TE1,ECA109,KYSE150",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27422937"
  },
  {
    "miRNA_name": "miR-98",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=2.4, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miR-99a",
    "cancer": "Esophageal Cancer",
    "cancer_subtype": "ESCC",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue Cell-line",
    "sample": "101 surgical tissues,3ESCC cell lines",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23292834"
  },
  {
    "miRNA_name": "miR-99a*",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Tissue",
    "sample": "20 patients who underwent neoadjuvant chemoradiotherapy for advanced rectal cancer",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responsers",
    "significance": "p<0.05",
    "detection_method": "TaqMan Low Density Arrays",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "Involved in response of rectal cancer to the chemoradiotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23167930"
  },
  {
    "miRNA_name": "miR-99a-3p",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Spain",
    "sample_type": "Tissue",
    "sample": "Tumor tissue samples of 78 patients with metastatic CRC",
    "expression": "Upregulated",
    "expression_details": "Upregulated in responders",
    "significance": "p=0.027",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Associated with Progression-free survival (PFS) and disease free survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Predicts chemotherapy response",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25197016"
  },
  {
    "miRNA_name": "miR-99b-3p",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "28 H.Pylori positive  & 24 H.pylori negative cancer tissues",
    "expression": "Upregulated",
    "expression_details": "Upregulated (H.pylori positive cancer tissues)",
    "significance": "p<0.05",
    "detection_method": "TaqMan miRNA assay",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/25167801"
  },
  {
    "miRNA_name": "miR-l195",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "12 pairs of colorectal cancer tissue and normal colonic mucosa",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "FDR value < 5%",
    "detection_method": "microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/21826996"
  },
  {
    "miRNA_name": "miRPlus-A1087",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=7.6, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-C1110",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.38, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1016",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Fold Change=10.9, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1033",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1067",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.13, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1101",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.43, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1172",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.47, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1173",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.37, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1192",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.39, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1238",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.36, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-E1285",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.38, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1026",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.42, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1027",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.32, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1155",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.43, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "miRPlus-F1215",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "6-paired rectal cancers and normal tissues.",
    "expression": "Downregulated",
    "expression_details": "Downregulated",
    "significance": "Fold Change=0.49, p<0.05",
    "detection_method": "miRCURY™ Array LNA miRNA chip",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22576798"
  },
  {
    "miRNA_name": "Panel (Let-7c miR-99a miR-125b)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Italy",
    "sample_type": "Tissue",
    "sample": "183 mCRC cases from 2 independent cohorts (cohort 1: 74 cases; validation cohort: 109 cases) treated with cetuximab or panitumumab",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "miRNA arrays",
    "marker": "Prognostic",
    "marker_details": "Associated with  significantly longer progression-free survival and longer overall survival",
    "therapy": "Chemotherapy",
    "therapy_details": "Signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "tumor_size": "Metastasis",
    "tumor_size_details": "Signature for metastatic colorectal cancer patients treated with anti-EGFR therapy",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24503111"
  },
  {
    "miRNA_name": "Panel (miR 21,135a, 335, 206 and let-7a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "North America",
    "population": "Canada",
    "sample_type": "Tissue",
    "sample": "15 primary tumours with adjacent normal tissue from patients that were disease-free at 4 years (cohort A) and 19 paired primary tumours with corresponding liver metastases (cohort B)",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "Specificity of 87% and sensitivity of 76% for the presence of metastases",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic indicator for presence of metastasis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "Metastasis",
    "tumor_size_details": "For detecting the presence of metastases",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22120473"
  },
  {
    "miRNA_name": "Panel (miR-1, miR-9, miR-124, and miR-137)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "387 colorectal tissue specimens, collected from 238 patients with UC (152 without neoplasia, 17 with dysplasia, and 69 with UC-associated colorectal cancer,validation study of samples from 90 patients without UC and 61 patients with UC-associated dysplasia or cancer",
    "expression": "Downregulated",
    "expression_details": "Increased methylation",
    "significance": "AUC=0.78",
    "detection_method": "bisulfite pyrosequencing analysis",
    "marker": "Diagnostic",
    "marker_details": "Biomarkers for Identifying High-Risk Patients with Ulcerative Colitis-associated Colorectal Cancer",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/28847750"
  },
  {
    "miRNA_name": "Panel (miR-107, miR-21, miR-196a,\nmiR-26b, miR-9, miR-142-3p, miR-30b, miR-150, miR-191 and miR-17)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Japan",
    "sample_type": "Tissue",
    "sample": "161 GC & adjacent normal tissues(for miR-107 real time pcr) and 5 pairs of GC & adjacent normal for panels of miRNA expression study",
    "expression": "Upregulated",
    "expression_details": "Upregulated (all Upregulated but miR-107 had highest Upregulatedregulation)",
    "significance": "p<0.001",
    "detection_method": "qRT-PCR based miRNA array,Real timT-PCR",
    "marker": "Prognostic",
    "marker_details": "Prognostic for miR-107worse survical rates with OS(P=0.002) and DFS(P=0.017)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "miR-107 showed significant association with depth of tumor invasion,lymph node metastasis and stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22407237"
  },
  {
    "miRNA_name": "Panel (miR-145, miR-106a and miR-17-3p)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum from pre- and post-operative CRC patients and normal subjects, 175 stage II/III CRC patients",
    "expression": "N/A",
    "expression_details": "N/A",
    "significance": "p=< 0.0001, AUC=0.886, AUC=0.85",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Shorter disease-free survival (DFS) (P < 0.0001 for miR-17-3p and P = 0.001 for miR-106a)",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26250939"
  },
  {
    "miRNA_name": "Panel (miR-16, miR-590-5p and miR-153)",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "To predict complete vs. incomplete response to neoadjuvant CRT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  },
  {
    "miRNA_name": "Panel (miR-16,miR-25,miR-92a,miR-451,miR-486-5p)",
    "cancer": "Gastric Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Gastric non cardia adenocarcinoma;GNCA, plasma: training set(40 GNCA & 40 control), validation set(48 GNCA & 102 control)",
    "expression": "Upregulated",
    "expression_details": "Upregulated (in GNCA plasma)",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic: miR-16,miR-25,miR-92a,miR-451,miR-486-5p panel in plasma is potential biomarker for early detection of GC",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24595006"
  },
  {
    "miRNA_name": "Panel (miR-193a-3p, miR-23a and miR-338-5p)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Malaya",
    "sample_type": "Tissue",
    "sample": "Paired cancer tissues (n = 30) and blood samples (CRC, n = 70; control, n = 32)",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.887, 80.0% sensitivity, 84.4% specificity and 83.3% accuracy",
    "detection_method": "microarray followed by qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23758639"
  },
  {
    "miRNA_name": "Panel (miR-19a-3p, miR-223-3p, miR-92a-3p and miR-422a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum,307 colorectal adenocarcinoma patients, 164 colorectal adenoma patients and 226 healthy controls.",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.810",
    "detection_method": "Miseq sequencing followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage",
    "tumor_size_details": "Could differentiate stage I/II CAC from controls and adenoma from carcinoma",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/25233400"
  },
  {
    "miRNA_name": "Panel (miR-200c and miR-18a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "Plasma from 78 patients with 86 healthy volunteers",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "Combined AUC of 0.839 with 84.6% sensitivity and 75.6% specificity",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Diagnostic marker",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24649179"
  },
  {
    "miRNA_name": "Panel (miR-20a, miR-130, miR-145, miR-216 and miR-372)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum of 253 patients who had chemotherapy treatment",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC= 0.841 and 0.918 for the two sets of serum samples",
    "detection_method": "TaqMan low-density arrays followed by qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Predictor to response to  chemotherapy",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24304648"
  },
  {
    "miRNA_name": "Panel (miR-21, let-7g, miR-31, miR-92a, miR-181b, and miR-203)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Serum",
    "sample": "Serum samples from 83 CRCs and 59 controls in validation set",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.923",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Non invasive biomarker for diagnosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24709885"
  },
  {
    "miRNA_name": "Panel (miR-21, miR-29c, miR-122, miR-192, miR-346, miR-372, and miR-374a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Plasma",
    "sample": "Plasma, Test cohort of 120 patients and validation cohort of 150 patient",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "CRC and colorectal adenomas= 86% to 90% accuracy",
    "detection_method": "microfluidic array technology",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27471839"
  },
  {
    "miRNA_name": "Panel (miR-21,miR-143, miR-148a, miR-194, miR-192, miR-200b, miR-200c, miR-10b, miR-26a, miR-145)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "USA",
    "population": "USA",
    "sample_type": "Tissue Cell-line",
    "sample": "48 pairs of samples (CRC and adjunct region normal tissues) and cell line",
    "expression": "Differential Expression",
    "expression_details": "Dysregulated",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26646696"
  },
  {
    "miRNA_name": "Panel (miR-21-5p, miR-20a-5p, miR-103a-3p, miR-106b-5p, miR-143-5p, and miR-215)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "138 patients with stage II colon cancer, Tissues",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic and Prognostic",
    "marker_details": "To classify patients at high risk of disease progression from those at low risk",
    "therapy": "Chemotherapy",
    "therapy_details": "High-risk group were found to have a favourable response to adjuvant chemotherapy",
    "tumor_size": "Recurrence",
    "tumor_size_details": "Predictive tool for disease recurrence in patients with stage II colon cancer",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/24239208"
  },
  {
    "miRNA_name": "Panel (miR-23a-3p, miR-27a-3p, miR-142-5p and miR-376c-3p)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Czech Republic",
    "sample_type": "Serum",
    "sample": "427 colon cancer patients and 276 healthy donors, Serum",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.922, Sensitivity=89% and specificity=81%",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early diagnostic and prognostic panel",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27485599"
  },
  {
    "miRNA_name": "Panel (miR-23b, miR-365-1 and miR-365-2)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "N/A",
    "population": "TCGA Data",
    "sample_type": "TCGA Dataset",
    "sample": "253 samples from TCGA Dataset",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "N/A",
    "marker": "Prognostic",
    "marker_details": "Associated with Prognosis",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26269151"
  },
  {
    "miRNA_name": "Panel (miR-29a and miR-92a)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "120 CRC and 37 advanced adenomas,  Fifty-nine age-matched healthy subjects",
    "expression": "Upregulated",
    "expression_details": "Upregulated",
    "significance": "p<0.001, AUC=0.883, Sensitivity=83.0% and Specificity=84.7%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Novel noninvasive biomarkers for early detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/19876917"
  },
  {
    "miRNA_name": "Panel (miR-342-3p, miR-361-3p, and miR-3621)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "Korea",
    "sample_type": "Tissue",
    "sample": "20 T1-stage CRC samples, FFPE tissue sections",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.947, 4% sensitivity, 85% specificity and 89% accuracy",
    "detection_method": "qRT-PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "TNM/Stage Metastasis",
    "tumor_size_details": "For predicting LNM in T1 stage",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/27096956"
  },
  {
    "miRNA_name": "Panel (miR-375, miR-424 and miR-92a)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "FFPE colorectal tissue samples from 91 surgical resections",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.968,  accuracy of 94.1%",
    "detection_method": "qRT-PCR",
    "marker": "Diagnostic",
    "marker_details": "Classifier : To discriminate carcinomas from adenomas",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22535378"
  },
  {
    "miRNA_name": "Panel (miR-409-3p, miR-7, and miR-93)",
    "cancer": "Colorectal Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Plasma",
    "sample": "80 plasma samples for microarray and 161 training and validation plasma samples by real time PCR",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "AUC=0.897",
    "detection_method": "qRT-PCR",
    "marker": "Prognostic",
    "marker_details": "Early Detection",
    "therapy": "N/A",
    "therapy_details": "N/A",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/23456911"
  },
  {
    "miRNA_name": "Panel (miR-4299 and miR-196b)",
    "cancer": "Colon Cancer",
    "cancer_subtype": "",
    "continent": "Asia",
    "population": "China",
    "sample_type": "Tissue",
    "sample": "Fresh biopsies, 126 patients with colon cancer",
    "expression": "Panel",
    "expression_details": "Signature",
    "significance": "AUC=0.877",
    "detection_method": "with laser capture microdissection and qRT- PCR",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemotherapy",
    "therapy_details": "Discriminating chemoresistant colon cancer",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "http://www.ncbi.nlm.nih.gov/pubmed/26626874"
  },
  {
    "miRNA_name": "Panel (miR-519c-3p and miR-561)",
    "cancer": "Rectal Cancer",
    "cancer_subtype": "",
    "continent": "Europe",
    "population": "Ireland",
    "sample_type": "Tissue",
    "sample": "12 pre-treatment FFPE rectal tissues",
    "expression": "Panel",
    "expression_details": "N/A",
    "significance": "N/A",
    "detection_method": "Microarray",
    "marker": "N/A",
    "marker_details": "N/A",
    "therapy": "Chemoradiotherapy",
    "therapy_details": "To predict good vs. poor response to neoadjuvant CRT",
    "tumor_size": "N/A",
    "tumor_size_details": "N/A",
    "reference": "https://www.ncbi.nlm.nih.gov/pubmed/22903298"
  }
]